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Abstract
Type 2 diabetes is associated with neurocognitive deficits and increased risk for dementia,
with high prevalence of diabetes occurring in old age. There are many known risk factors for
diabetes, including physical inactivity, obesity, and prediabetes. Studies show that
individuals who are at risk for diabetes (i.e., have one or more risk factors) already
experience some brain deficits seen in diabetes. One way to combat these deficits is aerobic
exercise; however the effects of resistance exercise in this population are relatively unknown.
The objectives of this thesis were to report on the current evidence of brain deficits in
prediabetes, and to assess the feasibility and preliminary efficacy of resistance training to
improve cognition and brain health (structure and function) in older adults at risk for
diabetes. A systematic review of cross-sectional and longitudinal studies assessing brain
deficits in prediabetes was conducted, as well as a 26-week pilot feasibility randomized
controlled trial (RCT) of resistance exercise among older adults at risk for diabetes (i.e.,
those living with prediabetes and/or obesity). The systematic review found that prediabetic
adults may experience deficits in structural connectivity, but whether deficits in brain volume
and cerebrovascular health are present is somewhat inconclusive and may be due to
inconsistencies across study methodologies. Results from the pilot feasibility RCT found that
resistance exercise, compared to a balance and stretching exercise control group, may
improve selective cognitive functions, mainly task-switching, selective attention and conflict
resolution, and item memory. Resistance exercise also led to less age-related decline in total
brain volume, less hippocampal atrophy, and increased functional activation patterns that
mimic that of younger adults and healthy older adults. When assessing feasibility, study
adherence, retention, and self-reported enjoyment were high, but recruitment was shown to
be challenging. As such, important recruitment recommendations for improving future trials
are included in this thesis. In conclusion, resistance exercise may lead to some improvements
in cognition and brain health in older adults at risk for diabetes, however a full-scale,
powered RCT is needed to further explore these possible effects.
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Summary for Lay Audience
Type 2 diabetes is a leading cause of disability among older adults and is associated with
brain and cognitive deficits. Individuals who have one or more risk factors for diabetes
including physical inactivity, obesity, or prediabetes (the state of having elevated blood sugar
levels that are below the diabetes threshold) already show signs of similar impairment.
Aerobic exercise, which aims to enhance cardiovascular function, is known to improve
cognition and brain health (structure and function) in this population; however, the effects of
resistance exercise, which aims to build muscle mass, are relatively unknown. The objectives
of this thesis were to summarize the results from studies published to date regarding the brain
deficits associated with prediabetes, and to determine whether resistance training may benefit
cognition and neuroimaging outcomes in older adults at risk for diabetes (i.e., prediabetics
and/or overweight or obese individuals) compared to balance and stretching exercises. The
literature review found that studies assessing brain deficits in prediabetes have yielded
largely mixed results, however deficits in structural connectivity may exist in prediabetes.
The resistance exercise study found that this type of exercise may improve certain areas of
cognition, such as the ability to switch focus between tasks. Additionally, neuroimaging
findings from this study showed that resistance exercise may slow age- and disease-related
brain shrinkage and lead to functional activation patterns that are seen in healthy adults. In
summary, resistance exercise may improve cognition and brain health in older adults at risk
for diabetes, however large-scale studies are needed to confirm these preliminary findings.
Important recommendations for future trials are also included in this thesis.
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Chapter 1

1

Introduction

Cognitive impairment and associated brain dysfunction is a major health concern among
older adults. Worldwide, up to 41% of individuals over the age of 50 are suffering from
cognitive impairment,1 and this often leads to a decline in mobility, functional independence,
and quality of life. Although neurocognitive decline occurs as a natural part of the aging
process, it is often exacerbated in clinical populations of older adults such as those with
diabetes, prediabetes, or obesity. This thesis will specifically examine such deficits in
prediabetic and overweight/obese older adults, and will investigate whether exercise can be
used as a lifestyle intervention strategy to improve cognition and brain health (structure and
function) in this population.

1.1 Neurocognition
Cognition is broadly defined as the mental functions involved in the gathering and
comprehension of knowledge. According to the fifth and most recent edition of the
Diagnostic and Statical Manual of Mental Diseases (DSM-5),2 there are six main domains
that make up cognition: complex attention, executive function, learning and memory,
language, perceptual-motor function, and social cognition, each containing subdomains. As
my research focuses primarily on the first three domains, the latter three will not be described
in detail in this thesis.
The first domain, complex attention, is made up of functions related to attention, or the
ability to actively process specific information. One subdomain of complex attention is
selective attention, the process of focusing on selected environmental stimuli while ignoring
irrelevant stimuli. This is a fundamental cognitive function as attention is a limited resource,
thus the ability to selectively direct one’s focus is extremely valuable. Moreover, selective
attention is considered a key underlying function for other cognitive abilities such as working
memory (described below) and nonverbal intelligence (the ability to analyze information and
problem-solve using visual reasoning).3 Evidence from functional magnetic resonance
imaging (fMRI; described in Chapter 1.2) research has shown that activation of sensory
cortical areas, primarily the parietal and frontal lobes, occurs during both auditory and visual
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selective attention;4 specific areas involved include the posterior parietal cortex and
prefrontal cortex (PFC).5 While the DSM-5 recognizes complex attention as being distinct
from executive function, attention is commonly considered a type of executive function
within the literature.
Executive function refers to a set of mental skills that are required for the cognitive control of
behaviour, that is the selecting and monitoring of behaviours to achieve a goal. Two
commonly studied subdomains of executive function are conflict resolution, the ability to
overcome conflicting perceptual inputs to achieve a desired behaviour, and task-switching
(commonly called set-shifting), the ability to shift focus between tasks. A number of fMRI
studies have found that the PFC, specifically the dorsolateral areas, underlies both conflict
resolution and task-switching.6,7 The anterior cingulate cortex (ACC) is also known to
support conflict resolution,6 while areas including the pre-supplementary motor area, parietal
cortex, and the frontopolar cortex also support task-switching.7 In addition, working memory,
which is the ability to hold a small amount of information in mind and use it in the execution
of cognitive tasks, is another important component of executive functioning that depends
critically on the medial temporal lobe (MTL) and PFC.8,9
The third DSM-5 cognitive domain includes both learning, the process of acquiring skill or
knowledge, and memory, the storing and recalling of information. Generally, the main brain
areas involved in these processes are the frontal lobe, hippocampus (a subcortical brain
region located within the MTL that plays an important role in memory consolidation and
storage), and other temporal lobe structures.10,11 Under the umbrella term of memory, there
are several types and ‘phases’, the latter of which includes short-term and long-term memory.
Short-term memory is defined as the ability to store information in one’s mind for short
periods of time (typically within seconds), whereas long-term memory (sometimes referred
to as delayed memory) deals with the storage of information for extended periods. While
working memory is a form of short-term memory since it involves the storage of information
for short periods of time, it is defined as an executive function as it uses information to
immediately plan and carry out behaviour.
For all memory types, there are three processes that are essential to its function; these are
encoding, storage, and retrieval. Encoding is the process by which information is learned,
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perceived, and related to existing knowledge, while storage is the process of maintaining this
information overtime. Retrieval (or recognition), on the other hand, is the process of recalling
and accessing information when it is needed. While each of these three processes are distinct,
they are also related and strongly rely on one another. For example, the strength by which a
memory is encoded is correlated to the likelihood that it will be effectively retrieved.12

1.1.1

Associative memory

One type of memory particularly relevant to this thesis is associative memory, defined as the
ability to learn and remember the relationship between items that are unrelated (e.g., faces
and names). Associative memory is thought to be one of the most essential memory functions
due to its usefulness and applicability, and has been argued to be critical for higher and more
complex memory performance.13 Associative memory allows people to make connections
and inferences, and is commonly applied to many life scenarios including observations and
interactions with others.14 Further, the ability to process multiple stimuli together allows
individuals to process information faster and more efficiently.15 This type of memory is often
used subconsciously in everyday life as we frequently memorize items within our
environment in conjunction with one another.
The neuroanatomical structures that underlie associative memory are largely located within
the MTL and surrounding areas of the brain.16 One of the main implicated MTL structures in
this type of memory is the hippocampus.16 Evidence from primate research shows that
hippocampal cells exhibit increased patterns of learning-related neural activity during the
formation of novel associative memories.16 However, some studies have also shown that cells
in other brain areas including the PFC, frontal motor-related areas, and striatum exhibit
similar patterns of neural activity during associative learning.16 Moreover, structures that are
functionally related to the hippocampus, such as the entorhinal, perirhinal, and
parahippocampal cortices, have been shown to underlie associative memory ability.16 These
areas are known to support memory encoding as well as related functions including memory
formation and memory consolidation;17,18 the latter occurs when temporarily learned
experiences are transformed into long-term memories.
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1.1.2

Neurocognition in aging and disease

The majority of cognitive functions, including functions previously discussed (e.g., selective
attention, conflict resolution, task-switching, working memory, long-term memory,
associative memory), are known to decline naturally with age.19–21 Such declines in cognitive
ability are said to begin in one’s 20’s and worsen with advanced age, with most decline
occurring after the age of 70.22 However, the rate and degree at which cognition declines
with age is highly dependent on a myriad of hereditary and environmental factors, including
one’s genetic makeup, education level, sex, and health behaviours (e.g., physical activity
levels, sleep patterns, diet). For example, higher fitness levels are positively correlated with
preserved cognitive ability late in life;23 this particular relationship will be further explored in
Chapter 1.6.
Evidence from neuroimaging studies demonstrate that age-related cognitive decline occurs
with neurodegeneration.24 As we age, humans experience a loss of neurons (fundamental
units (cells) of the brain; the brain contains roughly 86 billion neurons)25 and neuronal
connections that results in atrophy of brain tissue. Total brain volume (TBV) atrophy in
healthy individuals has been shown to occur by the age of 30, with greater decline in old
age.26 In fact, by the time healthy individuals reach the age of 60, the brain naturally
decreases ~0.3% per year.27 One brain area that is particularly susceptible to age-related
atrophy is the hippocampus.28 A meta-analysis estimated that the average annual rate of
hippocampal atrophy in healthy aging is 1.4%; in this review, the mean age range of study
participants was 69-83 years old.29 Moreover, hippocampal atrophy has been shown to be
correlated with deficits in memory function,30 and memory problems is one of the most
common cognitive complaints among older adults.19
In addition to atrophy, age is associated with changes in the brain’s hemodynamic response
(HR),31 which reflects the delivery of blood and oxygen to active neurons to support their
function (to be discussed further in Chapter 1.2.1). Specifically, studies show that age is
correlated with a decrease in neural activation in task-specific areas. For example, one study
found that age was associated with a linear decrease in neural activity in memory-related
areas (right middle frontal gyrus, bilateral precunei) during a spatial working memory task.32
In this study, age was also associated with decreased accuracy in task performance.32
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Another study assessed age-related differences in brain activation during working memory,
visual attention, and episodic retrieval tasks.33 In all three tasks, older versus younger adults
had weaker activity in the occipital lobe (consistent with decline in age-related sensory
processing abilities) but stronger prefrontal and parietal activity which may reflect functional
compensation.33 Taken together, it appears that the level in which brain areas are engaged in
cognitive tasks may differ with age, and decreases in neural activity in task-related areas may
reflect worsened cognitive performance. Research also shows that aging has a negative
impact on connectivity strength within functional and structural brain networks, particularly
those related to high level cognitive functions.34
Although declines in cognition and brain health are a natural part of aging, such declines can
occur at a faster rate than expected as a result of neurodegenerative disease. For example,
mild cognitive impairment (MCI), the precursor stage of dementia, occurs when individuals
experience declines in cognitive function (associated with a loss of brain tissue) that are
beyond normative aging (Figure 1.1). However, these declines do not significantly interfere
with everyday life. Dementia, on the other hand, occurs when there is more severe
impairment than MCI (Figure 1.1) that does interfere with activities of daily living. The most
common form of dementia is Alzheimer’s disease, which accounts for 60-70% of all
dementia cases and is characterized by severe deficits in memory, thinking, or decisionmaking abilities.35 It is believed to occur when there is an abnormal build-up of the proteins
beta-amyloid and tau in the brain. Beta-amyloid makes up a larger protein (amyloid) and
contributes to the formation of amyloid plaques around neurons which disrupts neuronal
communication and function; tau, however, creates neurofibrillary tangles in the brain which
disrupts the transport of nutrients and other important substances within neuronal cells.36
While Alzheimer’s disease can occur in young-to-middle adulthood, it primarily affects
individuals aged 60+, and is currently the fifth leading cause of death in older adults.37
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Figure 1.1: Model of clinical trajectory of dementia as compared to normal
aging.
Source: Sperling RA et al. (2011)38 (copyright access granted via Copyright
Clearance Center)
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1.2 Magnetic resonance imaging
Magnetic resonance imaging (MRI) is a non-invasive imaging technique that uses magnetic
fields and radio waves to produce high-resolution images of tissues and organs within the
body. It is commonly used to examine neurocognitive abilities and detect abnormalities in the
brain, and is the most frequently used imaging technique of the brain and spinal cord.39 The
strength of the magnetic field applied is measured in Tesla units, named after Nikola Tesla
who discovered the rotating magnetic field in 1882.40 The greater the Tesla strength of a
scanner, the greater the detail and quality of the images that it produces. The majority of
research studies use scanners that operate at a strength of 1.5 or 3 Tesla.
To briefly describe the physical principles behind MRI,41 we must first consider the
properties of water molecules within the body. The human body is made up of 60-70% water,
and each water molecule contains two hydrogen atoms and one oxygen atom. Protons
(nuclei) of hydrogen atoms are naturally charged particles that spin around an axis and
behave like a magnet (have a north and south pole). At any moment in time, the billions of
hydrogen protons within the body are in random positions as they spin on their axes.
However, when a strong external magnetic field is applied during an MRI scan, hydrogen
protons in the body are temporarily aligned with that field. Radio waves are then applied to
deflect the magnetic field and force the protons to spin out of equilibrium. When the radio
wave frequency (RF) source is turned off, protons ‘relax’ and realign with the magnetic field,
and this causes a signal (also a radio wave) to be emitted. These emitted signals are detected
by MRI coils in the form of an electrical current and are transformed using a mathematical
calculation called a Fourier transformation42 to produce cross-sectional images of tissues
within the body.
Different tissues in the body relax at different rates when the RF source is turned off,
therefore the intensity of the received signals allows us to differentiate between various tissue
types. The time taken for the hydrogen protons to fully relax once the RF source is removed
is measured in two ways: (1) the time it takes to realign with the magnetic field, which is
called T1 relaxation, and (2) the time it takes to return to their previous axial spins, which is
called T2 relaxation. MRI, then, is made up of a series of RF pulse sequences which
determine the appearance of the outputted images. Repetition time (TR) is the time between
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RF pulses, and echo time (TE) is the time between the RF pulse and the produced signal. T1weighted images (characterized by short TR and TE) provide excellent structural anatomical
detail, while T2-weighted images (characterized by long TR and TE) are useful in identifying
pathology. In brain MRI, these images provide static information on the shape, size, and
integrity of grey matter and white matter in the brain (i.e., components of structural MRI, or
sMRI). In addition, the two main characteristics that determine MRI image quality are spatial
resolution and signal-to-noise ratio. Spatial resolution is mainly determined by the imaging
voxels (volumes that makes up three-dimensional space), while signal-to-noise ratio is a
measure of the true MRI signal versus unavoidable background quantum noise. Further
details on the complexity of principles underlying MRI is beyond the scope of this thesis.
There are several advantages of MRI in comparison to other imaging techniques. Generally,
some of its advantages are that it: (1) has high spatial resolution, (2) can produce images in
multiple planes, (3) does not use ionizing radiation, which can damage cells following high
exposure, and (4) is non-invasive. There are, however, some disadvantages to this imaging
technique, including that it (1) may be uncomfortable for patients (e.g., is loud), (2) requires
patients to remain extremely still while inside the scanner, as motion can cause artefacts
resulting in distorted images, (3) cannot be done in patients with metal implants or electronic
devices due to the strong magnetic field applied in the scanner, and (4) is expensive.

1.2.1

Functional MRI and the brain

Functional MRI, unlike sMRI, provides dynamic physiological information about the brain
(e.g., what areas of the brain are used for specific functions). It is an indirect measure of
brain activity based on changes in cerebral blood flow. An increase in neural activity, which
involves the firing of neurons in a specific area of the brain (e.g., during a cognitive task),
stimulates an increase in blood (hemoglobin) to that brain region in order to supply active
neurons with the energy they need; this process makes up the HR. During the HR,
oxygenated hemoglobin (i.e., hemoglobin that has oxygen molecules attached to it) increases
in brain areas that are active. Hemoglobin is a protein within red blood cells that is
responsible for transporting oxygen throughout the body. Oxygenated hemoglobin is
diamagnetic, meaning that it repels magnetic forces, while deoxygenated hemoglobin (i.e.,
hemoglobin that does not have oxygen molecules attached to it) is paramagnetic and is
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attracted to magnetic fields. Therefore, fMRI picks up stronger signals from areas that have
higher levels of oxygenated hemoglobin compared to deoxygenated hemoglobin which
creates more magnetic distortion, and this concept forms the basis of blood oxygen leveldependent (BOLD) fMRI. To note, in comparison to neuronal activity, the HR is quite slow
(milliseconds versus seconds, respectively). Thus, fMRI has lower temporal resolution
compared to other measures of neural activity such as electroencephalography (which records
electrical activity directly from the scalp). However, as briefly mentioned, fMRI has high
spatial resolution (approximately 3-4 mm).43

1.3 Type 2 diabetes
Type 2 diabetes (T2D), a chronic health condition characterized by impaired glucose
regulation in the body, is the most common form of diabetes making up 90-95% of all
cases.44 An estimated 462 million people, or 6.28% of the world’s population, have T2D,45
which is considered the fastest growing global epidemic.46 Type 2 diabetes occurs as a result
of the body’s ineffective use of insulin (Figure 1.2), a hormone produced by beta islet cells
(β-cells) in the pancreas to regulate blood glucose (sugar) levels. Glucose, the body’s primary
source of energy that mainly comes from food, enters the bloodstream upon the digestion of
food; insulin is then released from the pancreas to allow muscle, fat, and liver cells to absorb
the sugar for energy and storage. In T2D, cells become resistant to insulin and are unable to
properly absorb sugar from the blood, leading to excess glucose in the bloodstream. By
comparison, type 1 diabetes occurs when β-cells in the pancreas can no longer produce
insulin (Figure 1.2), and is caused by an autoimmune reaction.
There are many factors that contribute to the development of T2D. One such factor is one’s
genetic makeup, including mutations in genes involved in controlling glucose levels. For
example, mutations of the TCF7L2 (transcription factor 7-like-2) gene have been shown to
disrupt insulin secretion and glucose production,47 while ABCC8 (adenosine triphosphatebinding cassette transporter sub-family C member 8) mutations are known to negatively
affect insulin regulation.48 In addition, a major lifestyle risk factor for T2D is a lack of
regular exercise, which can contribute to both the development and progression of T2D and
its complications. This was demonstrated in a large prospective cohort study that found that
the risk for T2D was significantly higher in those with low versus high levels of moderate-to-
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vigorous exercise per week.49 In line with this, a review found that exercise (e.g., walking)
can reduce the risk for T2D by up to 50%.50 Additional factors that can contribute to the
development of T2D include excess body weight, poor sleep, smoking, alcohol consumption,
and characteristics of metabolic syndrome including high fat around the waist, high
triglycerides, and low levels of high-density lipoprotein cholesterol.
Chronic hyperglycemia (excess blood glucose levels) as a result of T2D leads to many
physical health complications, including deficits in the body’s nervous, circulatory, and
immune systems. For example, hyperglycemia disrupts the body’s immune response and
impairs its ability to fight off invading pathogens; this may occur as a result of cytokine
(protein that supports immune cells) production suppression, deficits in phagocytosis
(process by which cells engulf bacteria and foreign substances), and immune cell dysfunction
associated with T2D.51 Additionally, chronically high blood sugar levels lead to blood vessel
damage, specifically atherosclerosis (thickening or hardening of arteries). As such, patients
with T2D often experience hypertension (high blood pressure), coronary artery disease, eye
damage (i.e., damage to blood vessels in the eye), and even premature mortality.52,53
Furthermore, diabetes is among the leading causes of kidney failure, and individuals with
T2D have a two- to three-fold increased risk of a heart attack or stroke.53 According to the
American Heart Association, approximately 68% of people aged 65 or older with T2D will
die from heart disease and 16% from stroke.54
The majority of T2D cases occur in older adults aged 60+ compared to other age groups.55
Thus, as the world’s aging population continues to rapidly increase, so will the prevalence of
T2D. Previous projections have suggested that the number of T2D cases in older adults aged
65+ will increase by 4.5-fold between 2005 and 2050.56 The prevalence of T2D in older
adults may be even higher than what is known, as it has been reported that up to one-third of
older adults with T2D go undiagnosed.57 Compared to younger adults, older adults may be
especially at high risk for T2D due to a combination of insulin de-sensitivity and impaired
pancreatic function,58 as well as cardiovascular comorbidities, that occur with age. Moreover,
age-related insulin resistance appears to be primarily associated with adiposity, sarcopenia,
and physical inactivity, all of which also typically increase with age.59
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Figure 1.2: Healthy pancreatic function and pancreatic function in type 1 and
type 2 diabetes.
Source: MedlinePlus, National Library of Medicine60 (non-copyrighted)
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1.3.1

Neurocognition in type 2 diabetes

Type 2 diabetes is a known risk factor for both MCI and Alzheimer’s disease. In fact,
research shows that individuals with T2D have more than a 50% higher risk of developing
dementia compared to those without diabetes.61,62 Specifically, a meta-analysis found that
those with T2D had a 73% greater risk of developing all type dementia and a 56% risk of
developing Alzheimer’s disease.62 Interestingly, T2D has been shown to share some of the
same etiological mechanisms as MCI and Alzheimer’s disease. For example, the dominant
gene associated with the presence of Alzheimer’s disease is apolipoprotein E (APOE),
specifically the ε4 allelic variant, and this gene is also involved in the regulation of glucose
and lipid metabolism.63 Studies have found that brains that express APOE ε4 display
significant deficiencies in glucose uptake and metabolism.64 It has also been shown that the
presence of APOE ε4 in those with T2D significantly increases the risk for Alzheimer’s
disease.63
In relation to dementia risk, T2D is associated with a significant reduction in cognitive
ability. A meta-analysis of cross-sectional studies showed that people with T2D perform
worse than those without T2D in the cognitive domains of information-processing, visual
memory, verbal memory, attention, and executive function.65 Similarly, a systemic review
found deficits in processing speed, attention, memory, and cognitive flexibility (the general
ability to adapt thinking and behaviour to one’s environment) in T2D, and these effects were
greater in those aged 65+.66 In a longitudinal study, T2D was also shown to be a significant
predictor of cognitive decline across six years in measures of global cognitive function,
perceptual speed, and declarative memory (a form of long-term memory that involves
conscious recall).67 Further, there is evidence to suggest that the duration of T2D may have
an impact on cognitive impairment severity, with longer durations being correlated with
greater dysfunction.68
Neuroimaging studies have also revealed that individuals with T2D exhibit reduced brain
volumes (including total and regional white matter volume (WMV) and grey matter volume
(GMV)) and other brain heath deficits when compared to those without diabetes.69 For
example, a large cross-sectional study found that patients with T2D, compared to those
without, had lower total GMV, WMV and hippocampal volume (HV) that was associated
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with worse cognitive function.70 In this study, a loss of grey matter was found in the medial
temporal, anterior cingulate, and medial frontal lobes, while white matter atrophy was
localized to the frontal and temporal regions.70 Likewise, a review by Ryan et al. (2014)
found less GMV, WMV and HV in diabetics compared to healthy controls.71 Specifically,
grey matter atrophy was shown to occur in the temporal, frontal, and limbic brain regions,
which is a hallmark of early Alzheimer’s disease.71 This review also demonstrated that grey
matter atrophy may contribute to the cognitive deficits that are observed in T2D.71 Deficits in
functional brain connectivity and cerebrovascular health including cerebral infarcts, white
matter hyperintensities (WMHs), and microbleeds (which will be explored later on in this
thesis) have also been shown to be associated with T2D in many studies, and are linked to
cognitive dysfunction.72–74
Cognitive and brain dysfunction in T2D can be attributed to several potential underlying
mechanisms. Firstly, cerebral infarcts are known to lower the threshold of amyloid in the
brain, allowing for the development of amyloid plaques as seen in Alzheimer’s disease.75
Secondly, WMHs associated with T2D have been shown to occur with cerebral amyloid
angiopathy (the buildup of amyloid on artery walls in the brain) which leads to
cerebrovascular decline.75 Thirdly, in hyperinsulinemia (high blood insulin levels) which
often occurs in T2D, peripheral insulin can cross the blood brain barrier and result in the
deposition of beta-amyloid and tau.75 Additionally, hyperglycemia has been shown to be
linked to increased advanced products of glycosylation (AGEs; proteins or lipids that become
harmful when they combine with glucose in the blood) that are related to microvascular
complications in T2D.75 Finally, a reduction of lipoprotein receptor-related proteins (LRPs),
which help remove beta-amyloid and mediates its transportation from the brain, has been
shown to occur in T2D.75 While these mechanisms are believed to mediate the effects of T2D
on cognitive and brain health, the direction of causality remains debated upon (i.e., whether
they contribute to deficits in T2D or vice versa).

1.4 Prediabetes
One major risk factor for T2D is prediabetes. Sometimes referred to as intermediate
hyperglycemia, prediabetes is the state of having elevated blood glucose levels that are
beyond the normal range but below the T2D threshold. Globally, the number of people with
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prediabetes (based on impaired glucose tolerance (IGT), described below) is estimated to be
around 352 million (7.3% of the adult population), and this number is projected to reach 587
million by 2045.76 These estimates are based on IGT only, thus actual prevalence rates may
be even higher based on other diagnostic criteria76 that will be explored in this Chapter. Of
those with prediabetes, most are unaware that they have it,77 as common symptoms (e.g.,
increased thirst and urination, fatigue, excess hunger) often go undetected. Additionally, up
to 70% of prediabetes cases will progress to T2D.78 Annually, prediabetes has a T2D
conversion rate of approximately 5-10%, with a similar rate of cases converting back to
normoglycemia each year.78 Potential causes of prediabetes are similar to that of T2D, and
have been discussed in Chapter 1.3.
According to the World Health Organization (WHO), prediabetes is defined as having (1)
impaired fasting glucose (IFG) based on fasting plasma glucose (FPG) 6.1 to 6.9 mmol/l (110
to 125 mg/dl), and, if measured, 2-hour plasma glucose (2-h PG) <7.8 mmol/l (140 mg/dl),
and/or (2) IGT based on FPG <7.0 mmol/l (126 mg/dl) and 2-h PG ≥7.8 and <11.1 mmol/l
(140 and 200 mg/dl); glucose refers to venous plasma glucose levels, and the 2-hour test
occurs after ingestion of 75 g of an oral glucose load.79 In comparison, diagnostic criteria for
the American Diabetes Association (ADA) includes a lower FPG threshold (5.6 to 6.9
mmol/l, or 100 to 125 mg/dl) for IFG, does not recommend a 2-h PG measurement for IFG,
does not include a FPG measurement for IGT (but has the same 2-h PG criteria of ≥7.8 and
<11.1mmol/l (140 and 200 mg/dl), and has an additional diagnostic measure of glycated
hemoglobin (HbA1c; occurs when sugar molecules attach to hemoglobin) 5.7 to 6.4%.80
Differences between these criteria, and their potential effects on diagnoses of prediabetes,
will be explored in Chapter 2.

1.4.1

Neurocognition in prediabetes

Within the literature, prediabetes has been shown to be associated with an increased risk for
cognitive decline and accelerated cognitive dysfunction across many studies. Examples of
cognitive domains that are disrupted in prediabetes include global cognitive function, verbal
fluency, memory, and executive function.81,82 One study found that prediabetes was
associated with faster cognitive decline over nine years when compared to diabetes-free
status.81 In this study, older adults with prediabetes had a clinically relevant decline in
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performance on the Mini-Mental State Examination (MMSE), a measure of global cognition
(including orientation, language, complex commands, etc.).81 Other studies, described in a
review by Papunen et al. (2020), show fairly consistent findings of cognitive decline in
prediabetes.83 However, when assessing underlying structural deficits in prediabetes, results
are largely inconsistent between studies. Cui and colleagues (2019) found that prediabetic
adults, compared to healthy controls, had reduced left HV, which is commonly seen in
T2D.84 In contrast, a study by Schneider et al. (2017) found no significant difference in HV
between prediabetics and healthy participants.85 Other conflicting evidence has been found
for volumetric measures of total brain, grey matter, white matter, and additional regional
brain areas in prediabetics, as well as measures of cerebrovascular health and structural
connectivity, which will be closely examined in Chapter 2.
Alterations in functional connectivity and hemodynamic activity in the brain may underlie
cognitive deficits seen in prediabetics. However, very little research has been conducted on
these topics in prediabetes. One cross-sectional study in adults assessed brain functional
connectivity patterns in the default mode network, an area that has disrupted connectivity in
T2D, but found no differences in functional connectivity between prediabetics and healthy
controls.86 Another study by van Bussel and colleagues (2016) found that prediabetics, on the
other hand, had disrupted global functional brain networks when compared to healthy
controls, but to a lesser extent than diabetics (trending).87 Aside from these two studies,
however, functional brain health in prediabetics is largely unknown.

1.5 Obesity
A second major risk factor for T2D is obesity, a complex and progressive disease defined as
having excessive body fat (adiposity) that is associated with health risk.88 Essentially, it
occurs when the body’s energy intake is greater than energy expenditure. Obesity is often
diagnosed by calculating body mass index (BMI), which takes into account one’s height (in
meters (m)) and weight (in kilograms (kg)) and is calculated by height / weight. A BMI of
under 25 is considered healthy, while a BMI of 25 or greater is considered a health concern
(25-29.9 is defined as being overweight, and 30+ as obese). Body mass index is the most
commonly used and convenient measure of obesity. While it does not directly measure body
fat, it has been shown to be moderately correlated with direct measures taken via skinfold
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measurements, bioelectrical impedance, dual-energy X-ray absorptiometry (DXA), and other
tests.89 Further, there is evidence to suggest that BMI is similarly correlated to health status
as direct measures of obesity. For example, one study showed that BMI measures were
highly correlated with DXA measures, and these were related to cardiovascular risk factors in
similar ways.90
Along with T2D, obesity is a major global health epidemic. The prevalence of obesity has
nearly tripled since the mid-1970’s, and its rate continues to steadily increase.91 In 2016, 1.9
billion people (39% of adults) worldwide were overweight, and, of these, 650 million were
obese.91 Further, more than 2.8 million people die each year as a result of being overweight
or obese, and this disproportionally affects older adults who are at greater risk for premature
death.92 Obesity increases the risk of developing many debilitating chronic illnesses in
addition to T2D, including coronary heart disease.93 Moreover, health complications (e.g.,
cardiovascular impairment, including hypertension) associated with obesity appear to worsen
as BMI increases.94 In old age, obesity is also associated with greater limitations in activities
of daily living and functional disabilities.95 A review found that obesity is related to the
development of mobility impairments in older adults, and this included the ability to walk,
climb stairs, and rise up from a seated chair position (i.e., daily tasks).95 Hospitalization is
also common among older overweight and obese populations, which amounts to a heavy
burden on the healthcare system.96
Like T2D, there are many variables that contribute to obesity, including environmental,
genetic, biological, and socioeconomic factors. Risk factors include, but are not limited to, an
unhealthy diet, lack of physical activity, low socioeconomic status, exposure to obesogens
(artificial chemicals that disrupt lipid metabolism), and mutations of specific genes.97 The
most commonly implicated gene in obesity is MC4R (melanocortin-4 receptor gene), which
plays a key role in regulating energy homeostasis in the body; mutations of this gene have
especially been implicated in early-onset obesity (i.e., in young children).98 The disruption of
hormones that regulate food intake and metabolism, such as leptin, can also lead to obesity.99
Leptin is produced in adipose tissue and signals the hypothalamus in the brain to regulate
appetite.100 In addition, insulin resistance that often occurs in obesity may be the result of
impaired insulin-stimulated glucose transport in adipocytes (cells that store fat), which is
caused by the downregulation of the protein GLUT4 (glucose transporter type 4).101 To note,
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there are many additional physiological mechanisms that may underlie obesity, however they
are beyond this dissertation’s scope.

1.5.1

Neurocognition in obesity

Research has shown that obesity is associated with cognitive impairment and is a known risk
factor for dementia.102 In a cross-sectional study, adults with obesity (based on BMI) versus
those with normal weight were almost four times more likely to exhibit poor executive
function as measured via the Trail Making Test (TMT).103 Additionally, a systematic review
of 17 cross-sectional studies in adults found that obesity was associated with cognitive
dysfunction in all cognitive domains that were measured, including complex attention, verbal
and visual memory, and decision-making.104 However, it should be noted that included
studies in this review varied in terms of comorbidities that were controlled for in analyses,
and this makes it challenging to compare between studies.104 Another review assessing the
associations between obesity and cognition found that weight gain was associated with
impaired executive function, which may be caused by mechanisms such as systemic
inflammation or insulin resistance.105 Studies have also shown that cognitive impairment in
those who are overweight or obese may occur in response to impaired cerebral metabolism
and neuronal degradation.104
Interestingly, some studies in older adults have found that increased weight may have a
neuroprotective ability in old age,106 and the presence of leptin may be responsible for this.
Higher leptin levels in the body, which often occur in obesity,99 have been related to better
cognitive abilities,107 and have been found to modulate the clearance of beta-amyloid in
rodent research.108 Increased leptin levels may especially be important in late life, given that
leptin levels decrease naturally with age.109 One study in older adults aged 70-79 found that
those with higher serum leptin levels had less cognitive decline.110 Despite this, more
research on the effects of leptin on the brain in old age is needed, as this relationship is not
fully understood. Specifically, research on the potential interactions of increased leptin levels
and other obesity-related underlying mechanisms is needed.
Numerous studies have also shown that obesity is correlated with brain dysfunction,
including atrophy. Brain areas that appear to be most vulnerable to atrophy in overweight and
obese individuals include the hippocampus, cingulate cortex, and frontal lobes, and this
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parallels findings of impaired executive function and memory ability in obesity.111 A study
by Raji et al. (2010) found that obese individuals had atrophy in the frontal lobes, anterior
cingulate gyrus, hippocampus, and thalamus when compared to those with normal BMI.112
Similarly, a meta-analysis found associations between BMI and lower GMV in the medial
prefrontal cortex, bilateral cerebellum, and left temporal pole.113 Obese individuals have also
been shown to have smaller TBV compared to those with normal weight.114 In addition, BMI
is associated with a reduction in neuronal fiber bundle length, which is thought to contribute
to brain atrophy,111 and is marked by alterations in functional connectivity networks and
reductions in brain activation in areas associated with cognitive control.115,116

1.6 Exercise
Exercise is defined as a form of physical activity that is planned, structured, and repetitive,
and done with the intent of improving physical fitness. To note, the terms ‘physical activity’
and ‘exercise’ may be used interchangeably throughout this thesis, as this is a common
occurrence in the literature. Exercise is considered to be one of the most beneficial
behavioural therapies to promote health and prevent disease. Evidence from the literature
suggests that there is a linear relationship between exercise and health status, such that
greater amounts of exercise is related to larger health benefits.117 In general, exercise is
known to lower blood pressure and improve cardiovascular health, aid in weight
management, help maintain balance and stability, improve joint and muscle function, and
prevent depression, among many other benefits. Moreover, exercise is effective in the
primary prevention of over 35 chronic illnesses, including T2D, cardiovascular disease, and
certain cancers.118 In late life, exercise also helps prevent falls and falls-related injuries
including bone fractures. This is especially important given that falls are the most common
cause of injury in old age.119 In addition, studies show that exercise can reduce the risk of
death by 20-35%, however physical inactivity can increase one’s risk of all-cause mortality
by 52%.120
The two most common forms of exercise are aerobic and resistance exercise. The first,
aerobic exercise, is made up of endurance-type exercises (e.g., running, cycling, swimming,
rowing) that require increased oxygen intake to produce the energy needed for performance
output. Moreover, this type of exercise focuses on improving cardiovascular function.
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Resistance exercise (i.e., weight training), on the other hand, is exercise that increases muscle
mass and strength and requires less oxygen intake. While both exercise types are associated
with numerous health benefits, resistance exercise is particularly useful in old age as most
older adults, even those with mobility limitations, can perform some form of this exercise; by
comparison, older adults are often limited in aerobic capability. Improving muscle strength
through resistance exercise also helps reduce the prevalence of falls and age-related
sarcopenia,121 which is characterized by progressive muscle loss.
The WHO recommends that adults aged 18-64 get a minimum of 150 minutes of moderate
intensity (or 75 minutes of vigorous-intensity) aerobic exercise per week for sustained health
benefits.122 Additionally, it is suggested that adults participate in muscle-strengthening
activities (at a moderate or vigorous intensity) that involve all major muscle groups at least
twice per week.122 Older adults over the age of 65 are recommended to follow the same
guidelines as younger adults, but to also practice functional balance and strength training at a
moderate intensity or greater three times per week to enhance functional capacity.122 Older
adults with chronic conditions are encouraged to be as physically active as their abilities and
conditions allow.122
Despite existing recommendations, physical inactivity is recognized as one of the largest
public health challenges. Worldwide, less than 25% of adults meet the recommended levels
of physical activity,123 and older adults are often among the least active.124 In Canada, only
16.0% of adults aged 18 to 79 meet the recommended exercise amounts,125 and this number
continues to decrease after the age of 80.126 Exercise rates in older adults may be lower than
other age groups due to the prevalence of physical impairments and chronic illnesses
common in later life that prevent participation (e.g., osteoarthritis, osteoporosis). Moreover,
previously self-reported barriers to exercise in old age include a lack of self-discipline,
interest, enjoyment, knowledge, company, facilities, energy, and motivation to
participate.127,128

1.6.1

Exercise and neurocognition

There is increasing evidence that exercise not only improves bodily function, but also
preserves and promotes cognition and brain health. These neurocognitive benefits are largely
seen in childhood and old age when the brain is undergoing changes in structural and
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functional circuitry (i.e., developmental changes in childhood, age-related decline in old
age).129 Nevertheless, studies show that exercise benefits the brain across the entire
lifespan.129 In general, these benefits occur as a result of exercise-induced decreases in
neuroinflammation, increases in blood flow (and with this, oxygen and nutrients) to the brain,
and increases in brain chemicals that promote the growth of neurons.129–131 Importantly,
exercise is also known to help protect against Alzheimer’s disease and other types of
dementia. Combined results from several prospective studies have shown that regular
exercise can significantly reduce the risk for Alzheimer’s disease by 45%.132 Larson and
colleagues (2006) demonstrated that people over the age of 65 who engaged in any form of
exercise three or more times per week were less likely to develop dementia later on in life
when compared to those who exercised less than three times per week.133

1.6.1.1

Aerobic exercise

The majority of research in the exercise neuroscience field has primarily focused on aerobic
exercise, perhaps due to its important cardiovascular benefits. Findings from several studies
demonstrate that aerobic exercise leads to strong improvements in cognition and brain
structure and function, and these results occur well into old age.129,134 Cognitively, aerobic
training in older adults is known to improve executive functions that are supported by the
frontal cortex, including processing speed, concept formation, and fluency,135 as well as
memory.136 Evidence from fMRI research has found that six months of thrice-weekly aerobic
exercise increased brain activation in regions involved in attentional control and inhibitory
processes, namely the middle frontal gyrus and superior parietal cortex, in communitydwelling older adults.137 Six months of aerobic exercise has also been shown to increase
GMV and WMV in sedentary older adults, with the largest changes in GMV seen in the
frontal lobe in areas implicated in attention and memory.138
Converging evidence from both animal and human research shows that aerobic exercise is
associated with an increase in brain-derived neurotrophic factor (BDNF), which may serve as
a main underlying mechanism leading to neurocognitive improvements.139,140 Brain-derived
neurotrophic factor is a neuronal growth factor known to promote neuronal health and
neurogenesis (the development of new neurons) especially in the hippocampus.129 Increased
BDNF levels in the brain is associated with increases in long-term potentiation (LTP), which

21

enhances neuronal synaptic transmission and synaptic plasticity.129 Studies show that
decreased BDNF levels, particularly in older adults, may lead to neurodegeneration as well
as patterns of cognitive dysfunction seen in Alzheimer’s disease.141 In addition to the release
of BDNF, other neurophysiological processes that occur in response to aerobic exercise
include increased cerebral blood flow, brain angiogenesis (the development of new blood
vessels) supported by increased vascular endothelial growth factor (VEGF) levels, and the
release of neurotransmitters (chemical messengers in the brain) including dopamine,
serotonin, and acetylcholine which promote neuronal communication and cognitive
functioning.129,142

1.6.1.2

Resistance exercise

Resistance exercise has also been shown to preserve and improve neurocognition, although
there is less literature on this type of exercise compared to aerobic exercise. A recent
systematic review assessed the effects of acute and long-term resistance training on the brain
in young and older adults who were either healthy or diagnosed with a chronic illness (e.g.,
MCI, multiple sclerosis).143 All included studies showed improvements in at least one or
more cognitive or neurophysiological domain (e.g., improved executive function, increased
hemodynamic activity, increased cortical thickness) following resistance training.143 In older
adults specifically, a study by Liu-Ambrose and colleagues (2012) found that communitydwelling females who performed 52 weeks of twice-weekly progressive resistance training
exhibited better performance in tasks of executive function than those who engaged in
balance and toning exercises (control group).144 In this study, positive functional changes in
hemodynamic activity were also found in areas implicated in response inhibition (the ability
to suppress certain actions that interfere with goal-driven behaviour), including the left
anterior insula, lateral orbital frontal cortex, and anterior portion of the left middle temporal
gyrus (MTG).144 In another study, Suo and colleagues (2016) found that six months of
resistance training in older adults with MCI led to improvements in global cognition, and this
was related to increased grey matter in the posterior cingulate regions.145 Other studies have
shown that resistance exercise lowers white matter atrophy, reduces the development of
white matter lesions (WMLs), and preserves hippocampal atrophy in subfields that are
susceptible to Alzheimer’s disease.143,146
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Despite evidence demonstrating the positive impact of resistance exercise on the brain, some
studies have found contradictory results. For example, despite a randomized controlled trial
(RCT) in older adults showing improved memory performance following 24 weeks of thriceweekly resistance training,147 a separate RCT found no improvement in memory, but did in
executive function, following 52 weeks of twice-weekly resistance exercise.145 Differences in
findings may be attributed to differences in study designs, specifically the frequency,
duration, and intensity of the exercises. Indeed, studies have shown that these elements of
resistance training protocols are important to study results. For example, studies using lowerintensity resistance exercises have found no significant improvements in memory following
six months of exercise.148 However, studies using a resistance load of 50-80% of a one
repetition maximum (i.e., 1RM, described further in Chapter 3) have found positive
neurocognitive changes.129 Moreover, it appears that RCTs of resistance exercise that are six
months or greater yield the largest benefits to cognition and brain health, as do exercise trials
that involve more frequent training.129 One study assessing the effects of once- versus twiceweekly resistance training in older adults found improvements in selective attention and
conflict resolution in both groups after 52 weeks, however only the twice-weekly group had
improvements in functional plasticity of response inhibition processes.144
Improvements in cognition and the brain following resistance exercise are believed to be
mediated by various molecular and cellular changes. For example, studies show that
resistance exercise stimulates the release of insulin-like growth factor-1 (IGF-1), a neuronal
growth factor that promotes the growth, survival, and differentiation of neurons and is known
to play an important role in preventing Alzheimer’s disease.149 In animal models, low IGF-1
levels is associated with microvasculature degeneration in the brain as well as reduced
neurogenesis in the hippocampus.149 In a study in humans, higher serum IGF-1 levels were
found following moderate (50% of 1RM) and high (80% of 1RM) levels of resistance
exercise when compared to a stretching control group in older men.147 Additionally, older
adults with MCI had increased serum IGF-1 levels by ∼15% following high-intensity
resistance training.150
There is also evidence to suggest that resistance training reduces homocysteine, an amino
acid produced by the body that is used to make other substances in the body.151 High levels
of homocysteine in the body is a known risk factor for vascular disease and brain atrophy.152
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Twelve months of high-intensity resistance exercise (75-80% 1RM) has been shown to lead
to declines in serum homocysteine levels in older adults.153 Resistance exercise is also known
to have a positive effect on adipokines, which are signaling proteins secreted in adipose
tissue. Adiponectin, a type of adipokine, plays an important role in improving insulin
sensitivity, and low levels are correlated with insulin resistance and cognitive
dysfunction.154,155 A study by Park and colleagues (2019) found significant increases in
adiponectin following resistance exercise in postmenopausal women.156 Finally, decreases in
resistin (an adipose-derived protein correlated with inflammatory markers in Alzheimer’s
disease), increases in peripheral lactate (substance that allows glucose breakdown)
concentrations, and increases in plasma BDNF and VEGF have also been found to occur
following resistance training and are correlated with improved neurocognitive health.129,157–
159

1.7 Exercise in type 2 diabetes
Exercise is often used to combat physical and neurocognitive impairment that occurs in T2D.
It is well established that regular exercise plays an important role in blood glucose control,
insulin sensitivity, and cardiovascular functioning in T2D.160 In one of the largest
randomized trials evaluating the effects of physical activity in older adults with T2D
(expanding 16 study centres), it was found that physical activity (e.g., walking; up to 175
minutes per week) significantly improved HbA1c levels and cardiovascular risk factors.161
Specifically, moderate and vigorous aerobic training has been shown to improve insulin
sensitivity and glucose metabolism, increase GLUT4 protein expression which is key to
glucose homeostasis, and decrease adiposity in T2D.160,162,163 In a rat model, aerobic exercise
reduced blood glucose levels and led to higher neuronal density in the hippocampus.164
Additionally, aerobic exercise is known to improve cognitive outcomes among people with
T2D, specifically executive function, memory, and global cognitive function, and these are
related to reductions in insulin resistance.165 A study in older women with T2D found that
participants who underwent six months of aerobic training, compared to a control group, had
decreased HbA1c levels and improvements in performance on the MMSE.166
Evidence demonstrates that resistance exercise may also lead to important improvements in
health outcomes for those with T2D. Following 16 weeks of twice-weekly resistance

24

training, older diabetic men had a 46.3% increase in insulin action and a 7.1% decrease in
glucose levels, and also had decreased levels of visceral fat.167 An increase in muscle mass
following resistance exercise may be the key contributor to improving blood glucose uptake
in T2D. Since muscles are important targets for insulin, improving muscle function is
directly related to improving insulin sensitivity.168 Moreover, studies have shown that
resistance training in T2D populations may lead to similar or greater improvements in
cognition compared to aerobic training. For example, in one study, 10 weeks of either
aerobic or resistance exercise led to decreases in blood glucose levels, with a larger reduction
seen following resistance exercise compared to aerobic exercise.169 Six months of a
combined aerobic and resistance training program also led to improvements in white matter
integrity, HV, and TBV, as well as less decline in WMV in older adults with T2D.170
However, it cannot be discerned how aerobic and resistance exercise may have interacted to
produce positive effects in this study.

1.8 Exercise in prediabetes and obesity
As previously touched upon, both aerobic and resistance exercise have been shown to
improve health complications that are associated with prediabetes and obesity including
insulin resistance and cardiovascular impairment. Exercise is important to reducing blood
pressure, for example, which is often elevated in both obesity and prediabetes. In obesity
especially, exercise is key to increasing one’s total energy expenditure, which helps maintain
energy homeostasis and promotes weight loss (or prevents further weight gain). One
longitudinal study found that among older men, those with lower levels of general physical
activity (i.e., climbing stairs, walking, and participating in sports and recreational activities)
were more likely to gain weight overtime than those with higher levels of physical activity.171
Exercise-induced weight loss in overweight and obese adults has also been shown to improve
attention and executive control.172 In addition, a reduction in adiposity may be associated
with improved β-cell function.173
Further studies assessing cognition have shown that exercise can significantly improve
cognitive function in overweight and obese adults. For example, a cross-sectional study by
Coll-Padrós et al. (2019) found that aerobic exercise was associated with better global
cognitive function and improvements in functions related to the frontal lobe (attention,
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cognitive flexibility, working memory) in overweight and obese older people.174 Another
study assessed the combined effects of aerobic, resistance, flexibility, and balance training
program on cognition in older obese adults and found that this combination of exercises led
to improved cognition in areas such as word fluency and global cognition.175 However, it is
unclear which of these exercise modalities contributed to the positive findings. Research on
the independent effects of resistance exercise, in particular, on cognition in obese older adults
are needed. Similarly, studies that have assessed the effects of physical activity interventions
on brain health in overweight or obese adults have largely focused on the combined effects of
both physical activity and diet instead of physical activity alone. For example, Espeland et al.
(2016) found that a diet and physical activity intervention led to reduced WMHs overtime in
overweight or obese older adults; to note, this group were also diagnosed with diabetes.176
Examining the effects of exercise on prediabetes, Malin and colleagues (2012) found that
those who underwent 12 weeks of thrice-weekly aerobic and resistance training improved in
insulin sensitivity relative to a control group.177 In this study, the authors also found that
exercise led to similar improvements to insulin sensitivity as metformin, which is a common
antihyperglycemic medication.177 While these are positive findings, they too do not provide
information on which exercise modality contributed more to the results. Studies assessing the
neurocognitive benefits of exercise in older prediabetic participants, however, are quite
scarce. One study by Baker and colleagues (2010) found that six months of aerobic training,
compared to stretching exercises, in prediabetic older adults or those newly diagnosed with
T2D led to improvements in selective and divided attention, cognitive flexibility, and
working memory.178 However, whether resistance training would have similar effects in this
population, and whether they would improve in brain health in addition, is unknown.

1.9 Thesis overview
Neurodegeneration and cognitive dysfunction are major threats to our aging population. As
such, lifestyle strategies to improve and preserve cognition and brain health, especially in
clinical populations of older adults that are at high risk of impairment, are imperative. Based
on the literature, resistance exercise has been identified as one modifiable behaviour that can
benefit and preserve cognition and brain health. Importantly, this type of exercise has been
shown to have unique benefits to older adults compared to aerobic exercise. With this
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knowledge, the overarching goal of this thesis was to determine whether resistance exercise
could be used to improve neurocognitive function in a population of older adults that are
already experiencing neurocognitive decline (i.e., those who are prediabetic and/or
overweight or obese) and are at risk of further impairment associated with T2D.
Within the literature, less is known about the neurocognitive deficits experienced in
prediabetes compared to obesity, particularly in regards to structural brain impairments.
Thus, a systematic review was first conducted to compare studies that have assessed
structural deficits (brain volume, connectivity, cerebrovascular health) in prediabetes
(Chapter 2). The goal of this review was to determine where consistencies and
inconsistencies in findings may lie. Following this, a pilot RCT study was conducted to
assess the preliminary effects of a 26-week resistance exercise program on cognition, brain
structure, and brain function in older adults at risk for diabetes (Chapters 3 and 4).
Specifically, this pilot study aimed to establish whether older adults at risk for diabetes
would improve in complex attention, executive function, and memory following progressive
resistance training, and whether improvements in volumetric brain measures and neural
activation patterns would also be evident. Finally, the feasibility of conducting an RCT study
in our target population was examined (Chapter 5). This was important in identifying
whether a large-scale study would be feasible, and, if so, determining how the study protocol
could be improved to better meet the needs of our targeted population in future trials.
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Chapter 2

2

Brain deficits in prediabetic adults: A systematic review

The content in Chapter 2 has been published as:
Furlano JA, Horst BR, Nagamatsu LS. Brain deficits in prediabetic Adults: A systematic
review. J Neurosci Res. 2021;00:1-19. doi:10.1002/jnr.24830
Some of the published content has been edited for this thesis.

2.1 Introduction
Globally, diabetes is the fourth leading cause of disability,1 with over 400 million
documented cases worldwide.2 Type 2 diabetes (T2D) is characterized by high blood glucose
levels associated with insulin resistance and glucose intolerance. While T2D is often
accompanied by physical comorbidities such as cardiovascular disease and obesity, it is also
associated with neural dysfunction. Specifically, studies have shown that T2D is correlated
with deficits in brain health, including cortical and subcortical atrophy, reduced structural
connectivity, and cerebrovascular pathology such as WMHs.3-6 Possible mechanisms linking
T2D to neural dysfunction include hyperinsulinemia and abnormal β-cell function, chronic
systematic inflammation, vascular risk factors (e.g., hypertension, hypercholesterolemia), and
oxidative stress leading to neuronal death.7
One major risk factor for T2D is prediabetes, which is the state of having elevated blood
glucose levels that are below the T2D classification threshold (i.e., an intermediate level
between normal and diabetic levels). The full diagnostic criteria for prediabetes has been
presented in Chapter 1; briefly, some of the main differences between the WHO8 and ADA9
definitions of prediabetes are that the ADA uses a lower threshold for FPG and has an
additional measure of HbA1c. Prediabetes has been shown to be associated with cognitive
deficits in areas such as global cognitive function, visuospatial processing, language, episodic
memory, and executive function.5,10,11 As such, underlying deficits in brain structure and
cerebrovascular function in this population are expected. However, previous research
assessing the association between prediabetes and brain health have yielded largely mixed
results. While some studies have found no differences in brain volume or cerebrovascular
function between adults with normal blood glucose levels (normoglycemia) and those with
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prediabetes, other studies have found significant differences suggesting that prediabetics
experience some neural decline. For example, Schneider and colleagues (2017) found no
differences in TBV and HV between these two populations,12 while Hou and colleagues
(2016) found lower GMV for prediabetics in areas such as the right (ACC) and left MTG.13
Evidently, the relationship between prediabetes and brain health is unclear, and conducting a
systematic review of the literature will help summarize what is known thus far and identify
what future research may be needed.
One 2019 meta-analysis examining prediabetes and structural brain abnormalities found that
prediabetes is associated with increased risk for cerebral infarcts and WMHs, and decreased
GMV and WMV.14 However, this paper included some studies in which clinical
comorbidities that have been associated with neurological decline (e.g., stroke) were
present.14 Importantly, our review focused on individuals with prediabetes that were
otherwise neurologically healthy, which allows us to better understand potential brain
abnormalities that may be the result of prediabetes alone.
To our knowledge, this is the first systematic review to examine prediabetes and brain
deficits in otherwise healthy adults. In our review, we focused on brain volume (e.g., TBV,
GMV, WMV, cortical thickness), structural connectivity, and cerebrovascular pathology
(e.g., cerebral infarcts, microbleeds), as measured by MRI. These measures of brain health
were chosen based on what is currently known about neural deficits in T2D. Ultimately, we
aimed to identify areas of the brain that may be affected in prediabetes and the degree of
possible deficits, in hopes that our findings will help inform future research including
interventions targeted at improving brain health in this population.

2.2 Methods
2.2.1

Search strategy

Following the PRISMA reporting standards for systematic reviews, we conducted a
systematic search of PsychINFO, Scopus, Web of Science, Ovid MEDLINE, CINAHL and
EMbase databases to identify studies that examined the association between prediabetes and
brain health. We included the following medical subject headings (MeSH): (a) ‘Prediabetic
State’; (b) ‘Grey Matter’; (c) ‘White Matter’; and (d) ‘Magnetic Resonance Imaging’.
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Additionally, free text words such as ‘prediabetes’ ‘pre-diabetes’, ‘potential diabetes’,
‘prediabetic’, ‘frontal lobe’, ‘prefrontal cortex’, ‘medial temporal lobe’, ‘temporal cortex’,
‘parahippocampus’, ‘fusiform’, ‘hippocampus’, ‘diagnostic imaging’, ‘structural imaging’,
and ‘diffusion tensor imaging’ were included in the search with their related MeSH concept
using the Boolean operator ‘OR’, and main concepts were further searched together using
‘AND’. Studies were exported into Mendeley for review.

2.2.2

Selection of studies

Two reviewers (JAF and BRH) conducted an initial screening of exported studies based on
titles and abstracts. Only peer-reviewed articles that were published in English between 2009
and April 2020 were included in our study. Additional inclusion criteria included: (a) human
research; (b) participants aged 18 or older; (c) inclusion of a prediabetes group; (d) inclusion
of a healthy normoglycemic control group; and (e) outcome measures related to brain health
as measured using MRI. We excluded studies with the following criteria: (a) animal research;
(b) samples that had other clinical diagnoses (e.g., stroke, bipolar disorder); or (c) nonprimary research (e.g., abstracts, reviews, book chapters). Following the initial screening, a
full-text review was conducted by both authors (JAF and BRH). Reference lists from selected
studies were then reviewed and subjected to title and abstract evaluation in order to collect
relevant studies that may have been missed in our original search. Individual results of the
two reviewers were then compared, and consensus of final inclusion of articles was reached
by discussion with the third author (LSN).

2.2.3

Data extraction

Using a standardized form, two authors (JAF and BRH) performed data extraction. Extracted
data included: author(s), year of publication, study objective, study type, setting, population,
inclusion/exclusion criteria, brain health outcome measures, statistical analysis and health
covariates, summary of findings, study limitations, MRI resolution, MRI analysis and
exclusion criteria, classification metric for diabetes type, and specific details regarding each
group (i.e., T2D, prediabetes, normoglycemic control) if applicable including number of
participants, mean age and sex breakdown, average FPG, average 2-h PG, and average
HbA1c %.
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2.2.4

Quality assessment

To assess the quality of each study, we used eight questions based on the National Institutes
of Health Quality Assessment Tool for Observational Cohort and Cross-sectional Studies
(Table 2.1).15 The eight questions included were: (1) Was the research question or objective
clearly stated?; (2) Was the study population clearly specified and defined?; (3) Were
participant inclusion and exclusion criteria specified?; (4) Was a sample size justification or
power description provided?; (5) Are the main outcome measures clearly described?; (6)
Were key potential confounding variables measured and adjusted for in analyses (for
outcomes of interest)?; and (7) Was the prediabetes classification used recognized by an
international association? Question 7 was created specifically for this study. Two authors
(JAF and BRH) independently evaluated each study, and any discrepancies were discussed
with the third author (LSN).
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Table 2.1: Quality assessment of included studies.
Reference

1. Was the
research
question or
objective
clearly stated?

2. Was the
study
population
clearly
specified and
defined?

3. Were
participant
inclusion and
exclusion
criteria
specified?

+

+

+

-

+

+

+

+

+

+

-

+

+

+

+

+

+

-

+

+

+

+

+

+

-

+

+

+

+

+

+

-

+

+

+

+

+

+

+

+

+

+

+

+

+

-

+

-

+

Markus et al.
2017

+

+

+

-

+

+

+

Marseglia et
al. 2019

+

+

+

-

+

+

+

Bamberg et al
2017
Cui et al.
2019
Dong et al.
2019
Hirabayashi et
al. 2016
Hou et al.
201621
Hou et al.
201612
Liang et al.
2019

4. Was a
5. Are the main 6. Were key potential
7. Was the
sample size
outcome
confounding
prediabetes
justification or
measures
variables measured
classification
power
clearly
and adjusted for in used recognized
description
described?
analyses (for
by an
provided?
outcomes of
international
interest)?
association?
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Reitz et al.
2017

+

+

+

-

+

+

+

Rusinek et al.
2015

+

+

+

-

+

-

-

Saczynski et
al. 2009

+

+

+

-

+

+

+

Samaras et al.
2014

+

+

+

-

+

+

+

Schneider et
al. 2017

+

+

+

-

+

+

+

Shaw et al.
2017

+

+

+

-

+

+

+

Storz et al.
2018

+

+

+

-

+

-

+

van Agtmaal
et al. 2018

+

+

+

-

+

+

+

+

+

+

-

+

+

+

+

+

+

-

+

+

+

Vergoossen et
al. 2020
Walsh et al.
2018

“+” indicates the item was addressed in the article and “-” indicates that it was not addressed.
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2.3 Results
2.3.1

Selected studies

Our search of the combined databases yielded 1171 results, with 948 studies remaining after
duplicates were excluded. After completion of initial title and abstract screening, 52 articles
remained for full-text assessment. From these full-text articles, 64 additional studies from the
reference lists were identified for further screening based on titles. After further abstract
screening, 50 of these articles were excluded, leaving a total of 66 full text articles (original
database plus reference-mined) to be evaluated. After full-text review using eligibility
criteria, 19 studies were selected for data extraction. Figure 2.1 shows a flow diagram of the
review process for study selection, and Table 2.2 includes the description and characteristics
of included studies. To report study findings in our review, studies were divided into three
categories: volumetric measures, structural connectivity, and cerebrovascular health, wherein
some studies were included in more than one category.
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Figure 2.1: Flow diagram of included studies.
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Table 2.2: Study description and characteristics.
Reference

Location

Bamberg et al. Germany
2017

Study sample

Diabetes
classification
(prediabetes
diagnostic
measure)

Communitydwelling

Cross-sectional WHO
(case-control)

Total:
N=400, 56.3 ± 9.0
years†
42.2% female

Data from the
Cooperative
Health Research
in Region of
Augsburg
(KORA)

Prediabetes:
N=103, 58.3 ± 9.0
years†
35.9% female

Cui et al. 2019 China

Study design

Healthy controls:
N=243, 54.2 ± 9.0
years†
48.6% female
Hospital patients
Total:
N=63, 55.9 ± 8.0

Cross-sectional WHO

Brain health
outcomes

Confounding variables
MRI
adjusted in analyses
resolution
(for outcomes of
interest)

WMLs
ARWMC
CMBs

Age
Sex
Systolic blood pressure
Smoking status
HDL level
LDL level
Triglyceride level

3T

Subcortical GMV:
Thalamus
Caudate
Putamen

Age
Sex
Education
Head size

1.5T

51

years†
65.1% female

Pallidum
Hippocampus
Amygdala
Nucleus accumbens

Prediabetes:
N=21, 57.7 ± 6.6
years†
61.9% female

Dong et al.
2019

China

Healthy controls:
N=21, 52.4 ± 8.0
years†
66.7% female
Memory clinic
patients
Total:
N=60, 58.2 ± 4.6
years†
50% female
Prediabetes:
N=17, 58.1 ± 4.6
years†
52.9% female
Healthy controls:
N=22, 57.2 ± 4.1
years†
45.5% female

Cross-sectional ADA
(HbA1c)

Hippocampal subfield
volumes:
CA1
CA2 + CA3
CA4
Dentate gyrus
Hippocampal tail
Fimbria
Hippocampal fissure
Molecular layer
Subiculum
Parasubiculum
Presubiculum
GMV
WMV
CSFV

Age
Gender
Education
BMI
Hypertension
Total cholesterol level
Presence of ApoE4

3T

52

Hirabayashi et Japan
al. 2016

Communitydwelling
Total:
N=1238, 74.8 ± 6.8
years†
56.4% female
Prediabetes:
Not provided
‡

Hou et al.
201621

Taiwan

Cross-sectional WHO
Data from the
Hisayama Study

TBV to ICV (global
brain atrophy)
HV to ICV
(hippocampal
atrophy)
HV to TBV
(hippocampal atrophy
beyond global brain
atrophy)

Non-T2D:
N=952, 75 ± 7.0
years†
60.3% female
Hospital outpatients Cross-sectional ADA (FPG) WM tracts (FA, RD,
AD)
Total:
N=118, 53.1 ± 8.9
years†
44.1% female
Prediabetes:
N=64, 52.8 ± 9.7
years†
43.8% female
Healthy controls:

Fully adjusted models:
Age
Sex
Education
Hypertension
Total cholesterol level
BMI
Smoking status
Alcohol intake
Regular exercise
Cerebrovascular lesions
on MRI
Antidiabetic medication

1.5T

Global brain V
Age
Gender

3T

53

Hou et al.
201612

Taiwan

N=54, 53.5 ± 7.9
years†
44.4% female
Hospital outpatients Cross-sectional ADA (FPG) GMV
ACC V
Total:
PCC V
N=118, 53.1 ± 8.9
MTG V
†
years
STG V
44.1% female
Insula V

Fully adjusted models:
Global brain V
Age
Gender
BMI
Education

3T

Prediabetes:
N=64, 52.8 ± 9.7
years†
43.8% female

Liang et al.
2019

China

Healthy controls:
N=54, 53.5 ± 7.9
years†
44.4% female
Hospital
Cross-sectional ADA (IFG
inpatients/outpatient
and/or IGT)
s
Total:
N=60, 53.9 ± 7.1
years†
66.7% female
Prediabetes:

WMLs (FA, MD, RD, N/A
AD)
Initial t-test revealed no
differences in gender,
age, education, BMI,
hypertension, total
cholesterol level, LDL
level between groups
(prediabetes versus
normoglycemia), but

3T

54

N=30, 55.0 ± 6.7
years†
66.7% female

Markus et al.
2017

Germany

Healthy controls:
N=30, age=52.8 ±
7.5 years†
66.7% female
Communitydwelling
Total:
N=1330, 49.3 (36,
69)§ years†
55.9% female
Healthy controls:
N=759, 45 (36, 55)§
years†
62.5% female
IFG:
N=310, 54 (45, 62)§
years†
42.9 female
IGT:
N=83, 50 (40, 61)§
years†

significant differences
were found for
triglyceride level and
HDL level

Cross-sectional ADA (IFG
and/or IGT)
Data from the
Study of Health
in Pomerania
(SHIP)

GMV
WMV

Sex
1.5T
Age
Weight
Total brain V/intracranial
V ratio
Education
Smoking status
Total cholesterol
level/HDL level ratio
Estimated glomerular
filtration rate
Fasting time

55

71.1% female

Marseglia et
al. 2019

Sweden

IFG+IGT:
N=114, 59 (51, 66)§
years†
45.6% female
CommunityLongitudinal
dwelling or
(cohort) (6
institutional living years)
Total:
N=2746, 72.7 ± 10.2
years†
62.7% female
Prediabetes:
N=947, 74.6 ± 10.4
years†
65.6% female

Reitz et al.
2017

United
States

ADA
(HbA1c)

Data from the
Swedish
National Study
on Aging and
CareKungholmen
(SNAC-K)

Healthy controls:
N=1557, 71.3 ± 10.0
years†
63.4% female
CommunityCross-sectional ADA
dwelling, Medicare and longitudinal (HbA1c)
recipients
(cohort) (4
years)
Total:

TBV
GMV
WMV
HV
WMHV

Sex
Education
Socioeconomic status
BMI
Hypertension
Heart diseases

1.5T

GMV
WMV
HV
Cerebral infarcts
WMHV

Fully adjusted models:
ICV
Age
Sex
Education

1.5T

56

N=618, 80.0 ± 5.4
years†
69.3% female

Ethnic group
Presence of ApoE4
Hypertension
Smoking status
BMI
HDL level

Prediabetes:
N=224, 80.6 ± 5.6
years†
71.0% female

Rusinek et al.
2015

United
States

Healthy controls:
N=115, 79.8 ± 5.4
years†
66.1% female
Not specified
Total:
N=87, 52.2 ± 4.6
years†
57.5% female
Prediabetes:
N=27, 50.9 ± 4.5
years†
52% female
Healthy controls:
N=37, 51.8 ± 3.8
years†
59% female

Cross-sectional Not
GM CBF
association
recognized;
Quantitative
insulin
sensitivity
check index

N/A

3T

57

Saczynski et
al. 2009

Iceland

Communitydwelling
Total:
N=4415; 76.2 ± 5.5
years†
58.5% female
Prediabetes:
N=1599, 75.9 ± 5.4
years†
52.5% female

Samaras et al. Australia
2014

Healthy controls:
N=2327, 76.4 ± 5.5
years†
65% female
Communitydwelling
Total:
N=795, 78.3 ± 4.79
years†
51.4% female
Prediabetes:
N=346, 78.6 ± 4.8
years†
44% female

Cross-sectional ADA (FPG)
and WHO
Data from the
(FPG)
Age
Gene/Environm
ent
SusceptibilityReykjavik Study
(AGESReykjavik)

TBV
GMV
WMV
Cerebral infarcts
WMLs

Fully adjusted models:
Age
Sex
Education
Hypertension
Smoking status
Physical activity
BMI
Myocardial infarction

1.5T

ADA (FPG) TBV
HV
CSFV
Parahippocampal
Data from the
gyrus V
Sydney Memory
Precuneus V
and Ageing
Frontal lobe V
(MAS) Study

Age
Sex
Education
Non-English speaking
background
Smoking status
Hypertension
Lipid-lowering or
antihypertensive
medications
ICV

1.5T

Longitudinal
(cohort) (2
years)

58

Schneider et
al. 2017

United
States

Healthy controls:
N=343, 78.0 ± 4.8
years†
56% female
Communitydwelling
Total:
N=1713, 75.2 years†
60.6.% female
Prediabetes:
N=514, 75.2 years†
61.7% female
Healthy controls:
N=597, 75 years†
59.7% female

Cross-sectional ADA
(HbA1c,
Data from the
FPG)
Atherosclerosis
Risk in
Communities
Neurocognitive
Study (ARICNCS)

TBV
Lobule V:
Frontal
Temporal
Occipital
Parietal
Deep grey subcortical
structure V:
Thalamus +
Caudate +
Putamen +
Global Pallidum
Alzheimer’s disease
signature region V:
Parahippocampal +
Entorhinal +
Inferior parietal
lobules +
Hippocampus +
Precuneus +
Cuneus
HV
Cerebral infarcts
LIs

Age
3T
Sex
Race/field centre location
Education
Smoking status
Hypertension
Cardiovascular disease
Presence of ApoE4
ICV

59

Shaw et al.
2017

Australia

Communitydwelling
Total:
N=322, 63.1 ± 1.5
years†
50% female
Prediabetes:
N=62, 62.9 ± 1.4
years†
34% female

Storz et al.
2018

Germany

Healthy controls:
N=212, 63.1 ± 1.5
years†
55% female
Communitydwelling
Total:
N=243, 55.6 ± 8.9
years†
37.9% female

Lobar
microhemorrhages
Subcortical
microhemorrhages
WMHV
Cross-sectional WHO (FPG; Cortical thickness
and longitudinal two or more
(12 years)
measurement
s)
Data from the
Personality and
Total Health
Through Life
(PATH) Study

Age
Age2
Sex
Education
BMI
Presence of ApoE4
Hypertension
Physical activity
Depression status
ICV

1.5T

Note, these covariates
varied across analyses

Cross-sectional WHO
(case-control)

ARWMC

N/A

3T

60

Prediabetes:
N=48, 55.9 ± 8.9
years†
29.2% female

van Agtmaal
et al. 2018

Netherlan
ds

Healthy controls:
N=157, 54.2 ± 8.8
years†
43.3% female
Communitydwelling
Total:
N=2228, 59.3 ± 8.2
years†
48.3% female
Prediabetes:
N=347, 61.1 ± 7.6
years†
44.5% female
Healthy controls:
N=1373, 57.6 ± 8.1
years†
55.6% female

Cross-sectional WHO
Data from the
Maastricht
Study

GMV
WMV
CFSV
LIs
WMHV
CMBs

Fully adjusted models:
Age
Sex
ICV
Time between baseline
and MRI
BMI
Education
Smoking status
Total cholesterol
level/HDL level ratio
Triglyceride level
Estimated glomerular
filtration rate
Office systolic blood
pressure or 24-hour
systolic blood pressure
Blood pressure-lowering
and lipid-modifying

3T

61

Vergoossen et Netherlan
al. 2020
ds

Communitydwelling
Total:
N=2219, 59.3 ± 8.2
years†
48.5% female

Cross-sectional WHO
Data from the
Maastricht
Study

WM tractography:
Node degree
Topology:
Clustering
coefficient
Local efficiency
Global efficacy
Communicability

Prediabetes:
N=348, 61.2 ± 7.5
years†
44.8% female
Healthy controls:
N=1361, 57.6 ± 8.1
years†
55.8% female

Walsh et al.
2018

Australia

Communitydwelling
Total:
N=494, 64.7 ± 9.8
years†
49.2% female

Cross-sectional ADA (FPG;
two or more
Data from the
measurement
Personality and s)
Total Health
Through Life
(PATH) Study

TBV
GMV
WMV
Thalamus V
Corpus callosum V

medication
Urinary albumin
excretion
Age
Sex
Education
MRI date
BMI
Total cholesterol
level/HDL level ratio
Lipid-modifying
medication
Office systolic blood
pressure
Antihypertensive
medication
Cardiovascular disease
MRI lag time
Average node degree
Note, these covariates
varied across analyses
Age
Sex
ICV
Cohort (age group)
Education
Hypertension
Smoking status

3T

1.5T

62

Physical activity
Prediabetes:
N=95, 65.8 ± 10.0
years†
32.6% female
Healthy controls:
N=353, 63.7 ± 9.6
years†
55.0% female
†

Mean age.
Age range.
‡
Non-T2D group included both healthy controls (normoglycemic) and prediabetics.
F = female; T = tesla; V = volume; WM = white matter; GM = grey matter; TBV = total brain volume; GMV = grey matter volume; WMV =
white matter volume; HV = hippocampal volume; CFSV = cerebrospinal fluid volume; ICV = intracranial volume; WMHV = white matter
hyperintensity volume; WMLs = white matter lesions; CMBs = cerebral microbleeds; LIs = lacunar infarcts; CBF = cerebral blood flow;
ARWMC = age-related white matter changes; FA = fractional anisotropy; MD = mean diffusivity; RD = radial diffusivity; AD = axial
diffusivity; ACC = anterior cingulate cortex; PCC = posterior cingulate cortex; MTG = middle temporal gyrus; STG = superior temporal
gyrus; BMI = body mass index; HDL = high-density lipoprotein; LDL = low-density lipoprotein; IFG = impaired fasting glucose; IGT =
impaired glucose tolerance; FPG = fasting plasma glucose; HbA1c = hemoglobin A1c; WHO = World Health Organization; ADA =
American Diabetes Association.
§

63

2.3.2

Volumetric measures – 13 studies

Thirteen studies (nine cross-sectional, four longitudinal) assessed volumetric brain measures,
including TBV, GMV, WMV, cerebrospinal fluid volume (CSFV), HV, regional subfield
volumes, and cortical thickness. Results of these studies (comparing prediabetic and
normoglycemic groups) are summarized in Table 2.3.

2.3.2.1

Cross-sectional

One study by Hirabayashi and colleagues (2016) assessed the relationship between diabetes
status (normoglycemia, IFG, IGT, T2D) and brain atrophy in older adults.16 The authors
examined ratios of TBV to intracranial volume (ICV) as an indicator of global brain atrophy,
HV to ICV as an indicator of hippocampal atrophy, and HV to TBV as an indicator of
hippocampal atrophy beyond global brain atrophy.16 When compared to those with
normoglycemia, mean values for the three ratios were found to be similar in the IFG and IGT
groups.16 However, the 2-h PG (but not FPG) trend was significant for all three ratios,
indicating differences in diabetes measures.16
In another study examining IFG and IGT separately, Markus and colleagues (2017) measured
GMV and WMV in adults with normal glucose tolerance (NGT), isolated IFG, isolated IGT,
combined IFG and IGT (IFG+IGT), and undiagnosed T2D.17 Results showed significantly
lower GMV in the IFG group, but not in the IGT or IFG+IGT groups, when compared to the
NGT group.17 However, the IGT groups were underpowered.17 Significant inverse
associations were also found for FPG and 2-h PG levels with GMV, but no association was
found for HbA1c levels and GMV.17 Moreover, a 1 mmol/l increase in FPG was associated
with a decrease of 7.02 ml in GMV, whereas a 1 mmol/l increase in 2-h PG was associated
with a decrease of 1.97 ml in GMV.17 For WMV, no between group differences were found
across all groups.17
A third cross-sectional study examined WMV, GMV, and CSFV in adults.6 Compared to
normoglycemia, prediabetes was associated with significantly smaller WMV and larger
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CSFV.6 Interestingly, the regression coefficient of prediabetes with WMV was
approximately one-half that of T2D, suggesting a progressive decline.6 No differences were
found between prediabetes and normoglycemia for GMV.6 In general, higher HbA1c, FPG,
and 2-h PG levels were associated with lower WMV and GMV and higher CSFV.6
In a similar study, Saczynski and colleagues (2009) assessed differences in TBV, GMV, and
WMV in older adults with normoglycemia, IFG, and T2D.3 In adjusted models, no
significant associations were present between those with normoglycemia and IFG for any
volumetric measures.3 HbA1c levels were also not associated with brain volumes in general
analyses.3
Walsh and colleagues (2019) took a unique approach to examining TBV, GMV, WMV,
thalamus volume, and volume of the corpus callosum in adults.18 Participants were
characterized as having normal fasting glucose (NFG), IFG, or T2D based on glucose
measurements, and data was divided into quartiles based on brain volume sizes.18 In those
with average and small brains (50th and 25th percentiles, respectively), regression analyses
showed that IFG was positively associated with TBV.18 In individuals with average-sized
brains, IFG was positively associated with GMV, and in those with small brains, IFG was
positively associated with WMV.18 In those with large brains (75th percentile), BMI × blood
glucose interaction was positively associated with TBV.18
In a cross-sectional study measuring grey matter alterations in adults with IFG and those with
normoglycemia, those with IFG were found to have lower GMVs than those with
normoglycemia in the right ACC, right posterior cingulate cortex, left insula, left superior
temporal gyrus, and left MTG.13 In addition, serum glucose levels were negatively correlated
with total GMV and right ACC GMV.13 Similarly, a study assessing reductions in subcortical
grey matter structures (thalamus, caudate, putamen, pallidum, hippocampus, amygdala,
nucleus accumbens) showed significantly lower volumes for the left hippocampus, left
amygdala, and right putamen in prediabetics when compared to those with normoglycemia.19
No significant differences were found between prediabetes and T2D in this study.19
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Additionally, Dong and colleagues (2019) examined HV, hippocampal subfield volumes
(CA1, CA2 + CA3 combined, CA4, dentate gyrus, hippocampal tail, fimbria, hippocampal
fissure, molecular layer, subiculum, parasubiculum, and presubiculum), GMV, WMV, and
CSFV in adults with normoglycemia, prediabetes, and T2D.4 Compared to those with
normoglycemia, prediabetics had smaller left hippocampal tail volumes.4 No significant
differences were found between these two groups for other brain measures.4 Among all
participants, significant correlations were found between HbA1c levels and total HV, left
hippocampal tail, right presubiculum, and bilateral dentate gyrus, subiculum, and molecular
layer.4
A final cross-sectional study examined regional brain volumes in adults with normoglycemia,
prediabetes, and T2D.12 Volumetric measures were reported for total brain, lobules (frontal,
temporal, occipital, parietal), deep grey subcortical structure (defined as total volume of the
thalamus, caudate, putamen, globus pallidum), Alzheimer’s disease signature region (defined
as total volume of the parahippocampal, entorhinal, and inferior parietal lobules,
hippocampus, precuneus, cuneus), and hippocampus.12 Prediabetics did not significantly
differ in brain volumes when compared to those with normoglycemia.12 In general however,
increased HbA1c levels were associated with decreased TBV.12

2.3.2.2

Longitudinal

In a longitudinal cohort study in older adults, Reitz and colleagues (2017) assessed GMV,
WMV, and HV in those with NGT, prediabetes, undiagnosed T2D, and known T2D.10 At
baseline, there were no significant differences in measures between prediabetes and NGT.10
Comparatively, dysglycemia was associated with decreased WMV, GMV, and HV; however,
since prediabetes and T2D were grouped together within the dysglycemia classification, it is
unclear which group may be driving this association.10 In adjusted models, continuous
HbA1c levels were associated with lower TBV when the sample was restricted to NGT and
prediabetic individuals.10 Longitudinal analyses across four years also found that increased
dysglycemia was associated with a significant decline in GMV, but not WMV or HV,
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compared to NGT.10 When dysglycemia was separated into prediabetic and T2D groups, no
significant rate of change was observed, but it was noted that WMV and HV were
appreciably lower in these groups compared to NGT.10
A second longitudinal cohort study measured brain volumes (TBV, HV, CSFV,
parahippocampal gyrus volume, precuneus volume, and frontal lobe volume) in older adults
with NFG, IFG, and T2D.20 At the two-year follow-up, individuals who had IFG at baseline
showed significant declines in HV and parahippocampal gyrus volume compared to those
who had NFG at baseline.20 However, this relationship was altered when the blood glucose
status at the two-year follow-up was considered.20 Those who maintained stable IFG status
(IFG at both assessment times) had similar declines in brain volumes as those who had stable
NFG.20 Comparatively, those who developed an incident glucose disorder (NFG at baseline,
and IFG at follow-up) had significant decline in TBV and frontal lobe volumes, but not HV
or parahippocampal gyrus volume.20
Shaw and colleagues (2017) conducted a 12-year longitudinal study in older adults to
examine the association between blood glucose levels and cortical thinning in NFG, IFG, and
T2D.21 At baseline, cortical thickness did not significantly differ between those with IFG and
NFG.21 For IFG, a trending, yet non-significant difference was found between higher FPG
levels and age-related cortical thinning in the right insular cortex and an at-trend level result
was found in the right posterior cingulate cortex, right parahippocampal gyrus, left medial
orbitofrontal cortex, and left fusiform gyrus.21 Additionally, mean annual percent change
(APC) in cortical thickness was significantly associated with baseline FPG levels for IFG.21
Finally, increased FPG levels were associated with higher APC regardless of diabetes
status.21
In a final longitudinal cohort study in older adults, prediabetes but not T2D was associated
with smaller TBV, particularly in the WMV, when compared to those with normoglycemia;
no differences existed between prediabetes or T2D and normoglycemia for HV or GMV.5
However, hyperglycemia in general was positively associated with smaller TBV.5
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Longitudinally across six years, no significant differences in rate of decline for brain
measures were found between prediabetes or T2D and normoglycemia.5
In summary, of the 13 studies assessing volumetric measures, seven provide evidence that
prediabetics experience some brain volumetric decline compared to those with
normoglycemia.4,5,6,13,17,19,20 One study argued that brain deficits seen in prediabetes occur in
a progressive declining manner,6 such that prediabetics experience decline greater than those
with normal glucose levels but less than diabetics. Another study showed that prediabetes is
positively associated with various volumetric measures, depending on one’s brain volume
size.18 In addition, multiple studies showed that blood glucose level is positively correlated
with neural decline,4,5,6,10,12,13,16,17,21 even irrespective of diabetes status.21 Two studies also
found differences in results based on the varying diagnostic measures used,16,17 suggesting
that this may account for the variation in findings.
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Table 2.3: Results of volumetric measure studies.
Reference

TBV

GMV

WMV

HV

CSFV

Thalamus

Other

Cui et al. 2019

N/A

N/A

N/A

+
(left)

N/A

-

+
left amygdala, right putamen

Dong et al.
2019

N/A

-

-

-

-

N/A

caudate, pallidum, nucleus accumbens
+
left hippocampal tail

Hirabayashi et
al. 2016

N/A

N/A

N/A

N/A

N/A

N/A

Hou et al.
201612

N/A

N/A

N/A

N/A

N/A

N/A

Markus et al.
2017

N/A

+
(IFG group,
but not IGT or
IFG+IGT
groups)
-

-

N/A

N/A

N/A

CA1, CA2 + CA3, CA4, dentate gyrus,
fimbria, hippocampal fissure,
molecular layer, subiculum,
parasubiculum, presubiculum
global brain atrophy, hippocampal
atrophy, hippocampal atrophy beyond
global brain atrophy
+
right ACC, right PCC, left insula, left
STG, left MTG
N/A

+

-

N/A

N/A

N/A

Marseglia et al.

+
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2019
Reitz et al.
2017
Saczynski et
al. 2009
Samaras et al.
2014

N/A

-

-

-

N/A

N/A

N/A

-

-

-

N/A

N/A

N/A

N/A

+
(incident
glucose
disorder)

N/A

N/A

-

-

N/A

+
Frontal lobe (incident glucose disorder)

Schneider et al.
2017

-

N/A

N/A

-

N/A

N/A

Shaw et al.
2017
van Agtmaal et
al. 2018
Walsh et al.
2018

N/A

N/A

N/A

N/A

N/A

N/A

N/A

-

+

N/A

+‡

N/A

+‡

+‡

+‡

N/A

N/A

-

Parahippocampal gyrus,
precuneus
lobules: frontal, temporal, occipital,
parietal; deep grey subcortical
structure: thalamus + caudate +
putamen + globus pallidum;
Alzheimer’s disease signature region:
parahippocampal + entorhinal +
inferior parietal lobules, +
hippocampus + precuneus + cuneus)
cortical thickness
N/A
corpus callosum

“+” indicates significant findings in the prediabetes group (smaller volume) compared to the normoglycemic group; all results were statistically
significant.
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“-” indicates non-significant differences between the prediabetes and normoglycemic groups.
‡
larger volume in the prediabetes group compared to the normoglycemic group.
IFG = impaired fasting glucose; IGT = impaired glucose tolerance; ACC = anterior cingulate cortex; PCC = posterior cingulate cortex; MTG =
middle temporal gyrus; STG = superior temporal gyrus.
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2.3.3

Structural connectivity – 3 studies

Three cross-sectional studies examined structural connectivity in adults (e.g., microintegrity,
white matter organization). Results of these studies (comparing prediabetic and
normoglycemic groups) are summarized in Table 2.4.
In one study, Hou and colleagues (2016) used a type of diffusion-weighted MRI (dMRI)
known as diffusion tensor imaging (DTI) to assess microintegrity alterations of white matter
tracts in both adults with IFG and those with NFG.22 Three parameters were used to assess
microintegrity: fractional anisotropy (FA; measures the fraction of diffusion of water in
tissue that is directionally dependent), radial diffusivity (RD; the magnitude of diffusion
perpendicular to axonal fiber tracts), and axial diffusivity (AD; the magnitude of diffusion
parallel to axonal fiber tracts).22,23 FA values were found to be lower in the bilateral anterior
thalamic radiation (ATR), left superior longitudinal fasciculus (SLF), and left inferior
longitudinal fasciculus (ILF) of those with IFG compared to those with NFG.22 Additionally,
those with IFG had lower RD values in the bilateral ATR and left ILF, and lower AD values
in the bilateral ATR and left SLF.22 Serum preprandial glucose levels were also negatively
correlated with FA values in the left ATR and left ILF in those with IFG.22
A second DTI study measured FA, mean diffusivity (MD; the overall directionally averaged
magnitude of diffusion23), RD, and AD to assess microscopic WMLs.24 Compared to adults
with normoglycemia, FA was smaller in the right part of the corpus callosum body, right
superior longitudinal fasciculus, and SLF in prediabetics.24 No significant differences were
found in MD, RD, or AD values between these groups.24
In a final dMRI study, Vergoossen and colleagues (2020) assessed white matter network
organization in adults.25 Specifically, the authors examined the number of white matter
connections (node degree) between several brain regions as well as topology (graph
measures, including clustering coefficient - number of connections between nearest
neighbours of a region as a proportion of total possible connections, labelled as “clusters”;
local efficiency - average efficiency of local clusters; global efficiency - the inverse of the
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average shortest path length; and communicability - a measure of all possible paths of
communication between regions).25 Results showed that individuals with prediabetes had
significantly lower node degrees (i.e., fewer white matter connections) compared to those
with normoglycemia.25 Prediabetics also had smaller tract volumes of several
intrahemispheric connections associated with aging, compared to those with
normoglycemia.25 In addition, the local efficiency and clustering coefficient were lower (i.e.,
weaker local connectivity) in prediabetics compared to those with normoglycemia, although
these effects diminished in fully adjusted models.25 In general, continuous measures of
hyperglycemia were associated with lower node degree, as well as higher communicability
(likely the result of increased WML load).25 However, in fully adjusted analyses, the
association between HbA1c and communicability was non-significant, but was significant for
FPG and 2-h PG.25
In summary, all three studies assessing structural connectivity demonstrated some deficits in
prediabetes.22,24,25 Deficits seen in prediabetes included DTI abnormalities and altered neural
network organization and function. One study argued that prediabetes accelerates aging
processes in the brain, and found varying results based on diagnostic measures used.25 Two
studies also provided more evidence that continuous levels of hyperglycemia is associated
with neural decline.22,25
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Table 2.4: Results of structural connectivity studies.
Reference
Hou et al. 201621

FA

RD

AD

+
+
+
ATR, left SLF, left ILF ATR, left ILF ATR, left SLF
Liang et al. 2019
+
corpus callosum body,
left and right SLF
Vergoossen et al.
N/A
N/A
N/A
2020

MD

Node degree

Other

N/A

N/A

N/A

-

N/A

N/A

N/A

+

+
tract volumes of intrahemisphereic
connections
clustering coefficient, local
efficiency global efficiency,
communicability

“+” indicates significant findings in the prediabetes group (greater deficits in structural connectivity) compared to the normoglycemic group; all
results were statistically significant.
“-” indicates non-significant differences between the prediabetes and normoglycemic groups.
ATR = anterior thalamic radiation; SLF = superior longitudinal fasciculus; ILF = inferior longitudinal fasciculus.
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2.3.4

Cerebrovascular health – 8 studies

Eight studies (six cross-sectional, two longitudinal) examined cerebrovascular pathology,
including cerebral infarcts, cerebral microbleeds (CMBs), WMHs, and WMLs. Results of
these studies (comparing prediabetic and normoglycemic groups) are summarized in Table
2.5.

2.3.4.1

Cross-sectional

One study assessed differences in vascular pathology (cerebral infarcts, lacunar infarcts (LI),
lobar microhemorrhages, subcortical microhemorrhages) and WMH volume (WMHV) in
adults with normoglycemia, prediabetes, and T2D.12 No significant differences in
cerebrovascular measures were found between prediabetes and normoglycemia.12
A similar cross-sectional study in adults assessed differences in LIs, WMHV, and CMBs.6
Compared to normoglycemia, prediabetes was associated with more LIs and larger WMHV,
specifically deep cortical WMHs and periventricular WMHs.6 Interestingly, the regression
coefficients of prediabetes for WMHV were approximately one-third to one-half that of the
T2D coefficient, suggesting a progressive nature of decline.6 Prediabetes was not associated
with the presence of CMBs.6 Additionally, continuous hyperglycemia was associated with
LIs and higher WMHV.6 Another study measuring cerebral infarcts and WMLs in older
adults found no differences between IFG and normoglycemia.3 In this study, HbA1c levels
were also not associated with cerebral infarcts in general analyses.3
A fourth cross-sectional study examined grey matter cortical perfusion in adults using arterial
spin labeling MRI in normoglycemia, prediabetes (insulin resistant), and T2D.26 Grey matter
cerebral blood flow was found to be significantly lower in prediabetes, compared to
normoglycemia, but not in T2D as most diabetics were being treated with medications to
lower their blood pressure.26
Finally, in a cross-sectional case-cohort study, Bamberg and colleagues (2017) examined the
presence of WMLs, CMBs, and age-related white matter changes (ARWMC) in adults.27 No
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significant differences in WMLs were found between normoglycemia and prediabetes.27
Prediabetics were shown to have higher ARWMC scores compared to those with
normoglycemia, but these results attenuated after adjustment.27 No significant differences
were observed in CMBs across all groups (normoglycemia, prediabetes, T2D).27 On the
contrary, one cross-sectional case-control study did find significantly higher ARWMC scores
in adults with prediabetics compared to those with normoglycemia.28

2.3.4.2

Longitudinal

One longitudinal cohort study assessed WMHV and number of cerebral infarcts in older
adults with NGT, prediabetes, and T2D.10 The authors found no significant differences
between measures in NGT versus prediabetes at baseline.10 In adjusted models, continuous
HbA1c levels were positively associated with WMHV.10 Moreover, continuous HbA1c levels
in NGT only were associated with higher WMHV.10 Dysglycemia was associated with higher
WMHV and more cerebral infarcts, however as previously mentioned prediabetes and T2D
were grouped together within the dysglycemia classification.10 In longitudinal analyses
across four years, no significant differences in rate of change of brain measures were found,
but those with dysglycemia had persistently higher WMHV compared to NGT.10
Lastly, a separate longitudinal study in older adults found that prediabetes was not associated
with larger WMHV or faster WMHV accumulation over time (across six years) compared to
those with normoglycemia.5 However, hyperglycemia was positively associated with larger
WMHV in this study.5
In summary, only three of the eight studies assessing cerebrovascular health showed deficits
in prediabetes (cerebral infarcts, CMBs, WMHs, WMLs).6,26,28 One study previously
mentioned again provided evidence of the progressive nature of decline,6 such that
prediabetics experience decline greater than those with normoglycemia but less than
diabetics. Three studies also demonstrated that increased hyperglycemia in general is
associated with decline in cerebrovascular health.5,6,10 Even within a normoglycemic range,
increased HbA1c levels was shown to be associated with brain deficits.10
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Table 2.5: Results of cerebrovascular health studies.
Reference
Bamberg et al.
2017
Marseglia et
al. 2019
Reitz et al.
2017
Rusinek et al.
2015
Saczynski et
al. 2009
Schneider et
al. 2017

Storz et al.
2018
van Agtmaal
et al. 2018

Cerebral
infarcts
N/A

LIs

CMBs

WMHV

WMLs

ARWMC

Other

N/A

-

N/A

-

-

N/A

N/A

N/A

N/A

-

N/A

N/A

N/A

-

N/A

N/A

-

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

-

N/A

N/A

N/A

-

N/A

+
CBF
N/A

-

-

N/A

-

N/A

N/A

N/A

N/A

N/A

N/A

+

lobular microhemorrhages,
subcortical
microhemorrhages
N/A

N/A

+

-

+

N/A

N/A

N/A

“+” indicates significant findings in the prediabetes group (greater cerebrovascular pathology) compared to the normoglycemic group; all results
were statistically significant.
“-” indicates non-significant differences between the prediabetes and normoglycemic groups.
LIs = lacunar infarcts; CMBs = cerebral microbleeds; WMHV = white matter hyperintensity volume; WMLs = white matter lesions; ARWMC =
age-related white matter changes; CBF = cerebral blood flow.
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2.3.5

Quality of included studies

As described in Table 2.1, all 19 articles included in this systematic review stated their
research objective clearly, defined their study population, specified their inclusion and
exclusion criteria, and described their outcome measures in detail. Of the 19 articles, only
one provided a sample size calculation or power description, and 16 accounted for
appropriate confounding variables in their relevant MRI data analyses. One article did not
use a prediabetes classification that was recognized by an international association (e.g.,
WHO or ADA).

2.4 Discussion
We conducted the first systematic review to our knowledge examining brain health in adults
who have prediabetes but are otherwise healthy. Based on our review, we found that deficits
in structural connectivity appear to be present in prediabetics. Other deficits that may exist in
this population include smaller brain volumes and cerebrovascular pathology; however,
mixed results in these areas were found.
Specifically, for studies that examined brain volume, no single brain region had consistent
positive findings (indicative of reduced brain volume in prediabetes) across studies. For
example, HV was lower in prediabetics compared to those with normoglycemia in Cui et al.
(2019)19 but no significant differences between groups were found in Marseglia et al. (2019)5
or any of the other studies assessing HV.4,10,12,20 Similarly, positive findings from studies
assessing cerebral infarcts, LIs, CMBs and other indicators of cerebrovascular health
(indicative of pathology in prediabetes) were inconsistent. Comparatively, some
consistencies were found across structural connectivity studies, as both dMRI studies
measuring FA showed lower levels in prediabetics compared to those with
normoglycemia.22,24 Thus, it may be the case that some changes in brain microstructure (e.g.,
FA) are present in prediabetes prior to measurable macro-level changes such as reduced
WMV.
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Surprisingly, one volumetric study found that prediabetics had larger TBV, GMV, and WMV
compared to those with normoglycemia (this was mediated by brain volume size).18
Regardless of brain size, increased brain volume in IFG may be the result of
neuroinflammation as an initial effect of hyperglycemia.5,6 To note, this study also did not
provide a power calculation or sample size calculation, and thus the validity of their
statistical findings may be questioned. In a separate study, prediabetes but not T2D was
associated with smaller TBV.5 However, whether T2D is associated with smaller TBV
remains controversial, as other studies have shown that this association exists.3,12 Another
surprising finding was that in one study, RD values were shown to be lower in prediabetics
compared to those with normoglycemia, suggesting that prediabetics may experience less
myelin abnormalities than healthy controls.22 While some research has shown that RD is
positively correlated with dysmyelination or demyelination,29 other research has suggested
that alterations in white matter microintegrity may instead be derived from glial cell
alterations.30 Evidently, it currently remains unknown as to what RD values represent, thus
RD results must be interpreted with caution. Furthermore, as suggested by the authors, more
research on RD and the causes of variation is needed.22
A more general finding from our review is that blood glucose levels may correlate with brain
decline regardless of clinical definitions of diabetic status. The majority of studies in our
review that assessed correlational evidence of blood glucose levels and brain health decline
found a positive relationship between the two.4,5,6,10,12,13,16,17,21,22,25 Moreover, even those with
normoglycemic status may begin to experience some brain deficits with increases in blood
glucose.10,21 As previously mentioned, a fundamental mechanism that may explain the
association between elevated glucose and deficits in brain health is cardiovascular
comorbidities such as hypercholesterolemia and hypertension, which may lead to
microvascular changes, endothelial dysfunction, and atherosclerosis.17,31 Studies have shown
that elevated glucose levels, even in the normal range, lead to the production of advanced
glycation end products (AGEs) and promote oxidative stress, which may lead to neuronal
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dysfunction and cell death.17,32,33 Thus, brain deficits may occur in any scenario in which
there are increases in blood glucose levels as a result of micro-level changes.
Importantly, one possible explanation for inconsistencies across study findings in our review
is varying diagnostic measures used and definitions of prediabetes. For example, the oral
glucose tolerance test (OGTT) used to produce 2-h PG levels has been shown to have low
reproducibility,34,35 yet may have superior sensitivity compared to FPG.36 The majority of
studies in our review that used FPG or OGTT also only collected single-measurements of
glucose which may lead to low accuracy in diagnoses. Additionally, whether HbA1c is an
appropriate diagnostic tool for diabetes remains controversial. Currently, the WHO does not
consider HbA1c to be a suitable diagnostic test for diabetes,8 however the ADA argues that it
is a reliable measure of chronic glycemia,9 as it correlates well with long-term diabetes
complications.37 As such, the accuracy and reliability of diagnostic measures used in
included studies may be questioned, and could have resulted in misdiagnoses and/or false or
missed results. Furthermore, some studies in our review that directly compared diagnostic
measures16,17,25 found significant differences in results between tests, highlighting the need
for a more standardized diagnostic measure.
Aside from diagnostic variability, there are several other limitations of the included studies
that should be addressed. First, no studies considered the duration of prediabetes diagnosis in
their sample. One study, for example, showed that duration of T2D is correlated with greater
brain deficits,12 and this may also be the case in prediabetes. Second, some studies that had
three groups (T2D, prediabetes, normoglycemia) ran omnibus testing without additional posthoc testing, thus it was not clear where differences between groups existed and made it
difficult to assess the relationship of prediabetes and T2D. Third, there was a wide variation
in study methodologies, including setting, inclusion/exclusion criteria, adjusted covariates in
analyses, and MRI scanners used. As such, the heterogeneity between studies makes it
difficult to compare between them and make concrete conclusions, and could be the
reasoning behind inconsistent findings. Most studies in this review also did not conduct a
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power calculation or provide a sample size justification, and thus the validity of findings may
be questionable.
Another large limitation is that the majority of studies did not provide effect sizes of
significant findings, particularly those pertaining to between-group differences. Thus, we
were unable to appropriately gauge the magnitude of results seen in prediabetes, nor
determine whether non-significant results were due to inadequate power to detect differences.
In addition, most studies had age ranges that included both middle and older adults, thus we
cannot comment on the results of these two groups separately, and how age may have
affected results. Typically, glucose levels increase with age,38 and thus older adult groups
may have experienced more brain deficits compared to younger adults as a result of the
natural aging process. Lastly, one limitation to our review is that cross-sectional and
longitudinal studies do not allow us to infer causal relationships between variables, hence we
cannot conclude that prediabetes causes brain deficits.
Future studies assessing prediabetes and brain health should use more consistent diagnostic
tools and procedures to be able to produce replicable results. Moreover, more longitudinal
studies are needed to assess the relationship between changes in glucose levels and brain
health over time. More research evaluating structural connectivity changes is also needed to
provide stronger evidence for its relationship to prediabetes and its potential for further
structural decline. Additionally, one study in our review explicitly provided evidence that
prediabetes is progressive in nature,6 such that greater neural decline occurs as
normoglycemia progresses to prediabetes and eventually T2D. As such, more studies
examining direct comparisons between prediabetes and diabetes are needed in order to shed
light on this possible progression of the disease.
Finally, as our review focused mainly on structural deficits in prediabetes, future studies
should also examine functional activation patterns and connectivity in this population.
Currently, there are only two known studies that have examined this. One study by Liu and
colleagues (2019) assessed functional connectivity in the default mode network in
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prediabetics and found no differences compared to healthy normoglycemic controls.39
Another study by van Bussel et al. (2016) found that prediabetics display altered functional
brain networks compared to controls.40 Evidently, more research on brain function in
prediabetics is needed.
In conclusion, this systematic review presents some evidence that prediabetics may
experience deficits in brain volume, structural connectivity, and cerebrovascular health
compared to non-diabetics. However, more cross-sectional and longitudinal studies that use
standardized protocols are needed to allow for more direct comparisons between studies.
Ultimately, understanding micro- and macro-level changes in the brain that may occur in
prediabetes can help inform future intervention work in this population.
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Summary
This chapter reported findings from a systematic review of cross-sectional and longitudinal
studies that examined brain deficits in prediabetic adults using MRI. Results show that
deficits in structural connectivity may be present in prediabetes, however mixed results were
shown for volumetric measures and cerebrovascular health. These findings suggest that
changes in brain microstructure may be present in prediabetes prior to measurable macrolevel changes. Additionally, blood glucose levels were positively correlated with brain
deficits regardless of diabetes status (e.g., even in normoglycemia). A mechanism that may
explain this association is cardiovascular comorbidities that often occur in prediabetes,
including hypertension.
One possible explanation for the inconsistencies across study findings is the use of varying
diagnostic measures and definitions of prediabetes, highlighting the need for more
standardized measures and classifications. Future studies should consider using multiple
measurements of glucose to increase accuracy, and it is suggested that HbA1c be measured
for a better indication of chronic glycemia levels.
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Chapter 3

3

Scientific outcomes: Cognitive changes following 26
weeks of resistance exercise in older adults at risk for
diabetes

This chapter will explore the cognitive changes in older adults at risk for diabetes following a
26-week pilot randomized controlled trial of resistance exercise. A manuscript for the
reported findings is currently in preparation.
Some content in Chapter 3 is from the following published protocol manuscript:
Furlano JA, Nagamatsu LS. Feasibility of a 6-month pilot randomised controlled trial of
resistance training on cognition and brain health in Canadian older adults at-risk for
diabetes: study protocol. BMJ Open. 2019;9(10),e032047. doi:10.1136/bmjopen-2019032047

3.1 Introduction
Dementia, including Alzheimer’s disease, affects approximately 55 million people
worldwide,1 and is a major cause of disability among older adults.2 One of the largest
modifiable risk factors for dementia is T2D,3 characterized by high blood glucose levels. In
fact, individuals with T2D are at a 50% or greater risk of developing dementia compared to
those without T2D.4,5 Furthermore, there is increasing evidence that T2D is associated with
deficits in a variety of cognitive domains. In a meta-analysis, it was shown that adults and
older adults with T2D experience deficits in all evaluated cognitive abilities, including
processing and motor speed, attention, non-verbal reasoning, and memory, when compared
to diabetes-free individuals.6
Importantly, older adults with prediabetes (i.e., those with elevated blood glucose levels that
are below the T2D cutoff) already show evidence of cognitive decline. In one cross-sectional
study, prediabetes in adults and older adults was found to be related to some deficits in global
cognition, processing speed, and executive function compared to normal glucose tolerance.7
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Similarly, Marseglia and colleagues (2016) found that older adults with prediabetes perform
significantly worse on cognitive tasks assessing memory, perceptual speed, and category
fluency compared to healthy age-matched controls.8 Within the same data set, prediabetes
was also found to be associated with faster cognitive decline over nine years compared to
diabetes-free status.9 Moreover, glucose regulation has been shown to be inversely related to
cognitive function. This was demonstrated, for example, in a study by Convit and colleagues
(2003) where a negative correlation was found between glucose levels and delayed memory
recall even in healthy middle-aged and older adults.10
Another risk factor for T2D is obesity, a common comorbidity of prediabetes. Like
prediabetics, overweight (BMI 25–29.9) or obese (BMI 30 and above) individuals already
experience some cognitive dysfunction that is associated with T2D. One review and metaanalysis found that those with obesity showed impairments in executive function (response
inhibition, cognitive flexibility, working memory), while overweight participants showed
deficits in inhibition and working memory specifically.11 In another review assessing the
relationship between executive function and excessive body weight, most included studies
found that overweight or obese individuals have impaired inhibitory control, working
memory, and cognitive flexibility compared to those with in the normal weight range (BMI <
25).12 Taken together, it appears that older adults at risk for T2D experience cognitive
deficits that may worsen as the progression to T2D occurs, and intervention strategies aimed
at improving cognitive function in this at-risk group may represent an ideal time point to
prevent or delay future decline.
One promising lifestyle intervention that may improve cognitive function is exercise. Baker
and colleagues (2010) assessed the effects of aerobic training in sedentary older adults with
prediabetes or newly diagnosed T2D (the majority of participants were prediabetic).13
Participants were randomly assigned to an aerobic training or stretching control group, in
which they completed their respective exercise four times per week for six months.13 Results
showed that compared to the control group, those in the aerobic training group improved on
tasks of executive function including selective and divided attention, cognitive flexibility,

89

and working memory.13 Despite the majority of research on exercise and cognition focusing
on aerobic training, there are other forms of exercise that may also be beneficial for older
adults. Specifically, resistance training has been shown to improve cognitive function and
brain health in several populations of older adults. One study in sedentary women with mild
cognitive impairment found improvements in executive function and associative memory
following six months of progressive resistance training.14 Another study showed that six
months of moderate-to-high intensity resistance exercise improved short- and long-term
memory, attention, and executive function in older men.15 Furthermore, resistance training
has additional benefits for older adults, such as improving muscle function and reducing
sarcopenia,16 and may be useful for older adults who may suffer from some physical or
mobility limitations and cannot perform aerobic training. As most older adults can perform
some form of resistance training, it therefore provides older adults with an alternative form of
exercise that may benefit cognition.
Further benefits of resistance training are highlighted in animal and human research focused
on neural mechanisms. Research in rats have shown that resistance training may increase
IGF-1,17,18 known to have neuroprotective abilities associated with improved cognitive
function.19 Other research has shown that low levels of IGF-1 are associated with IGT and a
higher risk for T2D in humans. For example, Friedrich and colleagues (2012) found that low
levels of IGF-1 serum concentrations are associated with insulin resistance in adults of
various ages.20 Schneider et al (2011) measured IGF-1 levels in non-diabetic individuals and
assessed incident diabetes during follow-up, and found that patients with low IGF-1 levels
were at an increased risk for glucose intolerance and developing diabetes.21 Based on these
combined findings, resistance training may be particularly useful in not only improving
insulin resistance and reducing one’s risk of developing T2D, but also improving cognitive
function in our study population.
To our knowledge, this is the first study to examine the effects of resistance training on
cognition in older adults at risk for diabetes (i.e., those with prediabetes and/or obesity). To
address whether resistance training may benefit cognitive function in this population, a large-
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scale RCT is needed. However, we first conducted a pilot RCT to assess the feasibility and
efficacy of this training program in this at-risk group. Although the primary outcome
measure of this study was feasibility of the exercise program, here we will present
preliminary efficacy findings on cognition. Specifically, we hypothesized that 26 weeks of
thrice-weekly resistance training would lead to improvements in attention, executive
function, and memory in older adults at risk for T2D when compared to balance and
stretching exercises.

3.2 Methods
3.2.1

Study overview

We conducted a single-blinded pilot RCT of thrice-weekly resistance exercise for 26 weeks
in older adults at risk for T2D. Data was collected from November 2017 to August 2019.
Cognitive and physical assessments were conducted at baseline, midpoint (13 weeks), and
trial completion (26 weeks), and were conducted on Western University campus in London,
Ontario, along with all exercise sessions. To assess changes in brain structure and function,
MRI was done at baseline and trial completion at the Centre for Functional and Metabolic
Mapping at Robarts Research Institute; MRI findings are described in Chapter 4. Ethics
approval was obtained from the Health Sciences Research Ethics Board at Western
University, and our trial was registered at clinicaltrials.gov (ID NCT03254381; released
August 3, 2017). Written informed consent was obtained from all participants. The Standard
Protocol Items: Recommendations for Interventional Trials and Consolidated Standards of
Reporting Trials checklists were completed.
Initial screening of participants was conducted via telephone, and interested participants were
invited to come into the lab for three testing sessions on separate days to confirm eligibility
and collect baseline measures. Session 1 consisted of MRI screening and baseline cognitive
and physical testing (1.5 hours), while session 2 consisted of collecting FPG (which required
participants to fast eight hours prior to testing) and completing descriptive questionnaires (30
minutes). Assessments were divided into two days to avoid participants having to complete
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cognitively and physically demanding tests while fasting. Individuals who were deemed
eligible at the end of session 2 then completed an MRI scan during session 3 (1.5 hours;
described in Chapter 4). After baseline assessments were complete, participants were
randomized (randomisation.com; random block sizes of two, four and six) into either the
resistance training group or balance and tone (control) group by the Primary Investigator.
Participants were informed of their group allocation in order to obtain their personal
physicians’ approval to exercise, however they did not have direct contact with the other
exercise groups nor were they made aware of our hypotheses. All assessment staff were
blinded to group allocation.

3.2.2

Recruitment and Sample size

We recruited participants from the city of London, Ontario (urban community) on a rolling
basis via posters in community centres, short presentations at community seminars, word-ofmouth, and advertisements in the Villager Publications Community Magazine (print) and
Kijiji (online). We chose these recruitment methods based on the recommendation of
researchers at Western University whom have had success in recruiting older adults for
similar studies. Enrolment in the study was ongoing until we reached our target sample size
(10 participants per arm). This was the recommended size for a pilot study in which the fullscale trial would have an anticipated medium effect size (0.3 ≤ d < 0.7) and power of 0.80.22

3.2.3

Inclusion and exclusion criteria

To be included in our study, individuals had to: (1) be community-dwelling, (2) be aged 6080 years, (3) be ‘at risk’ for T2D, where they have BMI ≥ 25 and/or FPG 6.1 to 6.9 mmol/l;
the glucose range is based on the WHO’s classification of prediabetes,23 (4) score >24/30 on
Mini-Mental State Examination (MMSE)24, (5) score >6/8 on the Lawton and Brody
Instrumental Activities of Daily Living (IADL) Scale,25 (6) have visual acuity of at least
20/40 with or without corrective lenses, (7) speak and understand English fluently, and (8)
complete the Physical Activity Readiness Questionnaire and obtain their physician’s
clearance to start a supervised exercise program.26
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We excluded those who: (1) had a medical condition for which exercise was contraindicated,
(2) had participated regularly (>1/week) in structured resistance or aerobic exercise within
six months, (3) had been diagnosed with neurodegenerative disease (including dementia or
Parkinson’s disease), (4) had experienced a vascular incident (including stroke or myocardial
infarction), (5) had been diagnosed with a psychiatric condition, (6) had untreated
depression, (7) was on hormone replacement therapy, (8) had clinically significant peripheral
neuropathy or severe musculoskeletal or joint disease, (9) was taking psychotropic
medications, or (10) was unable to participate in MRI (had metal or electronic implants or
was claustrophobic).

3.2.4

Descriptive measures

To describe our sample and/or assess eligibility, we collected the following measures: (1)
demographic information (age, sex, education, income), (2) medication use, (3) falls history,
(4) sleep quantity and quality using a monthly questionnaire, (5) number and type of
comorbidities using the Functional Comorbidity Index,27 (6) ability to perform daily tasks
using the IADL, (7) depression screening using the Geriatric Depression Scale (GDS),28 and
(8) global cognitive impairment using the MMSE and Montreal Cognitive Assessment
(MoCA).29 FPG and BMI measures are described in section 3.2.8 below.

3.2.5

Feasibility outcomes

Our primary outcome measure of feasibility was assessed mainly via participant recruitment,
adherence, and retention rates. These outcomes will be presented in Chapter 5.

3.2.6

Cognitive outcomes

All standardized tests used to measure cognition were chosen based on their use within the
resistance exercise literature.
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3.2.6.1

Executive function

Selective attention and conflict resolution was measured via the Stroop Test.30 This test
features three conditions, in which participants are instructed to read words as quickly as
possible. For the first condition (A), participants read out words (names of colours) printed in
blank ink (e.g., ‘RED’). For the second condition (B), participants read out the colour of the
X’s that appear on the sheet (e.g., XXX printed in red ink, with the correct response being
‘red’). For the third condition (C), participants name the colour of the words (e.g., RED
printed in blue ink, with the correct response being ‘blue’), thus ignoring the written word
itself. Each condition has 80 trials, in which time to complete all trials (in seconds) is
recorded for each condition. We calculated the difference between time to complete
conditions C and B of the task, with lower scores indicating better cognitive performance.
Additionally, task-switching was measured via the TMT (Parts A and B).30 For this test,
participants are instructed to connect a set of 25 dots as quickly and accurately as possible,
and time to complete the task (in seconds) is recorded. In Part A, participants connect
encircled numbers (1 to 24) in sequential order. In Part B, participants connect encircled
numbers (1 to 12) and encircled letters (A to L) in alternating fashion (i.e., 1-A-2-B-3-C,
etc.). The time difference for completing Part B minus Part A was calculated, with lower
scores indicating better performance.
To assess working memory, we used the Digit Span Test (Forward and Backward).31 Both
conditions consist of seven pairs of random number sequences that are read out loud by the
assessor (one number per second), with each pair containing the same number of three or
more digits. The digits are increased by one across pairs of sequences (up to nine). For the
Forward test, participants repeat each sequence as it is read, while in the Backward test
participants repeat the sequence in reverse order. Testing ceases when the participant fails to
recollect both sequences within one pair. Scores range from 1 to 14 (one point is given for
each correct sequence). To measure the central executive component of working memory, we
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calculated Forward minus Backward scores, with lower scores indicating better working
memory.

3.2.6.2

Other

Participants completed the Rey Auditory Verbal Learning Test (RAVLT) to assess auditoryverbal memory.32 For this test, assessors read out a list of 15 random words (one per second)
over five trials and instruct participants to recall as many words as possible after each trial.
The assessor then presents a separate list of 15 unrelated words to participants, who are
instructed to recall as many words as possible from the new list. Immediately following this,
participants are instructed to recall as many words as possible from the original list.
Following a 20 minute delay, participants again are asked to recall as many words as possible
from the original list (out of 15). Performance on the last task (20 minute delay recall) was
used to determine long-term memory ability, with higher scores indicating better memory.
Finally, the Alzheimer’s Disease Assessment Scale–Cognitive 12 (ADAS-Cog 12) was used
to assess various cognitive functions (e.g., language, constructional praxis, orientation)
associated with risk for Alzheimer’s disease.33 For this test, participants complete several
tasks including naming the fingers of their dominant hand, naming a set of 12 common
objects, drawing geometric shapes, identifying their location and date, and recalling words.
The maximum score on this test is 80, with lower scores indicating better performance.

3.2.7

MRI outcomes

Brain structure and function were assessed via MRI in a 3 Tesla Siemens scanner. MRI
outcomes are discussed in Chapter 4.

3.2.8

Physical outcomes

One repetition maximum (1RM; which is a physical measure of an individual’s maximum
muscle strength during a single movement repetition) for the quadricep muscles was recorded
for both resistance training and balance and tone groups. One repetition maximum for
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additional muscle groups (latissimus (lat) dorsi, hamstrings, pectoralis major, biceps, triceps,
deltoids, trapezius muscles) was also recorded for the resistance training group for the
purpose of determining progressive resistance loads. In addition, balance and mobility were
measured using the Short Physical Performance Battery (SPPB; administered monthly)34 and
the Timed Up and Go (TUG) Test.35 For the SPPB, participants perform a side-by-side, semitandem, and tandem stand (each for 10 seconds). In this test, participants also perform a four
meter walk (timed) and a five-time chair stand (timed). A higher total score (out of 14) on the
SPPB indicates better performance. For the TUG, participants are instructed to stand up from
a chair, walk three meters at their usual pace, turn around and walk back to the chair and sit
down in it (timed), where a lower score indicates better performance. Finally, participants
completed the Six Minute Walk Test which is an aerobic test that measures the distance an
individual can walk in six minutes at a self-determined pace.36
Other physical measures included: (1) BMI calculated via height and weight, (2) FPG using a
glucometer following participant fasting, (3) hip and waist circumference, and (4) monthly
levels of leisure, household, and occupational physical activity using the Physical Activity
Scale for the Elderly (PASE) questionnaire, where a higher score (out of 793) indicates
greater physical activity levels.37

3.2.9

Exercise intervention

Participants in both groups completed 60 minutes of exercise (including 10 minutes of warmup and 10 minutes of cool-down) three times per week on non-consecutive days for 26
weeks. Exercise protocols were adapted from those developed by Dr. Teresa Liu-Ambrose
and used successfully in similar interventions.14,38,39 Classes were made up of 2-4 participants
(based the exercise room’s available capacity) and were led by 1-2 trained fitness leaders
who were undergraduate students in the School of Kinesiology at Western University. All
participants were asked not to engage in structured exercise outside of the study’s exercise
program, and to maintain their usual diet and sleeping patterns when possible.
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3.2.9.1

Resistance exercise

Participants in this group underwent progressive resistance training (i.e., loading was
increased over time). Participants used seven programmable pressurized air weight machines
(leg press, lat pulldown, leg curl, chest press, bicep curl, tricep curl, seated row) and
completed body weight exercises to target primary muscle groups as listed in section 3.2.8 of
this Chapter. The number of sets completed and the weight lifted for each exercise was
recorded at every class for all participants. Warm-up and cool-down sessions consisted of
walking on a treadmill or using an elliptical machine at a light pace (based on participant
preference). The exercise protocol was individualized to meet each participant’s physical
needs.
The first three weeks of the exercise program was used to introduce participants to the
weights and machines, and allow them to become familiar with the machines’ set-up.
Participants exercised using a light and easy resistance during this time and were monitored
for proper form by instructors. At the end of week 3, 1RM was calculated on all exercise
machines. Since calculating a true 1RM may be impractical for older adults due to their
fragility, we instead calculated predicted 1RM using the following validated formula:
Weight ÷ (1.0278 - (0.0278 × Number of repetitions)),
which takes into account both the weight being applied and the number of repetitions
comfortably possible.40 This formula is more accurate the closer the repetitions are to one
and becomes unreliable beyond ten.40 Therefore, assessors needed to first take an educated
guess as to what weight the participant would be able to lift that would not exceed ten
repetitions (this was adjusted if it became apparent that the weight was far too light).
Participants were closely monitored to prevent discomfort or injury.
For weeks 4 and 5, applied weight was based on increasing percentages of predicted 1RM
(Table 3.1). Weight gradually increased (and number of reps decreased) until participants
were able to complete two sets of 6-8 reps at 80% of predicted 1RM. Participants reached
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this target by the end of week 5. After this, training stimulus was increased in increments of
1kg using the 7RM method—when two sets of 6-8 reps were completed with proper form
and without discomfort. In addition, participants completed two sets of 6-8 mini-squats,
mini-lunges, and lunge walks at each class. To increase load for squats and lunges over time,
participants used hand-weights (starting with five pounds and increasing by 2-5 pounds)
beginning at week 4.
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Table 3.1: Resistance exercise protocol.
Week

Exercise load

1-3

Light load, 10-15 reps, 1-2 sets

4

1RM testing (day 1)
55% 1RM, 15 reps, 2 sets (day 2)
61% 1RM, 13 reps, 2 sets (day 3)

5

67% 1RM, 11 reps, 2 sets (day 1)
73% 1RM, 10 reps, 2 sets (day 2)
80% 1RM, 8 reps, 2 sets (day 3)

6-26

80% 1RM, 6-8 reps, 2 sets (with added resistance)

1RM = one repetition maximum (predicted).
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3.2.9.2

Balance and tone exercise

Participants in the control group engaged in light exercises including balance and stretching
exercises; only bodyweight was applied (i.e., no additional loading). These specific balance
and tone exercises have not been shown to significantly improve cognitive function in
previous research.41 Warm-up and cool-down sessions consisted of stretching as a group, and
the exercise protocol was individualized as needed. The control group served to control for

confounding variables in the study such as socialization, commitment to the program, and
any lifestyle changes associated with completing the program.

3.2.10

Monitoring

While this study was low risk, adverse events associated with exercise or physical testing
were possible, such as pain, discomfort, shortness of breath, or injury. All participants were
monitored closely by instructors for symptoms of these occurrences during exercise sessions.

3.2.11

Data analysis

Means (standard deviations (SD)) and percentages by group were used to describe baseline
characteristics of our sample. Since pilot studies are used to estimate possible effects rather
than formally testing hypotheses,42,43 we focused on descriptive statistics and estimation
(means, standard errors (SEs), medians, confidence intervals (CIs)) to infer the possible size
and direction of effects, and did not report p-values. Thus, cognitive and physical results are
presented as means and SE at baseline, midpoint, and trial completion, and change over time
is presented as means and 95% CIs. This method of presenting data has been used previously
in pilot trials, including a similar pilot exercise study in diabetic older adults.44 Lastly,
bivariate Spearman correlation coefficients were used to examine the possible magnitude and
direction of associations between change in characteristics across the trial (trial completion
relative to baseline), namely BMI and FPG with cognitive outcomes. Quality assessment of
data was performed and discussed by two researchers to identify scores that were unreliable
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(i.e., not plausible). However, since this was a pilot study, potential outliers that were deemed
possible were included in analyses.

3.3 Results
Screening, recruitment, and study retention is summarized in Figure 3.1 (further details will
be provided in Chapter 5). Twenty-four participants were included in our trial, with 13
participants being randomized to the resistance training group and eleven to the balance and
tone group. One balance and tone participant dropped out of the study at week ten due to
health issues, therefore only their baseline data was used in our analyses in line with the
intent-to-treat principle.45 To note, some participant data is missing for outcome measures
due to: assessor errors (e.g., incorrect timing on tests), unreliability (i.e., scores that were not
plausible), or purposefully not collected (e.g., one balance and tone participant did not
complete quadricep 1RM testing at midpoint due to joint discomfort).

3.3.1

Descriptive measures

Baseline characteristics of participants are described in Table 3.2. The mean age of
participants (n = 24) was 68.7 years ± 5.7 (50% female). At baseline, all participants were
overweight or obese (mean BMI 31.4 ± 5.0 kg/m2), while four participants (16.7%) had
prediabetes (mean FPG for all participants was 5.3 ± 0.8 mmol/l). Two participants with
prediabetes were randomized to the resistance training group, and two to the balance and
tone group.
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Figure 3.1: Recruitment flow diagram.
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Table 3.2: Baseline characteristics of participants.
Variable
Age, years
Female – n (%)
Education – n (%)
High school diploma
Some college
College/trade degree
Bachelor’s degree
Graduate degree
Annual income
Over $20,000
Under $20,000
BMI, kg/m
FPG, mmol/l
Sleep per night, hours
FCI, max. 18 pts
IADL, max. 8 pts
GDS, max. 15 pts
MMSE, max. 30 pts
MoCA, max. 30 pts
2

Total (n = 24)

RT (n = 13)

BAT (n = 11)

68.7 ± 5.7
12 (50)

68.2 ± 6.0
6 (46.2)

69.3 ± 5.6
6 (54.5)

2 (8.3)
6 (25.0)
3 (12.5)
8 (33.3)
5 (20.8)

2 (15.4)
3 (23.1)
2 (15.4)
4 (30.8)
2 (15.4)

0 (0)
3 (27.3)
1 (9.1)
4 (36.4)
3 (27.3)

4 (16.7)
20 (83.3)
31.4 ± 5.0
5.3 ± 0.8
6.9 ± 1.1
1.5 ± 1.3
7.8 ± 0.5
2.3 ± 2.5
27.5 ± 1.8
24.9 ± 2.9

3 (23.1)
10 (76.9)
30.9 ± 3.0
5.2 ± 0.9
6.8 ± 0.9
0.8 ± 0.7
7.9 ± 0.3
1.8 ± 2.1
27. 5 ± 2.1
25.0 ± 2.1

1 (9.1)
10 (90.9)
31.9 ± 6.7
5.3 ± 0.8
7.0 ± 1.3
2.5 ± 1.3
7.7 ± 0.6
2.9 ± 3.0
27.5 ± 1.5
24.8 ± 3.7

Note: All data expressed as mean ± standard deviation unless otherwise indicated.
BMI = body mass index; FPG = fasting plasma glucose; FCI = Functional Comorbidity
Index; IADL = Lawton and Brody Instrumental Activities of Daily Living; GDS = Geriatric
Depression Scale; MMSE = Mini-Mental State Examination; MoCA = Montreal Cognitive
Assessment; RT = resistance training group; BAT = balance and tone group.
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3.3.2

Cognitive outcomes

Changes in cognitive outcomes by group over the 26-week intervention are shown in Table
3.3 (midpoint > baseline, and trial completion > baseline) and are presented visually via box
plots in Figure 3.2 (trial completion > baseline). Note, when presenting means, SEs, and
medians at each timepoint in Table 3.3, we used all available data; however when calculating
mean and CIs for change over time (midpoint > baseline, or trial completion > baseline), we
only included participants who had data from both timepoints (i.e., had no missing data).

3.3.2.1

Executive function

Compared to those in the balance and tone group, participants in the resistance training group
showed sizable improvements in TMT at trial completion relative to baseline (Table 3.3,
Figure 3.2). At midpoint, improvements on the TMT were already apparent in the resistance
training group (Table 3.3). Interestingly, however, those in the balance and tone group
showed improvements on the TMT at midpoint but had worse performance at trial
completion (Table 3.3).
Both groups had comparable improvements in selective attention and conflict resolution
(Stroop Test) at midpoint relative to baseline, but the resistance training group had greater
improvements at trial completion compared to the balance and tone group (Table 3.3, Figure
3.2). Surprisingly, the balance and tone group but not the resistance training group improved
in working memory (Digit Span) at trial completion relative to baseline (Table 3.3, Figure
3.2); at midpoint, however, both groups had improvements, but these were very small for the
resistance training group (Table 3.3). To note, there was more variability in the resistance
training group scores than the balance and tone group scores in these measures (Figure 3.2).

3.3.2.2

Other

Relative to baseline, the balance and tone group improved more than the resistance training
group at trial completion in long-term memory (RAVLT, 20 minute delay condition), with
some improvements also seen at midpoint for both groups (Table 3.3, Figure 3.2). In
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addition, both groups improved on the ADAS-Cog 12 at both timepoints relative to baseline
(Table 3.3, Figure 3.2), but these changes are not considered clinically significant in the
literature.46
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Table 3.3: Cognitive outcomes by group.
Variable

RT
Stroop (C-B)
TMT (B-A)
Digit Span (FB)
RAVLT (20
minute delay)
ADAS-Cog 12
BAT
Stroop (C-B)
TMT (B-A)
Digit Span (FB)
RAVLT (20
minute delay)
ADAS-Cog 12

Baseline

Midpoint

Trial completion

Mean (SE) Median

Mean (SE) Median

Mean (SE) Median

Δ Baseline to
midpoint
Mean (95% CI)

44.1 (7.2) 43.5
b
33.7 (5.0) b35.3
2.5 (1.1)
3.0

40.2 (4.0) 36.9
b
25.3 (3.8) b19.4
2.2 (0.8)
2.0

36.9 (3.8) 33.4
e
23.1 (3.6) e23.6
3.5 (0.7)
4.0

-3.8 (-18.7, 11.0) -8.9
-11.9 (-19.6, -4.1) -12.3
-0.3 (-3.1, 2.5)
-1.0

-7.2 (-23.5, 9.8) -9.7
-9.6 (-21.8, 2.5) -3.2
1.1 (-1.2, 3.4)
0.0

b

8.5 (1.2)

9.0

e

1.2 (-0.9, 3.2)

2.0

1.7 (-0.5, 3.8)

2.0

-2.0 (-3.5, -0.5)

-1.7

-1.4 (-2.9, 0.1)

-1.7

7.0 (1.2)

b

7.5

9.0 (1.6)

e

10.5

7.1 (1.1)

6.3

5.0 (0.7)

4.5

5.6 (0.9)

52.4 (6.1)
40.9
(11.8)
1.9 (0.7)

49.6
24.0

a

43.6 (6.7)
a
27.4 (4.0)

a

50.7
a
28.7

a

41.6 (2.8) a41.4
d
41.5 (6.0) d41.2

-3.8 (-20.6, 12.9)
-2.4 (-14.4, 9.6)

-3.3
-0.4

-5.8 (-13.4, 1.7) -7.5
11.0 (-2.6, 24.5) 13.1

2.0

a

-0.2 (0.4)

a

0.0

a

-2.3 (-3.9, -0.7)

-1.5

-1.1 (-3.0, 0.8)

-0.5

b

b

c

12.1 (1.5)

c

14.0

d

14.0

4.3 (0.1, 8.4)

4.5

5.3 (2.1, 8.5)

5.0

a

4.1 (0.8)

a

3.5

a

3.2

-0.6 (-2.6, 1.5)

0.0

-1.5 (-3.3, 0.4)

-1.5

7.0 (1.5)

5.3 (1.1)

5.0

5.7

1.0 (0.7)

4.7

Median

Δ Baseline to
trial completion
Mean (95% CI) Median

a

1.0

12.5 (1.1)

d

3.1 (0.4)

a

Stroop (C-B) = Stroop Test condition C minus condition B; TMT (B-A) = Trail Making Test part B minus part A; Digit Span (F-B) = Digit Span
Test Forward minus Backward; RAVLT (20 minute delay) = Rey Auditory Verbal Learning Test 20 minute delay condition; ADAS-Cog 12 =
Alzheimer’s Disease Assessment Scale–Cognitive 12; RT = resistance training group; BAT = balance and tone group; SE = standard error; CI =
confidence interval.
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a

Missing data for n = 1 (dropout).
Missing data for n = 1 (data collection error).
c
Missing data for n = 2 (1 dropout, 1 data collection error).
d
Missing data for n = 3 (1 dropout, 2 data collection errors).
e
Missing data for n = 3 (3 data collection errors).
b

107

Figure 3.2: Mean change in scores on cognitive tests (trial completion > baseline).
Note: the box represents the interquartile range, where the bottom line of the box represents
quartile 1 (25th percentile) and the top line represents quartile 3 (75th percentile); the whiskers
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represent the minimum and maximum values excluding outliers; ‘X’ represents the mean;
and the middle line of the box represents the median.
Stroop C-B = Stroop Test condition C minus condition B; TMT B-A = Trail Making Test
part B minus part A; Digit Span F-B = Digit Span Test Forward minus Backward; RAVLT
(20 minute delay) = Rey Auditory Verbal Learning Test 20 minute delay condition; ADASCog 12 = Alzheimer’s Disease Assessment Scale–Cognitive 12; RT = resistance training
group; BAT = balance and tone group.

109

3.3.3

Physical outcomes

Change in physical measures by group across the 26 weeks are presented in Table 3.4. A
larger increase in 1RM was seen for the resistance training group compared to the balance
and tone group (Table 3.4, Figure 3.3), and this was gradual from midpoint to trial
completion. Across the trial, most changes in other physical measures were small and
comparable for both resistance training and balance and tone groups, including FPG and BMI
(Table 3.4). However, the resistance training group had larger increases in PASE scores at
both midpoint and trial completion compared the balance and tone group, as well as larger
improvements on the six minute walk test at both time points (Table 3.4).
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Table 3.4: Physical outcomes by group.
Variable

RT
1RM, kg
BMI, kg/m2
FPG, mmol/l
Hip
circumference, cm
Waist
circumference, cm
PASE
SPPB
TUG, s
Six minute walk
test, m
BAT
1RM, kg
BMI, kg/m2
FPG, mmol/l
Hip

Δ Baseline to
midpoint

Baseline

Midpoint

Trial
completion

Mean (SE) Median

Mean (SE) Median

Mean (SE)

Median

Mean (95%
CI)

49.5 (3.9)

61.5 (4.9)

70.7 (3.5)

69.0

12.0 (4.9, 18.9) 9.0

30.9 (0.8) 30.7
5.2 (0.3)
5.1
110.2 (3.0) 111.0

30.7 (0.9) 31.3
5.3 (0.2)
5.1
110.9 (2.8) 110.5

30.3 (1.1)
30.5
5.5 (0.2)
5.4
h
112.5 (3.0) h111.0

-0.2 (-1.0, 0.6) 0.2
0.1 (-0.3, 0.5) 0.0
0.7 (-4.4, 5.8) 0.0

108.1 (3.3) 104.1

108.5 (3.4) 108.0

h

0.4 (-1.6, 2.4)

0.0

0.2 (-2.4, 2.8)

-0.1

b

135.9
(17.6)
10.5 (0.3)
8.3 (0.4)
503.0
(20.7)

136.7

144.8 (19.0) 138.0

12.7

35.9 (4.7, 67.1)

37.5

11.0
8.2
507.0

10.5 (0.4)
10.0
8.8 (0.5)
8.5
513.3 (16.0) 510.0

28.0 (-17.0,
73.0)
0.3 (-0.4, 1.0)
-0.6 (-1.7, 0.5)
24.1 (-21.1,
69.3)

0.0
-0.2
32.0

0.3 (-0.7, 1.3)
0.0 (-1.5, 1.4)
34.4 (-6.7,
75.5)

0.0
-0.2
48.0

9.1 (-2.6, 20.8)
0.4 (-0.7, 1.5)
0 (-0.5, 0.5)
2.7 (-3.9, 9.2)

13.0
0.1
-0.1
-0.5

9.1 (-3.2, 21.4)
0.0 (-1.2, 1.2)
0.3 (-0.3, 0.9)
5.2 (-0.4, 10.7)

8.0
0.0
0.4
2.2

b

b

101.0

10.0
8.8
465.0

50.4 (6.2) b51.5
31.9 (2.0) 29.9
5.3 (0.2)
5.6
c
c
113.4
112.0

f

64.0

22.0

21.2 (15.8,
26.5)
-0.6 (-1.8, 0.7)
0.2 (-0.3, 0.8)
4.2 (-1.3, 9.8)

109.5
(10.2)
10.2 (0.4)
8.8 (0.6)
478.9
(11.9)

50.0

Median

Δ Baseline to
trial
completion
Mean (95% Median
CI)

64.2 (6.2) f72.0
g
32.0 (2.8) g30.4
d
5.1 (0.2) d5.2
e
e
116.2
113.0

f

107.4 (3.9)

66.4 (6.8)
a
32.3 (2.4)
a
5.6 (0.2)
e
118.7 (5.6)

h

f

105.5

64.0
a
30.7
a
5.8
e
112.0

0.1
0.3
3.0

111

circumference, cm (5.7)
c
Waist
114.4
circumference, cm (5.9)
b
PASE
115.9
(15.2)
SPPB
9.5 (0.4)
TUG, s
8.6 (0.3)
Six minute walk
468.8
test, m
(25.0)

c

111.0

b

133.9

9.0
8.6
485.0

(6.8)
e
110.2
(6.4)
a
97.5
(11.0)
a
10.9 (0.3)
d
8.1 (0.4)
d
454.3
(21.5)

e

113.0

e

a

92.3

d

a

11.0
d
7.4
d
480.0

111.0 (6.5)

117.9
(12.0)
a
9.9 (0.5)
a
9.3 (0.9)
a
474.4
(21.7)

e

113.0

d

a

116.0

10.0
a
9.2
a
484.5

-4.6 (-11.4,
2.1)
-10.1 (-59.4,
39.1)
1.3 (0.2, 2.4)
-0.5 (-1.3, 0.2)
1.2 (-56.5,
58.9)

-3.0
15.0
1.5
-0.6
-5.0

-3.8 (-10.5,
2.9)
5.2 (-25.2,
35.7)
0.3 (-1.0, 1.6)
0.6 (-1.3, 2.5)
7.4 (-52.6,
67.3)

1RM = one repetition maximum (predicted) – quadricep; BMI = body mass index; FPG = fasting plasma glucose; PASE = Physical Activity
Scale for the Elderly; SPPB = Short Physical Performance Battery; TUG = Timed Up and Go Test; RT = resistance training group; BAT =
balance and tone group; SE = standard error; CI = confidence interval.
a
Missing data for n = 1 (dropout).
b
Missing data for n = 1 (data collection error).
c
Missing data for n = 1 (1 identified as unreliable).
d
Missing data for n = 2 (1 dropout, 1 data collection error).
e
Missing data for n = 2 (1 dropout, 1 identified as unreliable).
f
Missing data for n = 2 (1 dropout, 1 data not collected due to physical discomfort).
g
Missing data for n = 3 (1 dropout, 2 data collection errors).
h
Missing data for n = 4 (4 data collection errors).

-1.0
-4.4
-0.5
0.3
9.5
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Figure 3.3: Mean change in 1RM (trial completion > baseline).
Note: the box represents the interquartile range, where the bottom line of the
box represents quartile 1 (25th percentile) and the top line represents quartile 3
(75th percentile); the whiskers represent the minimum and maximum values
excluding outliers; ‘X’ represents the mean; and the middle line of the box
represents the median.
1RM = one repetition maximum (predicted) – quadricep; RT = resistance
training group; BAT = balance and tone group.
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3.3.4

Correlations

Table 3.5 shows correlations between change in BMI, FPG, and cognitive outcome measures
at trial completion relative to baseline. Interestingly, increased 1RM strength was moderately
correlated with reduced RAVLT scores. In addition, a weak-to-moderate positive correlation
was found for 1RM and Digit Span scores (i.e., increased 1RM was related to a decline in
performance on the Digit Span Test). Increased BMI had a weak-to-moderate association
with improved ADAS-Cog 12 scores, which was also surprising. Finally, increased FPG
levels was related to improved performance on the TMT (weak-to-moderate correlation). All
other correlations were weak in strength.
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Table 3.5: Spearman correlations for cognitive and physical outcomes (trial completion
> baseline).
Stroop (C-B)

TMT (B- Digit Span RAVLT ADAS-Cog 12
A)
(F-B)
(20 minute
delay)

1RM, kg

-.098

-.112

.393

-.571

-.021

BMI, kg/m2

.007

.098

-.076

.124

-.331

FPG, mmol/l

-.067

-.356

-.059

.010

-.181

1RM = one repetition maximum (predicted) – quadricep; BMI = body mass index; FPG =
fasting plasma glucose; Stroop (C-B) = Stroop Test condition C minus condition B; TMT
(B-A) = Trail Making Test part B minus part A; Digit Span (F-B) = Digit Span Test
Forward minus Backward; RAVLT (20 minute delay) = Rey Auditory Verbal Learning
Test 20 minute delay condition; ADAS-Cog 12 = Alzheimer’s Disease Assessment Scale–
Cognitive 12.
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3.4 Discussion
Results from the current study suggest that 26 weeks of thrice-weekly resistance training may
benefit certain cognitive domains in older adults at risk for diabetes. This is in line with
previous research that has shown that positive effects of resistance training on cognitive
function in older adults may be selective.38,47 In our study, the largest improvement in
cognition as a result of resistance training was seen in task-switching performance, as
measured by the TMT. The ability to switch between tasks is a higher-order function shown
to decline naturally with age,48 with greater impairment seen in many chronic illnesses
including hyperglycemia and obesity.49,50 Previous study findings have shown that endurance
exercise positively affects task-switching in older adults,51 as demonstrated in our study.
Moreover, the size of improvements seen in our study is similar to what has been statistically
found in another resistance training intervention in older adults;38 based on this, we can infer
that we would see similar cognitive improvements in large-scale resistance training trials in
our target population.
Another positive finding from our study–that resistance training improves selective attention
and conflict resolution–also corroborates previous work in older adults. Liu-Ambrose et al.
(2010) found that older adults who performed resistance exercise twice per week for 12
months significantly improved in selective attention and conflict resolution as measured by
the Stroop Test.38 Comparatively, our study found even greater improvements on the Stroop
task than this study did after progressive resistance training, however our frequency/duration
of exercise differed. Additionally, an important finding that emerged from the 12-month
study data set was that Stroop performance during the trial predicted maintenance of physical
activity post-intervention, such that those with greater improvements on the Stroop Test
remained more physically active than those with poorer scores.52 Improvements in selective
attention and conflict resolution along with other measures of executive function, also have
important implications to everyday living for older adults. For example, such executive
functions are known to be essential to balance, postural maintenance, ambulation, and the
prevention of falls.53 Furthermore, many studies show that executive functioning is positively
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correlated with basic activities of daily living, including preparing meals, handling finances,
driving, and shopping, among others.54
Notably, improvements in cognitive function (task-switching, selective attention, conflict
resolution) in response to resistance training in our study were already apparent to some
degree at trial midpoint. In line with this, previous studies have shown that improvements in
cognition can be evident after short-term resistance training. An RCT by Santos et al. (2020)
assessed the effects of resistance training on cognition after only 12 weeks of thrice-weekly
resistance training in community-dwelling older adults.55 At trial completion, the authors
found significant improvements in selective attention, conflict resolution, working memory,
and verbal fluency.55 However, the extent to which short-term resistance training such as this
has lasting effects on cognition is not well understood, thus more exercise studies with
follow-ups are needed. Moreover, cognitive improvements seen in our population early on in
the trial may be the result of the degree of impairment at baseline. Other clinical populations
of older adults (e.g., those with MCI) have been shown to experience cognitive benefits from
resistance training faster than healthy older adults,14,38 and this may be due to having worse
baseline cognition and therefore greater room for improvements. Future correlational studies
assessing cognitive abilities in our population versus healthy age-matched controls are
needed.
One possible explanation for why resistance training led to improvements in executive
function but not memory in our study is the use of higher-order cognitive functions to
perform the resistance training exercises. It may be that resistance exercise, compared to
other forms of exercise including aerobic training, is more cognitively stimulating and
demanding. Resistance training often requires learning new equipment as well as attention
and concentration while performing the exercises themselves (to ensure proper form, to count
repetitions, etc.). Thus, execution functioning is perhaps being strengthened in this manner
during resistance training. Additionally, findings on whether resistance training improves
memory remain fairly inconsistent in the literature, while more consistent research
demonstrates the positive relationship between resistance training and executive function.
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Liu-Ambrose and colleagues (2010) found no improvements in memory as measured by the
Digit Span Test, but did find improvements in executive function, following a progressive
resistance training intervention in older adults.38 Moreover, a systematic review by Loprinzi
et al. (2018) found that only three of eight studies provided some evidence of a positive
effect of resistance training on memory (episodic memory).56 Evidently, more RCTs
assessing the effects of resistance training on memory are needed.
An unexpected finding in the current trial was that balance and tone participants showed
some improvements in cognitive function. This differs from a previous resistance training
study in older adults that used a similar balance and tone protocol but found much smaller or
no improvements in cognitive function (e.g., on the Stroop and Digit Span tests) for control
participants.38 Given that our study only measured quadricep muscle strength and included
no other measure of muscle function in the balance and tone group, it is possible that this
group improved in muscle strength in an undetected way. Studies have shown that balance
and stretching exercises can in fact improve muscle strength57,58 that may be positively
related to cognition.59 As such, future trials may benefit from including additional tests of
muscle function, perhaps lean body mass measures for example, as well as further exploring
the potential physical and cognitive benefits that balance and tone exercise may have in older
adults at risk for diabetes. Other possible explanations for this unexpected finding, including
differences in socialization between the two groups, are discussed in Chapter 5. In addition,
some unexpected findings were seen in our correlational data. For example, it appears that
increased muscle strength may actually be associated with reduced scores on selective
cognitive tests, and increased BMI and FPG may be associated with better performance on
some tests. Since we did not assess statistical significance of measured correlations, nor did
we control for certain variables, future trials with a larger sample size are needed to better
examine the potential relationships between physical and cognitive outcomes in response to
resistance training.
While resistance training did lead to some improvements in cognition, it did not result in
improvements in most physical measures including BMI or FPG. In line with this, some
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studies have found that resistance training does not improve weight or glycemic control like
aerobic exercise does.60,61 However, a review and meta-analysis showed that resistance
training can lead to improvements in HbA1c levels, but high-intensity training leads to much
greater improvements than low-intensity training;62 this may be the result of greater glucose
uptake in skeletal muscle during high-intensity exercises.63 This is important as the majority
of insulin-stimulated glucose uptake occurs in skeletal muscle.64 Based on this, it is possible
that the resistance training group in our study did not exercise at a high enough intensity to
allow for increased glucose uptake. Although our trial participants did exercise at 80% of
their predicted 1RM, it has been shown that predicted 1RM may underestimate true 1RM
values in older adults,65 and thus participants may have been exercising at a lower intensity
than intended. Interestingly, though, participants in the resistance training group did improve
in aerobic function (walking ability) as measured by the six minute walk test. Future trials
with additional tests of aerobic function may help shed light on the relationship between
resistance training and aerobic function, and should examine the possible differences
between resistance training and aerobic training (as well as resistance training combined with
aerobic training) on physical and cognitive function in older adults at risk for diabetes.
When interpreting results, it is important to consider the potential clinical significance of
cognitive changes that occur in response to exercise. For example, changes seen in ADASCog 12 for both groups are considered non-clinically significant given that they were below
the literature-informed minimal clinically important difference (MCID) of three.46 Minimal
clinically important difference is defined as the smallest difference in a disease score that a
patient would benefit from and would lead to a change in the patient’s management plan.66
To our knowledge, MCIDs have yet to be established for many commonly used
neuropsychological tests such as the Stroop Test and TMT. Thus, large-scale prospective
population-based studies are needed to determine the usefulness of such tools in a clinical
context. Until this is achieved, one previously proposed way to measure meaningful change
from RCTs is the use of the Quality Adjusted Life Year (QALY), an internationallyrecognized tool which assesses both quality and quantity of life.66 Future trials may benefit
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from incorporating this tool or similar measures of disease burden to determine how
cognitive changes as a result of resistance training may benefit health long-term.
Importantly, there are several limitations to the current study that need be to addressed.
Firstly, given that this was an underpowered pilot study, it is important that results are
interpreted with caution. Furthermore, as we did not run inferential statistics, we cannot
conclude that trends (both between-group and across timepoints) are significant, nor were we
able to control for any variables that may affect results such as differences in baseline
characteristics between groups. Based on our findings, it may have been beneficial to control
for PASE performance in analyses had that been possible, as the resistance training group
had increased PASE scores over time compared to the balance and tone group. This suggests
that those in the resistance training group could have benefitted from additional leisure,
occupational, or household physical activity outside of the exercise program, which may
have affected results. While we did collect information on leisure physical activity and sleep,
it may also be advantageous to collect information on diet and other lifestyle behaviours that
could affect results.
Additionally, there were a number of errors in assessment delivery which resulted in missing
data. At times, assessors forgot to administer parts of the psychological questionnaires (e.g.,
the 20 minute delay recall test for the RAVLT) or mis-timed the completion of tasks such as
the TMT. Further supervision and check-ins may help to avoid this issue in the future and is
discussed further in Chapter 5. Other recommendations for future research include examining
how resistance training may affect individuals with hyperglycemia who have normal BMI
compared to those who are overweight but have normoglycemia. As our sample size was
small, and we were only able to recruit a very limited number of people with prediabetes
(who were all overweight or obese), we were unable to effectively test this. However, we
speculate that both groups would experience improvements in cognition following resistance
training, as individuals with hyperglycemia or obesity are known to experience cognitive
deficits and have been shown to benefit from other exercise types.13,67 Similarly, future
studies should assess potential differences between those who are overweight versus obese,
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since these groups are known to have some differing cognitive abilities.12 It would also be
interesting to examine potential sex differences, as women, in general, have been shown to
benefit more cognitively from exercise compared to men (which may be a result of
differences in hormones, body composition, etc.).68
Future studies should also assess the underlying neuropsychological mechanisms that may
explain the benefits of resistance training on cognition. For example, at the molecular and
cellular level, resistance training leads to the release of neurochemicals (including IGF-1)
that stimulate the growth of new neurons and blood vessels, as well as the strengthening of
neuronal connections.69 Resistance training has also been shown to lead to increased
cytokines such as interleukin-6, which reduces beta-amyloid levels in the brain that disrupts
brain cell function, and increased lactate levels that can lead to improved brain
metabolism.70,71 Understanding these mechanisms may also help link changes in cognition to
structural and functional brain changes as a result of resistance training. Finally, an
interesting future component to our trial would be to examine whether changes in cognition
that may result from our intervention last beyond the trial, as previous studies have shown
that positive effects on cognition from resistance training may persist at least one year after
study completion.52
In conclusion, our pilot study demonstrates the preliminary efficacy of a 26-week resistance
training program improving cognition in older adults at risk for diabetes. Resistance training
led to some improvements in cognitive function, mainly in attention and executive functions
that are important to everyday function in older adults. Based on our findings, there may also
be some benefits from balance and tone exercises in this population. In the future, large-scale
powered trials are needed to further explore our preliminary findings.
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Summary
This chapter assessed cognitive changes following 26 weeks of thrice-weekly progressive
resistance training in older adults at risk for diabetes. Compared to balance and tone exercise,
resistance training led to a larger increase in 1RM quadricep strength, which provides
evidence toward the effectiveness of the resistance training program in increasing muscle
mass as intended. For both groups, very small changes were seen in FPG and BMI across the
trial. When assessing cognition, those in the resistance training group improved in taskswitching, selective attention, and conflict resolution, whereas those in the balance and tone
group improved on two memory tasks. Based on these findings, it appears that resistance
training may improve select cognitive functions over others, and that there may be
unexpected benefits of balance and tone exercise. It is possible that the unexpected
improvements in the latter group may be a result of other factors (such as socialization)
outside the physical exercise itself. Considerations of ways to improve the study protocol and
reduce possible confounding variables that may account for these findings are discussed in
Chapter 5.
Having examined cognitive changes, we can gain a deeper understanding of the possible
effects of the resistance training intervention by investigating underlying changes to
neurological mechanisms in our target population. Moreover, exploring changes to brain
volume and functional activation patterns may provide insight into whether changes at the
structural and functional levels may be related to behavioural changes. In this regard, Chapter
4 examines structural and functional brain changes using MRI following the 26-week
resistance training intervention in older adults at risk for diabetes.
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Chapter 4

4

Scientific outcomes: Structural and functional brain
changes following 26 weeks of resistance exercise in
older adults at risk for diabetes

This chapter will explore the structural and functional brain changes in older adults at risk for
diabetes using MRI following a 26-week randomized controlled trial of resistance exercise.
A manuscript for the reported findings is currently in preparation.
Some content in Chapter 4 is from the following published protocol manuscript:
Furlano JA, Nagamatsu LS. Feasibility of a 6-month pilot randomised controlled trial of
resistance training on cognition and brain health in Canadian older adults at-risk for
diabetes: study protocol. BMJ Open. 2019;9(10),e032047. doi: 10.1136/bmjopen-2019032047

4.1 Introduction
Diabetes is associated with several anatomical and functional brain abnormalities. Crosssectional MRI work has demonstrated that individuals with T2D exhibit smaller brain
volumes, including TBV and regional volumes (e.g., HV), compared to healthy controls.1
Research assessing functional brain patterns have also shown that diabetics experience
reduced levels of brain activation associated with impaired cognitive function. One study by
Chen and colleagues (2014) found that those with T2D had reduced activation in the superior
and middle frontal gyri during a working memory task compared to healthy controls, and this
was correlated with worse memory performance.2 Taken together, this evidence suggests that
diabetics experience deficits in brain health and, consequently, are at an increased risk for
dementia.
Two major risk factors for T2D are prediabetes (the precursor stage of T2D) and obesity.
Statistically, up to 70% of individuals with prediabetes will develop T2D,3 and it has been
reported that roughly 30% of people who are overweight also have T2D.4 Compared to early
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life, these comorbidities occur more frequently in old age when the brain undergoes
neurodegenerative changes due to aging.5 Furthermore, given the evidence that diabetics
experience various structural and functional brain deficits, prediabetics and overweight/obese
individuals, especially in late life, are at high risk for brain dysfunction. However, whether
these individuals already experience deficits in brain health remains under investigation.
Based on findings from the systematic review presented in Chapter 2, it appears that
prediabetic adults and older adults may experience some deficits in brain structure. Marseglia
and colleagues (2019) showed that prediabetes is associated with smaller TBV, particularly
WMV.6 Similarly, Cui et al. (2019) found that prediabetics have reduced GMV in the left
hippocampus compared to healthy controls.7 Continuous hyperglycemia (measured via FPG)
has also been shown to be associated with lower WMV and GMV.8 In this study, structural
brain abnormalities observed in prediabetics were comparable to 2.1 years of brain aging,
suggesting that prediabetes accelerates brain health declines seen in natural aging.8 Despite
this evidence, findings are inconsistent across studies, and may be the result of varying
diagnostic measures and other methodological flaws as highlighted in Chapter 2.
Similar to prediabetes, obesity has also been shown to accelerate brain decline associated
with aging. Compared to normal weight people, the brains of overweight individuals (BMI
25-29) appear 8 years older, while the brains of obese individuals (BMI 30+) appear 16 years
older.9 More specifically, studies have shown that higher BMI is associated with lower brain
volumes, including HV, in overweight and obese older adults.10,11 One study in individuals
with both T2D and high BMI found a reduction in WMV compared to healthy controls.12 In
fMRI work, regions implicated in memory, including the hippocampus and dorsolateral
prefrontal cortex, have reduced activation in obese participants compared to healthy weight
participants.13
There are several potential mechanisms that may explain the association between prediabetes
and obesity with brain health dysfunction. In prediabetes, hyperglycemia may cause the
production of glycotoxins and promote oxidative stress,14 which can in turn lead to neuronal
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cell toxicity and death.15 Further, hyperglycemia is associated with cerebral endothelial
dysfunction,16 and ultimately cerebral perfusion and brain tissue ischemia.17 In obesity, high
BMI is linked to systemic inflammation, inefficient leptin signaling, and decreased cerebral
blood flow, all of which have been associated with brain dysfunction.18,19 Reduced cerebral
blood flow, in particular, is one of the top predictors of developing Alzheimer’s,20 and
studies have shown that areas of the brain vulnerable to Alzheimer’s disease, including the
hippocampus, have reduced blood flow as BMI increases.21
Evidently, there is a need for targeted interventions to improve brain health in individuals
with prediabetes and obesity. Moreover, these disorders provide a window of opportunity for
the prevention of further brain dysfunction seen in T2D. Exercise is one behavioural strategy
that is known to improve brain structure and function. Higher fitness levels are associated
with larger brain volumes, 22 and this may be the result of released neurotrophic factors such
as BDNF and IGF-1 that stimulate neurogenesis and preserve neuronal health.23 While most
exercise interventions to improve brain health focus on aerobic exercise, resistance training
has more recently been shown to have its own neurocognitive benefits, and is often more
widely accessible for older adults, as previously discussed. A recent systematic review
showed that resistance exercise interventions, ranging in weeks to several months in duration,
led to substantial functional brain changes accompanied by improvements in cognition, as
well as a reduction in brain atrophy, specifically white matter.24 Furthermore, these
improvements appear to hold true across several populations, including healthy and
cognitively impaired adults.24
To date, research has not yet examined whether resistance training may improve brain
structure and function in older adults at risk for T2D. To accomplish this, we first conducted
a pilot RCT to evaluate preliminary efficacy. Cognitive changes measured in this study via
neuropsychological tests were previously discussed in Chapter 3, thus this Chapter will focus
on MRI outcomes. Importantly, brain atrophy and other changes in brain health may be
detectable via MRI even before cognitive impairment is evident,25 and thus measuring brain
changes may help us further understand the potential benefits of resistance training. Based on
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what is known in the literature, we hypothesized that 26 weeks of resistance training in older
adults at risk for diabetes would lead to increased brain volumes, including TBV and HV, as
well as increased functional activation in memory-related areas during an associative
memory task.
As highlighted in Chapter 1, associative memory (the ability to memorize unrelated items in
conjunction) is one cognitive function that declines with age and neurodegenerative disease.
Areas of the brain implicated in learning associations include the occipital association cortex,
lingual and fusiform gyri, inferior temporal gyrus, inferior pre- and postcentral gyri,
orbitofrontal cortex, and precuneus.26 Additionally, hippocampal function has been shown to
be correlated with associative memory performance, as demonstrated in animal research
assessing neuronal firing patterns.27 Studies on the effects of resistance training on
associative memory have shown a positive causal relationship in older adults. For example,
one study found that six months of twice-weekly resistance training, compared to balance
and tone exercise, improves associative memory in older adults with MCI.28 In this study,
resistance training also led to increased activation in brain regions involved in memorizing
associations including the right lingual and occipital-fusiform gyri and the right frontal
pole.28 Therefore, in addition to increased functional activation in memory-related areas, we
hypothesized that 26 weeks of resistance training would lead to improved associative
memory performance in our study population.

4.2 Methods
4.2.1

Study design

We conducted a single-blinded pilot RCT to examine the preliminary effects of a 26-week,
thrice-weekly resistance exercise program on brain structure and function in older adults at
risk for T2D. Magnetic resonance imaging was completed at baseline and trial completion
(26 weeks) and was 1.5 hours long per session. Further details of our study design have been
reported in Chapter 3.

133

4.2.2

Participants

Older adults (aged 60-80) who were overweight or obese (BMI ≥ 25) and/or prediabetic
(FPG 6.1 to 6.9 mmol/l) were recruited from the community in London, Ontario, Canada.
Details of recruitment and inclusion/exclusion criteria can be found in Chapter 3.

4.2.3

Exercise intervention

Participants were randomized into either the resistance training or balance and tone (control)
group. Exercise classes were one hour in length and were instructor-led. Classes were made
up of 2-4 participants and were held three times per week on non-consecutive days for 26
weeks. Participants in the resistance training group underwent progressive resistance training
(i.e., loading was increased over time based on predicted 1RM), while participants in the
balance and tone group completed balance and stretching exercises. Study methods have
been described in detail in Chapter 3.

4.2.4
4.2.4.1

Outcome measures
Structural MRI outcomes

T1-weighted images (TR=2300, TE=2.98, voxel size=1x1x1 mm) were used to measure
whole brain and regional volumes. Percent brain volume change (PBVC) was calculated
using SIENA (Structural Image Evaluation, using Normalization, of Atrophy) in the FMRIB
(Functional Magnetic Resonance Imaging of the Brain) Software Library (FSL; Version
5.0.10), specifically within FAST (FMRIB’s Automated Segmentation Tool).29 SIENA is an
automated method for measuring brain change across multiple time points, and has been
shown to have an error rate of 0.2%.30 SIENA starts by extracting non-brain tissue from both
time-point whole-head input images, and registers the two brains using the skull images to
keep the scaling constant.29 It then estimates brain change between the two time points based
on mean edge displacement.29 Although fully automated, visual checks of output were
performed to minimize error during brain extraction, spatial alignment, and tissue
segmentation. SIENA was run for all participants, and PBVC by group was reported.
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SIENAX (an adaptation of SIENA to measure brain volume at a single time point) was used
to estimate GMV and WMV at both time points (as SIENA does not provide tissue type
calculations).29 Like SIENA, SIENAX first performs non-brain tissue extraction and
estimates the outer skull surface.29 The brain image is then registered to MNI152 (MNI =
Montreal Neurological Institute) standard space using the skull image to determine the
registration scaling, allowing for normalization of subject skull size.29 Next, tissue-type
segmentation is carried out in order to calculate volume estimation of grey and white matter
separately.29 Volumes for each participant at both baseline and trial completion were
recorded, and average volume change overtime by group was calculated.
Left and right HVs were calculated via FIRST (FMRIB’s Integrated Registration and
Segmentation Tool), which is FSL’s tool for automatic segmentation of subcortical
structures.31 It uses default settings for each structure which have been empirically
determined.31 FIRST was run for all participants at both time points, and left and right values
were added together to produce total HVs. Average change in total HV by group across the
trial was then reported.

4.2.4.2

Behavioural MRI outcomes

Performance on an associative memory task during fMRI was measured, where both
associative and item memory were assessed. The memory task was a mixed block/eventrelated design that had been used in a previous study of resistance exercise in older adults.32
The task required participants to view a series of photos of faces superimposed onto
sceneries, in which participants encoded and recalled items separately (face or scenery;
measure of item memory) and items in conjunction (face paired with scenery; measure of
associative memory) (Figure 4.1). The task featured six conditions: face encoding, face
recognition, scenery encoding, scenery recognition, face–scenery encoding, and face–scenery
recognition (Figure 4.1). Participants completed three blocks (runs), each comprised of the
six conditions with the order of conditions counterbalanced in pairs (encoding plus
recognition; e.g., scenery coding with scenery recognition). Each condition featured 12
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separate photos; each of the 12 photos appeared for three seconds, separated by a fixation
cross appearing for six seconds.
While performing the task inside the MRI scanner, participants used a two-button response
pad. During the encoding conditions, participants were asked to indicate one of the
following: (1) if the face shown was male or female (to help direct participants to
memorizing faces only; in this case, the scenery remained constant across photos), (2) if the
scenery contained liquid water (to help direct participants to memorizing scenery only; in this
case, the face remained constant across photos), or (3) if the face ‘fit well’ with the scenery
(to direct participants to memorizing the face with the scenery; there was no correct answer
to this question). Following each encoding condition, participants, in the recognition
condition, were asked to indicate whether they had previously seen each of the images during
the encoding sequence. Each recognition block contained six photos from the encoding
condition and six distractor photos. At the beginning of each condition (encoding or
recognition), instructions appeared on screen for 10 seconds to inform participants of what
their specific task was (e.g., to decide if the face is male or female (encoding), to indicate
whether they had seen the image previously (recognition)). Participants completed several
practice trials of each condition prior to completing the task in the scanner.
Task performance was determined using Signal Detection Theory, a method of measuring the
ability to differentiate between information under conditions of uncertainty.33 According to
this theory, there are four possible outcomes for the recognition conditions in the memory
task (Figure 4.2): (1) ‘hit’ – when a participant says they saw the image previously and they
actually had (correct); (2) ‘miss’ – when a participant says they did not see the image
previously but they had (incorrect); (3) ‘false alarm’ – when a participant says they saw the
image previously but they had not (incorrect); and (4) ‘correct rejection’ – when a participant
says they did not see the image previously and they had not (correct).33 Using hit and false
alarm data, d prime was calculated, which is a measure of signal detection that accounts for
response bias (i.e., participants are more likely to report that they did see an image versus
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reporting that they did not see an image).33 D prime is calculated using the following
formula:
d prime = z(H) – z(F)
where ‘H’ represents hits and ‘F’ represents false alarms.33 D prime values typically range
from 0 to 4.65, with larger values indicating better memory performance (i.e., more accurate
responses).34 D prime was calculated for both associative and item memory performance at
baseline and trial completion, and change in d prime over time by group was then reported.
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Figure 4.1: Associative memory task.
a) Item memory (face) condition; b) Item memory (scenery) condition; c) Associative
memory (face-scenery) condition.
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Participant responds ‘yes’

Participant responds ‘no’

Saw image

Hit

Miss

Did not see
image

False Alarm

Correct Rejection

Figure 4.2: Possible outcomes for the recognition conditions of the associative
memory task.
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4.2.4.3

Functional MRI outcomes

Functional MRI was used to assess changes in activation over time. Participants completed
the associative memory task (previously described) during BOLD imaging (TR=1000,
TE=30, slice thickness=2.5 mm). Using the correct response data (hits and correct rejections)
from the task, first-level fMRI analysis was performed in FSL’s FEAT (FMRIB’s Expert
Analysis Tool) to create signal contrasts during a single task run.35 The data modelling which
FEAT uses is based on general linear modelling (GLM).35 With this, a model is created to fit
the data, identifying where brain activation has occurred in response to a stimuli.35 The six
signal contrasts of interest were as follows: item (face or scenery) encoding, item
recognition, associative (face-scenery) encoding, associative recognition, associative > item
encoding, associative > item recognition. Pre-statistics processing included motion correction
using MCFLIRT (Motion Correction using FMRIB’s Linear Image Registration Tool),36
brain extraction using BET (Brain Extraction Tool),37 spatial smoothing using a Gaussian
kernel FWHM (full-width at half-maximum) of 5 mm, and registration and normalization
using a 2 mm MNI152 standard space image. Results were analyzed at a cluster threshold of
Z > 1.65, p = 0.05. Two researchers independently reviewed the output data to determine
final suitability for inclusion in analyses; a motion cut-off of 3 mm was used (i.e.,
participants with motion values above this were automatically excluded from analyses).
Higher-level analyses using fixed effects were then run to (1) create an average contrast over
the three runs for each participant at both time points, and (2) create a contrast across the
time points for each participant (trial completion > baseline).35 Following this, a multisubject higher-level analysis using mixed effects was done to create group contrasts.38 All
higher-level results were also analyzed at a cluster threshold of Z > 1.65, p = 0.05. The
multi-subject analysis produced clusters that showed significant change in activation for each
of the six signal contrasts (item encoding, item recognition, associative encoding, associative
recognition, associative > item encoding, associative > item recognition). Regions of interest
(ROIs) were then created based on identified clusters, and percent signal change (PSC) was
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calculated via FSL’s Featquery for each participant.35 From this, average PSC over time by
group was calculated and compared.

4.2.5 Data analysis
Behavioural outcomes are presented as means and SEs at baseline, midpoint, and trial
completion, and change over time is presented as percent change (average) and 95% CIs by
group. Structural and functional analysis was done in FSL, and these outcomes are also
presented as means and SEs at baseline and trial completion. Change overtime for sMRI
outcomes is presented as percent change and 95% CIs, while fMRI outcomes are presented
as change in PSC and 95% CIs. Quality assessment of data was performed and discussed by
two researchers. Potential outliers were included in analyses, as in Chapter 3, however some
fMRI data was excluded due to excess motion (described in section 4.3.4 of this Chapter).
Bivariate Spearman correlation coefficients were also used to examine the possible
magnitude and direction of associations between change (across the trial) in brain and
physical outcomes, as well as brain and cognitive outcomes from Chapter 3.

4.3 Results
4.3.1

Descriptive measures

Baseline characteristics of participants are described in Table 3.2 of Chapter 3. Briefly, A
total of 24 participants were randomized into our trial (13 into the resistance training group
and 11 in the balance and tone group). Participants were 68.7 ± 5.7 years old on average and
were 50% female. All participants were overweight or obese based on BMI, and four were
also prediabetic based on FPG.
Twenty-three participants completed both baseline and trial completion MRI scans, while
one participant (from the balance and tone group) only completed the baseline MRI due to
dropping out of the study after 10 weeks. This individual’s baseline behavioural and sMRI
data was used in analyses (except in PBVC calculations which requires input from two
timepoints), however their baseline fMRI data was excluded from analyses.
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4.3.2

Structural MRI outcomes

Structural MRI outcomes are presented in Table 4.1 and Figure 4.3, where percent change
across the trial is reported. Results show that the resistance training group had less of a
decline in TBV (presented as PBVC; -0.13%) compared to the balance and tone control
group (-0.37%). Similarly, less hippocampal atrophy was found in the resistance training
group (-1.24%) compared to the control group (-1.74%). However, the control group
increased in GMV and WMV (0.29% and 0.15%, respectively) compared to the resistance
training group who had a 1.18% decrease in GMV and a 0.91% decrease in WMV.
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Table 4.1: Structural outcomes by group.
Variable

Baseline

Trial completion

a

a

Mean (SE)

Mean (SE)

Δ Baseline to trial
completion
Percent change (95%
CI)

RT
PBVC
GMV

N/A
754939.81 (10206.60)

N/A
746013.50 (11272.60)

-0.13 (-0.58, 0.32)
-1.18 (-2.80, 0.44)

WMV

626335.00 (10483.75)

620351.896 (10442.01)

-0.91 (-2.95, 1.13)

7170.31 (215.56)

7082.39 (225.45)

-1.24 (-3.41, 0.93)

N/A
757173.07 (18523.49)

N/A
759611.69 (19958.85)

-0.37 (-0.83, 0.08)
0.29 (-0.92, 1.50)

WMV

653713.39 (17636.66)

653591.58 (14274.20)

0.15 (-2.45, 2.75)

HV

6968.00 (194.61)

6889.00 (216.81)

-1.74 (-4.73, 1.25)

HV
BAT
PBVC
GMV

a

Note: Volumes are in mm3.
PBVC = precent brain volume change (total brain volume); GMV = grey matter
volume; WMV = white matter volume; HV = hippocampal volume; RT = resistance
training; BAT = balance and tone group; SE = standard error; CI = confidence
interval.
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Figure 4.3: Percent volume change for brain measures (trial completion > baseline).
Note: the bars represent standard errors.
RT = resistance training group; BAT = balance and tone group.
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4.3.3

Behavioural MRI outcomes

At baseline, nine participants were missing partial associative memory task data (i.e., partial
conditions from 1-2 task runs). Data from three participants was missing due to task or fMRI
issues, five due to participant withdrawal (i.e., participants requested to only complete 2/3
task runs due to discomfort in the scanner), and one due to the participant being late to the
scan and therefore unable to complete all three runs in the allotted scanning time. At trial
completion, seven participants had partial behavioural data missing, in which data from four
participants was missing due to task/fMRI issues, and three due to participant withdrawal.
When assessing d prime results, participants in the resistance training group improved
slightly in item memory (i.e., increased d prime) across the trial when compared to the
balance and tone group (Table 4.2, Figure 4.4). In addition, both groups had small,
comparable decreases in associative memory over time (Table 4.2, Figure 4.4).
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Table 4.2: Behavioural outcomes by group.
Variable

RT
d prime (associative)
d prime (item)
BAT
d prime (associative)
d prime (item)

Δ Baseline to trial
completion
Percent change (95%
CI)

Baseline

Trial completion

Mean (SE)

Mean (SE)

2.0 (0.2)
1.5 (0.2)

1.8 (0.2)
1.7 (0.3)

-0.2 (-1.0, 0.5)
0.2 (-0.2, 0.7)

2.5 (0.8)
1.0 (0.1)

2.3 (0.5)
1.0 (0.1)

-0.3 (-2.0, 1.3)
-0.1 (-0.4, 0.2)

RT = resistance training; BAT = balance and tone group; SE = standard error; CI =
confidence interval.
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Figure 4.4: Mean change in scores on the associative memory task (trial completion >
baseline).
Note: the box represents the interquartile range, where the bottom line of the box represents
quartile 1 (25th percentile) and the top line represents quartile 3 (75th percentile); the whiskers
represent the minimum and maximum values excluding outliers; ‘X’ represents the mean;
and the middle line of the box represents the median.
RT = resistance training group; BAT = balance and tone group.
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4.3.4

Functional MRI outcomes

In addition to missing associative memory data described in section 4.3.3 of this Chapter,
additional task data was excluded for fMRI analyses. One participant was excluded from
both baseline and trial completion analyses due to excess head motion (i.e., > 3mm). At
baseline, two participants also had 1/3 memory task runs excluded, while an additional
participant had 2/3 runs excluded, all due to excess motion. At trial completion, one
participant had 2/3 runs excluded also due to motion. Altogether, we analyzed fMRI data
from 22 participants at baseline (19 with full data, three with partial data) and 22 at endpoint
(21 with full data, one with partial data). Since this is a pilot study, we included participants
who had at least one run of the task deemed usable in analyses at either time points.
We identified brain areas showing significant changes in hemodynamic activity between
groups at trial completion relative to baseline. The identified ROIs are presented in Table
4.3, Table 4.4, and Table 4.5. Across the trial, the resistance training group had a 0.11%
increase in activation in the postcentral gyrus during associative > item encoding compared
to the balance and tone group (Table 4.6, Figure 4.5). In addition, those in the resistance
training group had a 0.13% increase in activation in the precentral gyrus and a 0.11%
increase in the middle temporal gyrus (posterior) during associative > item recognition
compared to the balance and tone group (Table 4.6, Figure 4.5). Comparatively, those in the
balance and tone group had an increase in activation overtime in the anterior supramarginal
gyrus (by 0.18%) and juxtapositional lobule cortex (by 0.12%) during associative > item
encoding compared to the resistance training group (Table 4.6, Figure 4.5). No other areas
were identified as having significant between-group differences in activation for any of the
remaining four contrasts (item encoding, item recognition, associative encoding, associative
recognition) at trial completion relative to baseline.
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Table 4.3: Clusters identified as being significantly more active for associative > item encoding in the resistance training group
at trial completion compared with baseline.
Hemisphere
Left
Left
Left
Left
Left
Left
a

Region
Postcentral gyrus
Postcentral gyrus
Postcentral gyrus
Supramarginal gyrus
(anterior)
Postcentral gyrus
Superior parietal lobule

Cluster sizea
1539

Max Zb
3.17
2.95
2.76
2.68

MNI coordinatesc
X
-34
-38
-32
-52

Y
-38
-38
-26
-34

Z
40
48
68
38

2.67
2.64

-44
-28

-20
-44

56
48

Cluster size = size of maximum cluster in voxels.
Max Z = maximum Z statistic for the cluster.
c
MNI coordinates = location of the cluster maxima in Montreal Neurological Institute standard space.
b
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Table 4.4: Clusters identified as being significantly more active for associative > item recognition in the resistance training
group at trial completion compared with baseline.
Hemisphere
Left
Left
Left
Left
Left
Left
Right
Right
Right
Right
Right
Right
a

Region
Precentral gyrus
Precuneus cortex
Middle temporal gyrus
(posterior)
Postcentral gyrus
Superior temporal gyrus
(posterior)
Inferior temporal gyrus
(posterior)
Middle temporal gyrus
(posterior)
Supramarginal gyrus
(posterior)
Thalamus
Middle temporal gyrus
(posterior)
Precentral gyrus
Central opercular cortex

Cluster sizea
6593

5853

Max Zb
3.02
2.99
2.88

MNI coordinatesc
X
-38
-4
-72

Y
-4
-56
-28

Z
46
34
-10

2.84
2.81

-42
-58

-12
-34

28
4

2.79

-46

-36

-22

3.14

46

-36

0

3.13

56

-40

6

2.86
2.84

18
50

-24
-24

14
-10

2.83
2.83

30
42

-22
10

48
2

Cluster size = size of maximum cluster in voxels.
Max Z = maximum Z statistic for the cluster.
c
MNI coordinates = location of the cluster maxima in Montreal Neurological Institute standard space.
b
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Table 4.5: Clusters identified as being significantly more active for associative > item encoding in the balance and tone group
at trial completion compared with baseline.
Hemisphere
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
Left
a

Region
Supramarginal gyrus
(anterior)
Supramarginal gyrus
(anterior)
Precentral gyrus
Supramarginal gyrus
(anterior)
Inferior frontal gyrus
(pars opercularis)
Middle frontal gyrus
Juxtapositional lobule
cortex
Juxtapositional lobule
cortex
Superior frontal gyrus
Paracingular gyrus
Superior frontal gyrus
Superior frontal gyrus

Cluster sizea
3413

1206

Max Zb
3.13

MNI coordinatesc
X
-62

Y
-30

Z
42

3.08

-56

-30

42

3.06
2.99

-50
-64

2
-28

46
38

2.81

-52

12

16

2.79
3.1

-40
-4

8
0

48
60

3.04

-6

4

58

2.84
2.83
2.56
2.49

-2
-4
-2
-8

18
24
32
14

60
40
48
56

Cluster size = size of maximum cluster in voxels.
Max Z = maximum Z statistic for the cluster.
c
MNI coordinates = location of the cluster maxima in Montreal Neurological Institute standard space.
b
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Table 4.6: Percent signal change in brain regions identified as having significant
activation.
Variable
RT
a
PoCG
b
PreCG
b
MTGp
BAT
a
SMGa
a
JPC
a

Baseline
Mean (SE)

Trial completion
Mean (SE)

Δ Baseline to trial completion
Change in PSC (95% CI)

-0.08 (0.02)
-0.08 (0.03)
-0.06 (0.02)

0.03 (0.03)
0.05 (0.03)
0.04 (0.02)

0.11 (0.04, 0.18)
0.13 (0.04, 0.22)
0.11 (0.03, 0.19)

-0.27 (0.07)
-0.06 (0.05)

-0.08 (0.04)
0.06 (0.02)

0.18 (0.00, 0.36)
0.12 (0.01)

Encoding conditions
Recognition conditions
PoCG = postcentral gyrus; PreCG = precentral gyrus; MTGp = middle temporal gyrus
(posterior); SMGa = supramarginal gyrus (anterior); JPC = juxtapositional lobule cortex;
PSC = percent signal change; RT = resistance training; BAT = balance and tone group; SE =
standard error; CI = confidence interval.
b
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Figure 4.5: Significant changes in activation during the associative memory task
(trial completion > baseline).
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a. Resistance training group, associative > item encoding; main activation is found in the
left postcentral gyrus (arrow).
b. Resistance training group, associative > item recognition; main activation is found in the
left precentral gyrus. (arrow).
c. Balance and tone group, associative > item encoding; main activation is found in the left
anterior supramarginal gyrus (arrow).
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4.3.5

Correlations

Table 4.7 shows correlations between change in brain and physical/cognitive measures
(Chapter 3) at trial completion relative to baseline. For brain and physical outcomes, most
associations were weak, however, there were some surprising correlations including (1) a
moderate negative association between PBVC and 1RM (i.e., increased brain volume was
related to decreased 1RM), (2) a weak-to-moderate positive association between PBVC and
FPG (i.e., increased brain volume was related to increased FPG levels), and (3) a weak-tomoderate positive association between WMV and BMI (i.e., increased volume was related to
increased BMI).
For brain and cognitive outcomes, increased PBVC was moderately related to improved
ADAS-Cog 12 scores. Unexpectedly, however, increased PBVC was associated with a
decline in TMT performance, although this association was weak-to-moderate in strength.
Similarly, a weak-to-moderate positive association was found between GMV and TMT
scores as well as Digit Span scores (i.e., increased volume was related to a decline in
performance on both tests). For WMV, a weak-to-moderate positive correlation was found
with TMT scores and a weak-to-moderate negative correlation with RAVLT scores, as well
as a moderate positive correlation with Stroop scores; for all three correlations, increased
volume was associated with a decline in cognitive performance. A moderate negative
correlation was also found between WMV and ADAS-Cog 12 scores (i.e., increased volume
was related to improved scores). Finally, increased HV was moderately related to a decline in
Digit Span performance. All other associations were weak.
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Table 4.7: Spearman correlations between brain and physical/cognitive outcomes (trial
completion > baseline).
PBVC

GMV

WMV

HV

1RM, kg

-.433

.151

-.070

.106

BMI, kg/m2

.031

-1.48

.259

-.125

FPG, mmol/l

.344

.000

-.037

-.193

Stroop (C-B)

-.005

.093

.410

.007

TMT (B-A)

.278

.252

.320

.136

Digit Span (F-B)

-.128

.294

.156

.466

RAVLT (20 minute
delay)

-.016

-.086

-.222

.030

ADAS-Cog 12

-.570

.161

-.414

.045

1RM = one repetition maximum (predicted) – quadricep; BMI = body mass index;
FPG = fasting plasma glucose; Stroop (C-B) = Stroop Test condition C minus
condition B; TMT (B-A) = Trail Making Test part B minus part A; Digit Span (F-B) =
Digit Span Test Forward minus Backward; RAVLT (20 minute delay) = Rey Auditory
Verbal Learning Test 20 minute delay condition; ADAS-Cog 12 = Alzheimer’s
Disease Assessment Scale–Cognitive 12; PBVC = percent brain volume change (total
brain volume); GMV = grey matter volume; WMV = white matter volume; HV =
hippocampal volume.
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4.4 Discussion
This chapter examined the effects of a 26-week resistance training program on sMRI and
fMRI outcomes in older adults at risk for diabetes. Results from our pilot study demonstrate
that resistance training may preserve whole brain volume decline associated with aging.
Specifically, we found an average TBV decline of 0.13% in the resistance training group and
0.37% in the balance and tone group. The latter rate of decline is fairly consistent with what
has been shown to occur in age-related atrophy. For example, a longitudinal study in healthy
older adults aged 60-80 found an average rate of whole brain atrophy of ~0.5% per year.39
Similarly, another study found that nondemented older adults had a 0.45% annual decline in
TBV, while rates in those with early stages of dementia were double this.40
Contrary to our finding, a previous study in older adults found that twice-weekly resistance
training led to more TBV atrophy (-0.43%) when compared to balance and tone exercise.41
However, the authors of this study noted that this unexpected decline may be due to the
removal of beta-amyloid in the brain as a result of resistance training, and with it, cerebral
fluid shifts that could account for whole brain volume reductions.41 Strengthening this
argument, this study found improvements in cognitive function in response to resistance
training despite showing a decrease in TBV.41 Beyond this study, however, there is a lack of
RCTs examining the effects of resistance training on TBV in older adults. This is surprising
given that older adults are prone to whole brain atrophy as a result of aging, and this is
associated with cognitive deficits in important domains (e.g., memory, global cognition) as
well as an increased risk for dementia.42 Given our positive findings, more trials assessing the
effects of resistance exercise on brain volume in older adult populations who are at risk of
brain and cognitive decline should be prioritized.
Although our results show that the resistance training group had less TBV atrophy than the
control group, those in the resistance exercise group showed more GMV and WMV atrophy
overtime. These differing findings may be the result of the analysis tools used within FSL to
assess longitudinal changes. While SIENA is known to have a low error rate (0.2%),
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SIENAX has been shown to have a higher error rate of 1% and may not be the most
appropriate measure of longitudinal change (its main purpose is to be used in cross-sectional
analyses).42 Therefore, future trials should consider using additional analysis tools beyond
FSL to measure change in GMV and WMV, which would also allow for a direct comparison
to FSL’s output. Our study also showed less decline in HV following resistance exercise;
however, whether these changes are statistically significant cannot be concluded. In
comparison to our findings, a similarly designed study in older women with MCI found that
six months of resistance exercise led to a HV decrease of 2.17% (compared to a decrease of
1.75% in their balance and tone control group).43 However, these differences were not
statistically significant.43 Interestingly, the amount of HV atrophy seen in both groups in our
study is comparable to other clinical populations of older adults, such as those with
Alzheimer’s disease. For example, multiple longitudinal studies have shown that Alzheimer’s
disease patients have an annual HV loss of 3.5-3.98%.44,45 Evidently, more cross-sectional
studies are needed in older adults at risk for diabetes to better understand possible HV
impairment in this population.
One surprising finding in our study was that resistance exercise did not improve associative
memory performance. This contrasts a previous study which found that six months of twiceweekly resistance training, compared to balance and tone exercise, improved associative
memory in older adults.32 However, this study, compared to ours, involved individuals with
MCI.32 Given that deficits in associative memory have been shown to occur in mild
dementia,46 it might be the case that those with MCI experience greater deficits in associative
memory compared to our target population (and thus may benefit more from exercise).
Cross-sectional studies examining associative memory ability in our target population
compared to both healthy older adults and other clinical populations could help shed light on
potential group differences in brain health and cognition. Further, while we did not see an
improvement in associative memory, we did see an improvement in item memory in response
to resistance training, however these changes were very small. Future large-scale resistance
exercise trials are needed to examine these possible effects more closely.
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Interestingly, we did not see significant changes in activation in cortical areas that have been
previously implicated in associative memory and have shown to positively respond to
resistance training, such as the lingual and occipital-fusiform gyri.32 However, when
comparing trial completion relative to baseline (associative > item), those in the resistance
training group did have increased activation in the postcentral gyrus during encoding and in
the precentral gyrus and middle temporal gyrus during recognition when compared to the
balance and tone group. Previous research examining differences in brain function in young
versus older adults have found greater activation in these areas in younger adults.47 Similarly,
one study showed that greater activation in the precentral gyrus during a memory task was
evident in healthy controls versus Alzheimer’s disease patients.48 Based on these findings, it
appears that patterns of increased activation in our resistance training group may reflect that
of younger, healthy adults. On the contrary, individuals in the balance and tone group, when
compared to the resistance training group, had increased activation overtime in the
supramarginal gyrus and juxtapositional lobule cortex during encoding conditions. Activation
in the supramarginal gyrus has previously been implicated in the use of rehearsal strategies
during working memory encoding,49 and thus those in the balance and tone group may have
used this specific strategy to memorize images. Finally, impairments in working memory
have been shown to be associated with less activation in the juxtapositional lobule cortex,50
therefore it is possible that balance and tone exercise selectively improves memory function.
This is also in line with findings from Chapter 3, in which balance and tone exercise was
shown to improve working memory.
Given that those in the resistance training group did improve slightly in item memory during
the fMRI task, but not in other measures of memory as described in Chapter 3, it appears that
resistance training may improve certain types of short-term memory over others, namely
visual-item memory but not auditory-verbal memory. These findings may be the result of
participants using varying strategies for memorization depending on the type of memory task
(e.g., for visual but not auditory memory tasks, participants may have created categorical
representations or used visual traces). Coupled with the finding of increased activation
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patterns in the juxtapositional lobule cortex for the balance and tone group, future trials may
benefit from collecting self-reported data on the type of memory strategy employed by
participants to remember pictures.
A large limitation to the current study is the amount of participant data that was missing or
excluded in analyses. When collecting fMRI task data, we experienced multiple issues
running our memory task during the scan which required on-the-spot troubleshooting; this
was especially difficult given that MRI scans are on a strict time schedule. As a result,
several participants had partial memory task data excluded. Additionally, many participants
experienced discomfort while in the scanner and requested to not complete the full memory
task. Future trials should consider cutting down imaging time where possible, and developing
improved methods of task troubleshooting prior to scanning. Further suggestions on how to
improve these in the future are examined in Chapter 5. Moreover, it may be interesting to
assess participant performance on the associative memory task while outside of the scanner
to further assess behaviour outcomes and avoid any issues that occurred with use of the
scanner.
In addition, similar to Chapter 3 limitations, we are unable to make definite conclusions on
the effect of resistance training on brain structure and function in older adults at risk for
diabetes due to this being an underpowered study. As also previously highlighted, future
studies are needed to examine the underlying mechanisms (e.g., release of neurotrophic
factors, increased levels of neurotransmitters) by which resistance training may improve
brain structure and function, as well as the possible relationship between improvement in
brain health and cognitive function in our target population. In our study, we briefly explored
the relationship between change in brain health and cognitive/physical measures via
correlational analyses, which showed that there may be unexpected relationships between
outcomes (e.g., improved GMV was related to a decline in task-switching and working
memory performance). However, there is a need to explore our correlational findings further
as they were not statistically measured. Finally, future studies may also examine how quickly
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the positive effects of resistance training on brain structure and function may occur (e.g., <
six months) as well as their potential lasting effects.
To sum, resistance exercise appears to slow down total age-related brain atrophy and
possibly regional atrophy (HV) in older adults at risk for diabetes. Additionally, it was found
that increased activation patterns as a result of resistance training may lead to functionally
healthier brains in this clinical population. However, negative effects of resistance training
were found for GMV and WMV which may be the result of analysis methods used, and
resistance training did not improve associative memory performance as anticipated.
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Summary
This chapter assessed structural and functional brain changes following 26 weeks of thriceweekly progressive resistance training in older adults at risk for diabetes. Those in the
resistance training group showed less age-related TBV decline and HV atrophy compared to
the balance and tone group, however they did experience greater GMV and WMV decline
which may be the result of the analysis tool used for tissue type segmentation. When
assessing functional activation patterns during the memory task (associative > item),
resistance training led to increased activation during the encoding and retrieval phases that
mimics patterns of younger adults and healthy older adults. These findings suggest that
resistance training may lead to a functionally ‘younger’ and healthier brain. In comparison,
during the encoding phase, those in the balance and tone group experienced an increase in
activation in areas implicated in working memory and rehearsal memory, the latter of which
may indicate use of specific memory strategies in this group. Moreover, these activation
patterns may explain the improvements in short-term memory tasks seen in the balance and
tone group in Chapter 3. No other significant between-group activation patterns were found
in our fMRI analysis. Finally, despite activation patterns found in the resistance training
group, they did not improve in associative memory performance.
While our pilot MRI findings are promising, powered RCTs are needed in this population to
further assess these possible effects. In Chapter 5, the feasibility of conducting a large-scale
study in older adults at risk for diabetes is examined.
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Chapter 5

5

Process outcomes: Feasibility of conducting a large-scale
resistance training randomized controlled trial in older
adults at risk for diabetes

The content in Chapter 3 has been published as:
Furlano JA, Nagamatsu LS. Feasibility of a 26-week exercise program to improve brain
health in older adults at risk for type 2 diabetes: A pilot study. Can J Diabetes.
2020;45(6):546-552. doi:10.1016/j.jcjd.2020.11.001
Some of the published content has been edited for this thesis.

5.1 Introduction
Over three million Canadians are living with T2D,1 and this number continues to steadily
increase each year.2 While T2D affects people of all ages, older adults are particularly at high
risk for this disease. Studies show that older adults with T2D experience deficits in cognitive
function (e.g., executive function, processing speed, memory) and brain health (structure and
function).3,4 Importantly, both overweight/obese individuals and those with prediabetes (i.e.,
those at risk for T2D) already show some evidence of such decline.5-7 Therefore, intervention
strategies aimed at improving cognitive and brain health in this at-risk group is imperative, as
it may help prevent or delay future decline.
One lifestyle intervention strategy known to improve neurocognitive function is exercise. For
example, six months of structured aerobic training has been shown to improve memory and
executive function in older adults at risk for T2D.8 However, whether other types of exercise
may benefit this specific population, such as resistance training, is unknown. In other
populations of older adults, however, resistance exercise has been shown to improve both
cognitive and brain health. Nagamatsu et al. (2012) showed that six months of resistance
training leads to improved selective attention, conflict resolution, and associative memory, as
well as increased hemodynamic activity in associative memory-related areas (e.g., right
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lingual gyrus) in older adults with probable MCI.9 In another study, older adults with MCI
exhibited improved global cognition and increased cortical thickness of grey matter in the
posterior cingulate gyrus after 26 weeks of resistance training.10 In studies in healthy older
adults, resistance training has led to reduced cortical white matter atrophy,11 reduced
WMLs,12 and increased HV.13 These changes may be caused by the release of neurotrophic
factors through resistance training, in particular IGF-1 associated with neuroplasticity (e.g.,
angiogenesis, axon growth, etc.) and neuronal survival.14,15 Additionally, changes in response
to resistance training may be due to improved metabolic risk factors and reduced adiposity
via muscle mass development,16 and with this increased insulin-mediated glucose uptake in
muscles as well as improved insulin sensitivity.17,18
To address whether resistance training may benefit cognitive function and brain health in
older adults at risk for T2D, a powered RCT is needed. However, prior to conducting a largescale trial, there is first a need to assess the feasibility of conducting a resistance exercise
intervention in this population, to ultimately determine the accessibility of the program and
the ability to recruit this specific population. Prior to our study, we expected that recruiting
this population may be difficult, as these individuals may have low motivation to exercise,
low energy levels, and/or physical limitations that prevent them from being physically active.
In addition to this, prediabetes may go unnoticed and undiagnosed, as its symptoms (i.e.,
having elevated blood glucose levels beyond the normal range) may not be obvious.
To assess feasibility in our pilot study, we aimed to (1) examine recruitment, adherence, and
retention rates of program participants, and (2) assess delivery of the intervention and
barriers for study participation from the perspective of both program participants and
research assistants (RAs; i.e., exercise instructors) through feedback questionnaires. We
hypothesized that adherence and retention rates would be high, while recruitment rates would
be low. Ultimately, this study aimed to provide unique insight into strategies for working
with an at-risk population that has been relatively understudied to date, and to provide
methodological recommendations to implement into future trials.
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5.2 Methods
5.2.1

Study design

Details of our study design have been reported in depth in Chapter 3. Briefly, we conducted a
single-blinded pilot RCT to examine the feasibility of a 26-week, thrice-weekly resistance
training intervention in older adults at risk for T2D.

5.2.2

Participants

Participants were community-dwelling older adults aged 60-80 who were at risk for diabetes
(had BMI ≥ 25 and/or FPG 6.1 to 6.9 mmol/l). As previously mentioned, participants were
recruited through posters in community centers, short presentations at community seminars,
word-of-mouth and ads in the Villager Publications’ community magazine (print) and Kijiji
(online classified advertisement). Further details on inclusion/exclusion criteria can be found
in Chapter 3.

5.2.3

Exercise intervention

Following baseline assessments, participants were randomized into a thrice-weekly resistance
training or balance and tone (control) group for 26 weeks. Participants exercised in small
groups of 2-4 and all classes were led by 1-2 instructors (RAs). Timing of classes differed
per group depending on participant availability (ranged from morning to evening).
Participants in the resistance training group completed exercises using programmable
resistance machines and body weight/hand weights, while participants in the balance and
tone group completed balance and stretching exercises (as a group). Warm-up and cool down
time for the resistance training group consisted of walking on a treadmill or using an
elliptical machine, while participants in the balance and tone group performed stretches
together. Study methods have been described in further detail in Chapter 3.
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5.2.4
5.2.4.1

Primary feasibility outcome measures
Recruitment

Time and number of individuals screened to enroll 10 program participants per group was
recorded. Recruitment strategies (type, time of year) were also examined.

5.2.4.2

Adherence

Adherence to the exercise program, calculated by [(number of classes attended/78 classes
maximum) x 100%)], was recorded for both exercise groups. Our target adherence rate was
70%+, based on other exercise trials with similar populations of older adults.19,20 If
participants missed sessions, we followed-up with them via phone and offered make-up
sessions when possible. To promote adherence, participants were entered into a monthly gift
card draw based on number of classes attended, and were given a $50 honorarium for each
completed assessment timepoint (baseline, midpoint, trial completion). We also allowed
partners/friends (i.e., “support exercisers”) to participate in the exercise classes.

5.2.4.3

Retention

Number of program participants that completed the full exercise program by group was
recorded. Our target retention rate was 70%+, based on other exercise trials with similar
populations of older adults.19,20

5.2.4.4

Safety

The number and description of adverse events by exercise group was recorded.

5.2.4.5

Fidelity

To ensure consistency across exercise classes and help identify any potential program issues,
a questionnaire was completed by a non-study affiliate once per month in which s/he
attended and evaluated a randomly selected resistance training and balance and tone session.
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S/he assessed the structure of the class, including the delivery of the exercises by the RAs
and instructor-participant engagement.

5.2.5

Secondary feasibility outcome measures

5.2.5.1
5.2.5.1.1

Feedback questionnaires
Program participants

We administered an anonymous Qualtrics questionnaire via e-mail to all exercising
individuals at study completion. The 11-question mixed methods survey assessed perceived
successful elements of the exercise intervention, potential areas for program improvement,
and overall participant enjoyment and satisfaction with the study. The questionnaire featured
5-point Likert-scale questions (response options were “strongly disagree”, “disagree”,
“neutral”, “agree”, and “strongly agree”) and open-ended questions. The purpose of this
questionnaire was to gather further information regarding the feasibility of our intervention
and identify key strategies to working with this population for future full-scale RCTs.

5.2.5.1.2

Research assistants

We also administered a separate questionnaire to the RAs to complement the information
from program participants on how to improve future exercise interventions. This anonymous
Qualtrics questionnaire was sent via e-mail to all RAs when their volunteer roles ended. The
16-question mixed methods survey aimed to assess overall enjoyment as an RA, delivery of
the program, and any potential challenges faced/areas for improvement from the RA
perspective. Similar to the program participant questionnaire, the RA questionnaire included
both 5-point Likert-scale and open-ended questions.

5.2.5.1.3

Questionnaire analysis

Likert-scale questions featured both positive and reverse-coded negative statements. For
Likert-scale data, we calculated frequencies (percentages of responses), and collapsed
positive (“strongly agree” and “agree”) and negative (“strongly disagree” and “disagree”)
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responses. For each open-ended question, responses were grouped into categories based on
content similarities, and percentages of responses per category (out of total responses for that
question) were reported. Individually-based responses that could not be placed into existing
categories were not reported in the results unless we believed them to be especially important
for future trials. To describe overall findings, we grouped our results into four themes for
program participants (motivation to participate, perceived positive outcomes, constructive
feedback, and future exercise participation) and three themes for RAs (perceived positive
outcomes, constructive feedback and recommendations for future trials [program
participants], and constructive feedback and recommendations for future trials [RAs]).

5.3 Results
5.3.1

Descriptive statistics

Descriptive statistics of participants are presented in Table 3.2 of Chapter 3. The average age
of participants was 68.7 years ± 5.7 with 50% being female. All 24 participants were
overweight or obese and four were also prediabetic.

5.3.2

Feasibility

Figure 3.2 of Chapter 3 provides the CONSORT (Consolidated Standards of Reporting
Trials) diagram to show the flow of participants through our study. Ongoing recruitment of
program participants occurred over 17 months (October 2017 to February 2019), where a
total of 72 older adults were recruited (48 of which were ineligible or no longer interested in
participating in the study). Reasons for ineligibility included: low FPG and BMI, Parkinson’s
disease, T2D, untreated depression, stroke, metal implants preventing MRI, psychotropics,
hip injury preventing exercise, hormone replacement therapy, regular exerciser, and
physician advisory not to exercise. Reasons for no longer being interested in participating
after recruitment included MRIs, driving to the exercise lab in the Winter, and the time
commitment required for the study.
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Of the 72 people recruited, 58.3% were by newspaper ads, 15.3% by presentations at
community seminars, 12.5% by Kijiji ads, 8.3% by word-of-mouth, and 5.6% by community
posters (Figure 5.1). For participants who enrolled in the study and were randomized (n =
24), the majority were also recruited through newspaper ads (66.7%), with some being
recruited through Kijiji ads (12.5%), at community seminars (12.5%), and by word-of-mouth
(8.3%). Recruitment was highest during Fall and Winter months (i.e., October, January), but
depended highly on when newspaper ads were used. A summary of recommended
recruitment strategies, along with other items for optimization in future trials, is listed in
Table 5.1. In addition to the 24 eligible participants in our study, we had 3 support exercisers
also complete the exercise program.
We maintained a 95.8% retention rate of program participants in our study, with only one
balance and tone participant dropping out at week 10 due to health issues. Program
participant attendance averaged 84.4%, with a slightly higher attendance rate for the
resistance training groups (85.5%) compared to the balance and tone groups (83.3%). Six
participants completed between 2-13 make-up sessions due to missed classes. Missed classes
occurred most in the Winter and Summer months, and were mainly due to illness, vacation
time, and scheduling conflicts. The number of participants who completed MRI analysis,
including those with missing data, have been described in Chapter 4.
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Figure 5.1: Study recruitment methods.
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Table 5.1: Items for optimization in future RCTs.
Item
Recruitment

Description of Current Study
- Low recruitment rate; some months unsuccessful
- Newspaper ads, Kijiji ads, presentations at
community seminars successful
- Posters less successful

Optimization for Future Studies
- Use of newspaper ads, Kijiji ads, presentations at community
seminars
- Recruit in early Fall & Winter
- Ads emphasize that the program is free and instructor-led, with
the option to bring a friend

Participant
Blinding
Exercise
Program

- Program participants not blinded to group
allocation
- BAT exercises reportedly too repetitive
- Possibility that BAT groups socialized more
than RT groups (due to group warm-ups/cooldowns)
- Exercise sessions held mostly in the evening
- Varying class size
- MRIs reported as unenjoyable part of the study
- No formal RA training manual or handouts
- More RA practice sessions requested

- Physician added to the research team if possible
- Program participants blinded to group allocation
- Diversity of exercises for BAT
- Warm-up/cool-down protocol the same between groups
- Variety of class times
- Classes held during early day when possible

Study
Protocol

Program
- More program participant check-ins requested
Participant
- More performance feedback of program
Performance participants requested
Feedback

- Better inform program participants of MRI procedures
- Cut down MRI scanning time when possible
- RA training manual (covering training steps, work
expectations, troubleshooting procedures, etc.) developed
- Hold more RA practice sessions
- Program participants receive bi-weekly one-on-one check-ins to
review progress

MRI = magnetic resonance imaging; RA = research assistant; RCT = randomized, controlled trial; BAT = balance and tone group.
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5.3.3

Safety

We observed no significant adverse events during the course of this study.

5.3.4

Fidelity

Assessors reported high consistency between exercise classes (i.e., RAs closely followed
protocols, performed adequate equipment demonstrations, engaged with participants, and
successfully answered participant questions). No issues were reported.

5.3.5

Feedback questionnaires

5.3.5.1

Program participant questionnaire

Twenty individuals, out of 27 total (24 participants plus 3 support exercisers), completed this
questionnaire following completion of the study.

5.3.5.1.1

Motivation to participate

5.3.5.1.1.1

Open-ended responses

The largest motivating factor to participate in this study was identified as becoming more
active and improving physical fitness (48.1% of responses for this question). Other reasons
for participating included wanting to contribute to research (18.5% of responses), having an
interest in the research topic (14.8%), and the desire to improve their memory (7.4%).

5.3.5.1.2

Perceived positive outcomes

5.3.5.1.2.1

Likert-scale responses

Based on Likert-scale responses, 90% of participants reportedly enjoyed their participation in
the study. In addition, the majority of participants felt that they received sufficient
information about the study prior to participation (70%) and had adequate support from
research personnel throughout the study (90%).
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5.3.5.1.2.2

Open-ended responses

Participants reported that their favorite component of the study was socializing with
instructors and other participants (65.7% of responses) and improving their physical health
(20%). Similarly, in a separate question, the 2 most commonly reported benefits of study
participation were increased strength/mobility and fitness (53.3% of responses) and the
ability to socialize with others (16.7%). Other less reported benefits included receiving
instructor-led exercise sessions at no cost (6.7% of responses) and being shown correct
exercise techniques (3.3%).

5.3.5.1.3

Constructive feedback

5.3.5.1.3.1

Open-ended responses

The least favorite component of the study for participants was identified as timing of sessions
(27.3% of responses) and completing MRIs (22.7%). Other responses included the drive to
campus (13.6% of responses) and the repetitiveness and simplicity of balance and tone
exercises (9.1%). Similarly, in a separate question, the most difficult component of the study
was said to be timing of sessions (30% of responses) and MRIs (20%). One individual also
said staying motivated to exercise (5% of responses) was particularly challenging.

5.3.5.1.4

Future exercise participation

5.3.5.1.4.1

Likert-scale responses

Eighty-five percent of participants reported feeling more motivated to remain physically
active after participating in this study. Additionally, 70% of participants said that they would
participate in this program or a similar program in the future and 90% said they would tell a
friend to participate.

5.3.5.2

Research assistant questionnaire

RA feedback was provided by 28 RAs (73.7% of total RAs involved in this study).
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5.3.5.2.1

Perceived positive outcomes

5.3.5.2.1.1

Likert-scale responses

Assessing overall RA experience, it was reported that 100% of RAs enjoyed their
involvement. In addition, 100% of RAs said that they enjoyed running exercise sessions,
81.2% felt that the study was well-organized, and 92.6% said they would be an RA in this
study or a similar study again. For training and research support, 85.2% of RAs felt they had
received sufficient training for the position, 85.2% felt confident in their ability to address
program participant questions, and 77.8% said they received adequate support from research
personnel throughout the study.

5.3.5.2.1.2

Open-ended responses

RAs reported that their favourite component of being involved in the study was working with
participants (58.1% of responses). Other responses included gaining first-hand experience in
research (14% of responses), helping older adults (9.3%), and administering cognitive
assessments (4.7%) as this was another opportunity for one-on-one time with participants.

5.3.5.3
5.3.5.3.1

Constructive feedback and recommendations for future trials
(program participants)
Open-ended responses

The majority of RAs had no recommendations for improving the participant experience in
future trials (41.2% of responses), however some suggested developing faster ways for
participant sign-in at exercise classes (11.8%), having more diverse exercises (11.8%),
providing clearer instructions for participants at the beginning of the study (5.9%), and
offering frequent participant feedback throughout the study (5.9%).
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5.3.5.4
5.3.5.4.1

Constructive feedback and recommendations for future trials
(research assistants)
Open-ended responses

RAs reported that the most challenging aspects of the study were having to modify balance
and tone exercises due to lack of available equipment or altered group size (10.3% of
responses), keeping participants in the balance and tone group motivated (6.9%),
troubleshooting laboratory equipment (6.9%), ensuring that all participants followed the
protocol (3.4%), and handling participant complaints (3.4%).
While the majority of RAs said that there were no ways in which research personnel could
have improved their experience (40% of responses), a suggestion was having more balance
and tone exercises (5%) as participants tended to complete these sessions quickly. To
improve RA training, suggestions included having more RA practice sessions with one
another (28.6% of responses) and providing handouts that highlight example exercises and
RA expectations (21.4%), among others.

5.4 Discussion
To our knowledge, this pilot study is the first to assess the feasibility of conducting an RCT
of resistance training to improve cognitive and brain function in older adults at risk for T2D.
Results show that recruitment of this population is difficult as expected, however once
enrolled in our study, participants thoroughly enjoyed it and remained committed to the
exercise program as evident by high retention and adherence rates. Based on these findings, a
large-scale study was deemed feasible, and we identified key research strategies that may
improve future trials with this population.
Despite the challenge of recruiting participants, we were able to identify ways to optimize
recruitment rates for future studies. For example, it is recommended to recruit this population
in the Fall and Winter months, as this appears to be when older adults may have more time to
commit to a 26-week-long research study. Additionally, recruiting through newspaper ads,
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Kijiji ads, and community seminars (where research personnel can engage potential
participants directly) was shown to be effective. For recruitment ads, emphasizing the
benefits of study participation, such as receiving free instructor-led exercise sessions and
socializing with others, is highly recommended. To recruit prediabetic individuals in the
future, it may be helpful to collaborate directly with family physicians who can help identify
people who are at risk for T2D, as well as diabetes clinics.
In addition to recruitment methods, we also identified general strategies to working with this
population. For example, it is recommended to have regular check-ins with participants and
to offer frequent feedback on performance. Additionally, creating opportunities for more
socialization throughout the program may be helpful, and may lead to increased overall
enjoyment of and adherence to the exercise program, as shown in previous studies.21,22 Some
studies have even shown that offering social activities (e.g., coffee sessions) after each
exercise session helps improve program adherence in older adults,23 thus this could be
something to implement in the future. Other ways to increase program adherence include
allowing participants to bring a partner/friend to exercise alongside, and offering incentives
such as gift card draws based on number of classes attended.
Overall, both program participants and RAs expressed a high level of study enjoyment and
satisfaction. For example, a program participant said “It is wonderful for me to be able to
engage with positive, encouraging, energetic, knowledgeable, and fun volunteers. They gave
me more than exercise but confidence that the future might be better than I can imagine”.
While the majority of feedback from program participants was indeed positive, some general
recommendations for future studies included offering more diverse exercises and developing
ways to further keep participants, particularly those in the balance and tone groups,
motivated. Lastly, since MRIs were reported as a least enjoyable component of the study,
future trials should aim to better inform participants of MRI procedures (e.g., expectations,
scan length, the possibility of discomfort due to noise and tight space) and should consider
ways to cut down scanning time when possible.
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We acknowledge that there are several limitations to this study. First, the program participant
questionnaire did not collect information on group allocation, and as a result we were unable
to compare between-group differences. Similarly, since the questionnaire was completed by
all program participants (participants and non-participant partners) we were unable to
separate out responses from actual participants in the study. Additionally, our questionnaire
also included several open-ended questions which may have led to reduced completion rates.
Other study limitations included program participants not being blinded to group allocation
(due to needing individual physician approval to exercise), balance and tone groups possibly
socializing more than resistance training groups due to having group (versus individual)
warm-up and cool-down exercises, and limited exercise lab availability which led to having
mostly late-afternoon and evening classes. To remedy these in the future, it is recommended
to have a physician on staff if possible so that group allocation can be blinded as described in
Chapter 3 (or to directly contact each participant’s physician to privately inform them of
group allocation), to have similar warm-up and cool-down exercises for both balance and
tone and resistance training groups to increase consistency across groups, and to offer more
choices for timing of exercise sessions when possible.
Based on our findings, a large-scale study assessing the effects of resistance training on
cognitive and brain health in older adults at risk for T2D is feasible, provided that
recruitment challenges are addressed in the future. In order to properly analyze betweengroups differences, future studies will require larger sample sizes to determine whether
resistance training can improve cognitive and brain health over time for those at risk for T2D.
As there are several challenges to working with this at-risk population, we hope that our
study will inform future trials of best practices.
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Summary
This chapter assessed the feasibility of a large-scale RCT examining the effects of resistance
exercise on cognitive and brain health in older adults at risk for diabetes. Based on previous
feasibility studies in similar populations, a large-scale study was deemed feasible from our
results. Program participants reported high program enjoyment and satisfaction, and offered
minor recommendations for future studies (e.g., more diverse exercises particularly for the
balance and tone group, regular check-ins with participants, cutting down MRI scanning time
when possible). Moreover, program adherence, retention, and fidelity were high in this pilot
study, though recruitment was challenging. In our published manuscript, we identified key
strategies to improve recruitment in future trials including recruiting through community
seminars where research personnel can directly engage with potential participants, and
highlighting the social benefits of participation as this appears to be an attractive element to
the program. Strategies for study improvement that were identified in this feasibility trial will
be implemented into future large-scale trials.
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Chapter 6

6

Thesis discussion

6.1 Thesis summary
Broadly, this thesis aimed to assess the feasibility and preliminary effects of a resistance
training program to improve neurocognition in sedentary older adults at risk for diabetes (i.e.,
those with prediabetes and/or obesity). This population was targeted as these individuals are
known to experience some cognitive and brain deficits and are at risk of further decline
related to T2D. An additional aim of this thesis was to identify the type of brain deficits that
are associated with prediabetes based on the literature. Specifically, a systematic review
(Chapter 2) reported on current evidence of the structural and cerebrovascular brain
impairments experienced in prediabetes, as this appears to be less understood in this disease
compared to obesity. Subsequent chapters reported on the cognitive findings (Chapter 3) and
brain health outcomes (Chapter 4) from a 26-week resistance training pilot RCT in older
adults at risk for diabetes, as well as the feasibility of conducting a large-scale powered trial
(Chapter 5).

6.2 Findings and interpretations
6.2.1

Systematic review

The systematic review revealed that prediabetics may experience dysfunction in structural
connectivity compared to healthy age-matched individuals; such deficits included a lower
number of white matter connections and weaker localized connectivity. This is in line with
other DTI research showing that those with T2D exhibit white matter impairments (e.g.,
lower regional FA values)1 and is evidence that prediabetics already experience deficits
exhibited in T2D. Furthermore, the finding that prediabetics experience structural
connectivity deficits, coupled with research showing that resistance exercise benefits the
brain structurally (e.g., results in reduced cortical WMLs),2 highlights the need for studies to
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examine how resistance training may benefit DTI outcomes in older adults at risk for
diabetes.
An additional finding of the systematic review was that volumetric and cerebrovascular
outcomes in prediabetes were inconsistent across studies. As discussed in Chapter 2, this may
be the result of varying T2D diagnostic measures used in these studies. Given that the WHO
and ADA –two well-known health organizations– have conflicting definitions of prediabetes
to some degree, more research should focus on examining how they differ in terms of patient
health outcomes as well as developing a more standardized diagnostic criteria for
prediabetes. Clinically, differences in diagnostic criteria may result in incorrect diagnoses,
which may lead to some people being unnecessarily treated while others do not receive
treatment that is needed. In addition, despite varying study results, one consistent finding in
studies included in the systematic review was that increased blood glucose levels were
correlated with greater neural decline, independent of diabetes status. Importantly, this was
even evident in normoglycemia, suggesting that strategies to improve blood glucose across
all populations should be a health priority.

6.2.2

Pilot randomized controlled trial

Findings from the pilot RCT of resistance training in older adults at risk for diabetes showed
that resistance exercise may improve selective neurocognitive functions. Specifically, it was
found that 26 weeks of progressive resistance exercise may improve task-switching, selective
attention and conflict resolution, and item memory. This is an important finding as executive
function, attention, and memory have all been shown to be impaired in T2D,3 and
prediabetics and/or those who are overweight or obese are at high risk of such impairment.
Moreover, these functions are known to decline with age and are associated with the ability
to perform everyday tasks in old age,4,5 thus preserving them is important to promoting
independent living in later years. Despite these positive findings, however, more studies are
needed to determine the clinical relevance of these potential cognitive improvements, as this
is an area of research that is currently lacking.
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Our pilot study also found that balance and tone training may result in improvements in some
cognitive domains (e.g., working memory) in older adults at risk for diabetes, and thus future
research is needed to explore this possible relationship. As discussed in Chapter 5, one
explanatory theory is that socialization in the balance and tone group may have played an
important, and initially underestimated, role in promoting and improving cognitive abilities.
One study assessing socialization levels in individuals with age-related cognitive
impairments found that social engagement benefits cognition independent of other
nonpharmacological treatments including physical activity and intellectual stimulation.4 The
benefit of socialization was further demonstrated in our study via participant feedback
questionnaires, in which participants expressed that interacting with instructors and fellow
participants was the most enjoyable aspect of the exercise program. Based on these combined
findings, future exercise studies and other lifestyle intervention trials should include a large
social engagement component when possible. Research could also explore the differences
between exercise and exercise plus socialization in older adults at risk for diabetes, in order
to gain a deeper understanding of the possible effects of socialization on the brain in this
population.
In addition to cognitive changes, resistance exercise led to less total brain shrinkage that
occurs with age, and was shown to have a potentially positive effect on HV such that it may
slow down atrophy related to the disease of this clinical population. However, more studies
using inferential statistical measures are needed to confirm these results, as, for example,
previous research has found similar HV results that were not statistically significant.6
Resistance exercise in our trial also resulted in functional activation patterns during an
associative memory task that are seen in healthy populations and may indicate healthier
brains. While these results are promising and mimic previous studies described in Chapter 4,
we are unable to make conclusions about the underlying mechanisms of these findings. For
example, it is currently unknown whether resistance training improves beta-amyloid or IGF-1
levels in older adults at risk for diabetes, both of which are known to occur as a result of
resistance exercise in other populations including healthy older adults.7,8 Evidently, more
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human and animal trials measuring neurotrophic factors and molecular compounds in older
adults at risk for diabetes are warranted. Based on our pilot cognitive findings, future trials
are also needed to examine regional brain volumes in areas that support functions such as
task-switching, selective attention and conflict resolution, including the prefrontal cortex.
Conducting an executive function task during fMRI may also shed light on functional
activation patterns in related areas.
Overall, our pilot findings demonstrate that resistance exercise may benefit a clinical
population of older adults. Importantly, there are several benefits of resistance training that
other types of exercise, mainly aerobic, may not provide older adults. Firstly, as
demonstrated in our study, resistance training improves muscle abilities, and this is known to
promote neurocognition.9 A review showed that changes in muscle function (strength) and
structure (size) were positively linked to changes in brain structure.10 It has also been found
that increased quadricep strength is linked to better performance in global cognition and
executive function in older adults.11,12 Secondly, resistance training is accessible in that most
older adults can perform some form of it. For example, older adults who have lower limb
dysfunction can still participate in upper body strengthening exercises, but may be limited in
aerobic exercise options. Thirdly, resistance exercise is often cognitively challenging during
the learning and performing of exercises, which is often not the case for aerobic exercises
(e.g., running, swimming). Lastly, resistance exercise has been shown to reduce sarcopenia,
which affects up to 40% of older adults worldwide,13 in ways that aerobic exercise does not
(e.g., through improved muscle function).14
Nevertheless, countless studies have found that combining resistance and aerobic exercise to
promote neurocognition is more effective than the use of only one exercise modality. For
example, an RCT in older adults found that a combined training program (high intensity
aerobic and resistance exercise) led to greater benefits in immediate and delayed memory
when compared to aerobic exercise only.15 This may be due to aerobic and resistance
exercise improving cognition and brain health via distinct underlying mechanisms. Studies
have shown that resistance training may improve neural communication, reduce associative
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inflammatory markers, increase IGF-1 levels, and increase peripheral BDNF production.16
Aerobic exercise, however, is known to increase hippocampal levels of BDNF and TrkB
(Tropomyosin receptor kinase B; a receptor of BDNF) and glutamatergic proteins (glutamate
is an important neurotransmitter related to brain function).16 As such, future trials should
assess the effects of a combined aerobic and resistance exercise program on the brain in older
adults at risk for diabetes, and further examine these differing mechanisms.

6.2.2.1

Feasibility

While our pilot study provided important information on the preliminary effects of resistance
exercise on the brain, large-scale RCTs are needed to further explore these findings. As such,
we assessed the feasibility of conducting a large-scale trial in older adults at risk for diabetes.
Our findings showed high attendance and program retention rates, which were even higher
than a previous exercise trial in older adults with T2D (that our study was largely modelled
after).17 In our trial, we allowed participants to exercise with a friend or family member since
previous studies have shown that a lack of social support is a key barrier to physical
activity,18 and this may have led to high participation. Regardless, high adherence and
retention rates, as well as positive feedback received from study participants, is evidence of
the success of the exercise program in our target population. However, recruitment in older
adults at risk for diabetes, particularly those who are prediabetic, was challenging as
expected. Given that many people with prediabetes may be unaware of their diagnosis,
working with medical clinics and physicians in future trials may optimize study recruitment.

6.2.2.2

Applications and implications

Based on our pilot RCT findings, prediabetes and obesity may represent a window of
opportunity to improve neurocognition through a lifestyle intervention, and prevent further
decline associated with T2D. Compared to pharmacological interventions which are often
costly and can have negative side effects, exercise is an excellent cost-efficient and widely
available tool to improve neurocognitive and physical health related to diabetes. For
example, a systematic review and meta-analysis found that exercise was superior to
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pharmacological interventions in reducing visceral adiposity.19 Exercise has also been found
to be better at regulating blood lipid levels and lowering blood pressure compared to drug
interventions.20 Further, these changes in physical function are known to be positively related
to neurocognitive abilities.21,22 Taken together, these findings demonstrate the effectiveness
of exercise as a disease prevention and treatment tool, particularly in T2D and related
complications. Our study findings add to this literature by demonstrating that resistance
exercise, as an alternative to aerobic exercise in older adults, may improve the brain in a
population of older adults who are experiencing decline and are at risk for further decline.
Ultimately, our findings have the potential to help prevent diabetes-related complications and
dementia, and in turn help reduce the global burden that these diseases have.

6.2.2.3

Limitations

It is important to note that our pilot study has several overarching limitations. Firstly, the use
of a single measurement of FPG to diagnose prediabetes is a large study limitation, and may
not be an effective measure of change in glucose overtime (i.e., may have resulted in seeing
no changes in glucose levels following resistance exercise in our trial). Although convenient,
it is instead recommended to use two or more measurements to increase reliability and/or to
collect HbA1c which has been shown to be a better indicator of chronic hyperglycemia.23
However, this would require additional laboratory visits and/or a nurse on staff to draw
blood. Future large-scale studies should incorporate these changes into the study design when
possible. Future trials could also assess whether findings differ if the ADA’s classification of
prediabetes, which has a lower FPG threshold than that of the WHO, is instead used. In
addition, the use of BMI as a measure of obesity has its own limitations. Despite being a
widely used tool, BMI does not take into consideration factors such as muscle mass and bone
density which may affect calculations, and therefore may not be reflective of true body fat
levels. Other measures of body fat that may be more reliable include bioelectrical impedance
and dual-energy x-ray absorptiometry that measures body composition, although these
methods are more costly and resource-demanding. Future trials may consider using more
than one measure of obesity.
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Another study limitation previously described is that participants were not blinded to group
allocation. Allocation concealment helps reduce performance and ascertainment bias, as
knowledge of group assignment can affect trial behaviour and responses to outcomes.24 In the
future, having a physician on staff if possible to provide medical clearance would allow for
double blinding. Additionally, more physical health measures, such as insulin and lipid
levels, may also help shed light on the effects of resistance exercise on functions that are
known to decline in diabetes. Future trials could also assess self-reported barriers to exercise
in older adults at risk for diabetes, as this may help inform recruitment strategies as well as
overall strategies to promote participation in exercise. In line with this, future trials should
consider strategies to promote exercise use after completion of study programs, as it has been
shown that levels of physical activity often drop following the cessation of an exercise trial in
older adult groups.25 Lastly, as discussed in Chapter 3, our pilot results need to be interpreted
with caution as our study was underpowered and did not include the use of inferential
statistics.

6.3 Future directions
In addition to the future studies already proposed throughout this Chapter, research is needed
on the optimal levels, frequency, and type of resistance exercise to achieve positive health
outcomes, as these would help inform exercise guidelines and prescription use. Currently, the
WHO guidelines for resistance exercise are very broad, and merely suggest that adults and
older adults participate in muscle strengthening exercises two days per week.26 Unlike
aerobic exercise that has very specific guidelines, there are no further details as to what
resistance training should entail. This may be especially problematic for adults who are nonexercisers or are unfamiliar with resistance exercise, as they may struggle to incorporate this
type of exercise into their health regimes. Moreover, more research on resistance training is
needed to examine the best dose-response relationship. In our study, we were unable to
decipher the differences between the effects of the specific individual exercises used and the
major muscle groups that were targeted. Further, the majority of exercises were completed
with the use of exercise equipment that may not be accessible to all older adults. Thus, future
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trials should examine the effects of different exercises with emphasis on ones that can be
completed with limited or no equipment.
Based on the findings of our pilot trial, next steps in this research will be to conduct a largescale trial in older adults at risk for diabetes. In line with our pilot sample size calculation,
the recommended size for a main trial with a medium effect size of .80 is at least 34
participants per exercise group.27 Strategies discussed in Chapter 5 will be implemented to
improve recruitment methods as well as exercise study protocols in this larger trial. These
include, but are not limited to, ensuring more consistency in program delivery across groups
where possible to limit confounding variables, introducing the use of an additional blood
glucose measure (HbA1c) and potentially an additional obesity measure, collaborating with
medical health professionals where possible to improve recruitment, incorporating a measure
of disease burden such as QALY, and possibly introducing an executive function task to be
completed during fMRI. In addition, we will consider adding an aerobic exercise training
group to this trial to directly compare the effects of resistance versus aerobic exercise in older
adults at risk for diabetes. Finally, we are currently working to examine the effects of
resistance exercise on DTI measures in older adults at risk for diabetes.

6.4 Conclusion
In conclusion, this thesis demonstrates that 26 weeks of progressive resistance training may
lead to some improvements in cognition and brain health in older adults at risk for diabetes.
Important recommendations for future large-scale trials were provided and will be used to
further assess the effects seen in our pilot study. This thesis also showed that more studies
with standardized diagnostic criteria are needed to assess brain deficits in prediabetes. In
addition to already showing some neurocognitive impairment, individuals at risk for diabetes
are at high risk for both diabetes-related impairments and dementia, and thus more crosssectional and longitudinal research should be conducted in this understudied population.
Finally, given the usefulness of exercise as a brain and cognitive preservation tool, studies
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should focus on incorporating exercise into daily life in a way that is meaningful for older
adults at risk for diabetes as well as other clinical populations of older adults.
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